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Abstract   At the nascent focal adhesion, GTPase Rap1A recruits the adaptor protein RIAM 
(Rap1 Interacting Adaptor Molecule), and RIAM recruits the scaffold protein talin 
facilitating integrin activation (Lee et al., 2009). As the nascent adhesion matures, actin 
linkages are strengthened via recruitment of the talin-actin bridging protein vinculin. In vivo 
data shows that RIAM is not found in mature focal adhesions; furthermore RIAM and 
vinculin occupy the same binding sites within talin (Goult et al., 2013).  This thesis shows 
that RIAM-talin interaction is synergistic, with multiple domains simultaneously 
contributing to the binding. Vinculin and RIAM compete for talin, providing a mechanism of 
RIAM displacement by vinculin as adhesions mature. The interactions are thus 
characterised by a range biophysical techniques. 
  
SHARPIN (Shank associated RH-domain interacting Protein) potentially competes with talin 
for integrin binding (Rantala et al., 2011). SHARPIN interaction with the synaptic protein 
SHANK3 (SH3 and multiple ankyrin repeat domains protein 3) may provide a mechanism for 
SHANK3 recruitment to the adhesion (Lim et al., 2001). This thesis solves the structure of 
the SHANK N-terminal domain that contains the SHARPIN binding region. The structure 
shows the presence of a previously uncharacterised RA (Ras-association) domain that packs 
against the following ankyrin repeat domain. We show the RA domain binds with high 
affinity to the GTPase-Rap1A. Rap1A-SHANK could provide a negative feedback pathway for 
integrin regulation in adhesion. 
 
In the course of adhesion maturation multiple proteins are recruited to the adhesion 
complex; these proteins facilitate linkages to the actomyosin contractile machinery. One 
such protein is DLC1 (Deleted in Liver Cancer 1); DLC1 contains an LD-like motif that is 
homologues to the LD domains of the adhesion protein paxillin (Brown et al., 1996). This 
LD-like motif is responsible for tumour suppressor function and binding to talin (Li et al., 
2011; Cao et al., 2012). In this thesis we characterise the talin-DLC1 interaction using X-ray 
crystallography, and suggest mutations to disrupt the interaction in cell experiments. 
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                            Structural Aspects of focal adhesion dynamics 
1.1 - Introduction The extracellular matrix (ECM) is essential for multicellular 
organisms. Cell-cell and cell-matrix adhesions represent some of the most highly conserved 
signallosomes. Focal adhesions are the focus of this thesis, and adhesion proteins have 
orthologues in organisms as primitive as sponges and slime mould (Dictyostelium 
discoideum). This reflects the crucial role of cell-matrix adhesions in the evolution of 
multicellular organisms (Hynes et al., 2002; Cornillon et al., 2006; Sebe-Pedros et al., 2010). 
The ECM directs cell migration by providing chemokines that dictate cellular differentiation, 
proliferation and migration. An example of such a mechanism exists in wound healing 
where secreted PDGF (Platelet Derived Growth Factor) guides fibroblast and epithelial cells 
for repair (Pierce et al., 1989).  
 
Rap1A-GTPase is a downstream effector of PDGF and the NMDA (N-methyl-d-aspartate) 
receptor, and regulates focal adhesion formation (Pierce et al., 1989; La Fuente et al., 
2004). The effector RIAM is a direct binding partner of GTPase-Rap1A, and is believed to 
regulate adhesions through the recruitment of the cytoskeletal scaffold talin (Lee et al., 
2009). Talin subsequently recruits vinculin to secure actin linkages, and later DLC1 (Deleted 
in Liver Cancer 1) to negatively regulate Rho-GTPase function. 
 
Talin binding activates integrins (Calderwood et al., 2003); where as the SHANK3 binding 
protein SHARPIN inhibits activation (Rantala et al., 2011). SHANK3 can be localised to the 
cell membrane (Durand et al., 2012), and this recruitment is dependent on an unstructured 
N-terminal region (1-100). Thus the purpose of this thesis is to structurally characterise this 
region, suggesting a method of SHARPIN membrane recruitment, by testing potential 
SHANK3 binding partners. 
 
1.1 - Extracellular matrix   The ECM is a composite of proteins and polysaccharides 
that contribute to the structure and function of tissues. There are three major classes of 
ECM component, the collagens, the proteoglycans (e.g. heparin sulphate and perlecan) and 
multi-adhesive matrix proteins such as fibronectin and laminin (Geiger et al., 2001). 
Fibronectins are large (440kDa) proteins that are responsible for multiple interactions. 
Fibronectins interact with collagens and proteoglycans, as well as the cell surface ecto-
domain of integrin heterodimers (Geiger et al., 2001; Hynes et al., 1987). Matrix 
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composition varies with its location in the body and physiological function; this tailors the 
matrix for specific roles (Tanzer 2006). Cues from the ECM are responsible for providing 
appropriate signals that help to regulate tissue specific function. Inhibition of type IV 
fibronectin using siRNA (or anti-fibronectin and anti-integrin antibodies) negatively 
attenuates cleft formation and branching in murine embryos (Sakai et al., 2003). 
Conversely the application of exogenous fibronectin restores cleft formation in murine 
embryos (Sakai et al., 2003).  
1.2 - Cell-cell and cell-matrix junctions Cell-matrix junctions mediate the 
coupling between the actomyosin cytoskeleton and the ECM. Focal adhesions connect to 
the basal lamina, a specialised type of ECM secreted by epithelial cells that consists of 
laminin, fibronectin and perlecan. Focal adhesions function as lamellar signallosomes 
(Kanchanwong et al., 2010) that link the extracellular matrix with the actin dynamics and 
cellular morphology. Actomyosin cytoskeleton indirectly couples to the ECM through 
integrins within the cell membrane and the adaptor protein talin in the cytosol (Burridge 
1983). The talin-integrin complex provides a platform for the subsequent recruitment of 
other signalling proteins, including actin interacting protein vinculin and Rho-GAP DLC1. 
Proteins that indirectly regulate actin dynamics may also be recruited, such as SHANK3, 
Rich 2 and cortactin (Geiger et al., 1980; Durand et al., 2007; Durand et al., 2012; Li et al., 
2011; Cao et al., 2012). 
Figure 1 
 
 Figure 1 - Focal adhesions are multi-protein complexes that dynamically regulate cell attatchments. Proteins, most 
relevant to this study, are highlighted. Integrins form the connection to the extracellular matrix and are linked to 
the cytoskeleton through talin and vinculin.  SHANK3 is a scaffold protein that binds actin, cortactin and the GAP 
protein Rich2. DLC1 is a Rho-GAP protein recruited by talin. 
 
Rho-Kinase(ROCK) 
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1.3 - The Migrating cell Cellular chemotaxis is critical to the growth and maintenance 
of multicellular organisms. Cell migration requires a coordinated locomotion of intracellular 
protein networks within the actomyosin cytoskeleton. In lamellipodia, the initial adhesions 
formed by talin-integrin complexes create traction points that propagate actomyosin 
induced tensile force during migration (figure 2) (Horwitz and Webb, 2003; Plotnikov et al., 
2012). This force promotes stabilisation of the adhesion complexes through the 
recruitment of proteins such as vinculin, indirectly linking integrin and actin (Galbraith et 
al., 2002). In a similar way, scaffold proteins such as SHANK3 are recruited during neuronal 
growth cone formation and dendritic spine formation (Gerrow et al., 2006). Aberrant 
expression of SHANK3 is responsible for a variety of neurological pathologies; furthermore 
in dendritic spines SHANK3 colocalises with vinculin and phospho-paxillin at the end of 
actin tips (Durand et al., 2012).  
Specific proteins contribute to the initiation of the adhesion complex. RIAM (Rap1A 
Interacting Adaptor Molecule) is recruited to the leading edge by Rap1A (La Fuente et al., 
2004; Duchniewicz et al., 2006). In turn, talin is recruited by RIAM, inducing integrin 
activation (Burridge et al., 1983; La Fuente et al., 2004; Calderwood et al., 2002) (figure 3).  
At this early stage integrin inhibitory proteins may also be involved; one such protein is the 
LUBAC (Linear Ubiquitin Chain Assembly Complex) component SHARPIN (Shank binding RH 
domain containing protein). SHARPIN may be recruited to the early adhesion by, as yet, an 
unknown mechanism. This would facilitate a competing pathway to RIAM induced integrin 
activation (Del Rio et al., 2010; Rantala et al., 2011), where talin would be out-competed 
for integrin, and no activation would take place. 
Retrograde F-actin (Fibrous actin) flow is captured by talin, inducing talin stretch and 
vinculin recruitment (De Pasquale & Izzard 1991). Vinculin binds both actin and talin, thus 
coupling talin-integrin complexes to actomyosin (Bloch & Geiger 1980; Sefton et al., 1981). 
As the cell continues to migrate, the nascent adhesions mature in a transition zone 
between lamellipodia and lamellum.  Once mature, the adhesions at the lamellum remain 
stationary relative to the rest of the cell. Integrins at the trailing edge of the cell are 
endocytosed and transported to the leading edge (Caswell et al., 2009). 
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Figure 2 
  
                          
 
 
 
 
 
 
B 
A 
Figure 2 - Stages of cell migration. A) Fibroblast cell migration involves a protrusion of lamellipodia and 
subsequent nascent adhesion formation (1 and 2).  The nascent adhesion engagement with ECM provides 
a focal point of force that leads to enhanced stability (3). The cell continues to migrate, utilising cortical 
myosin contraction to propell the nucleus (4). Endocytosis at the trailing edge recycles integrin (5) 
(Abercombie et al., 1970, Pegrum et al., 1970). B) During neuronal growth cone formation, actin networks 
are responsible for the membrane protrusion in a manner analogous to the migratory fibroblast. 
 
5 
 
Figure 3 
                          
Figure 3 - Adhesion formation at the leading edge. 1) Talin is recruited to the cell membrane and activates integins. 2) Actin linkages are secured via talin and vinculin. 3) SHANK3 and 
SHARPIN may be recruited to the α-integrin tails and compete with talin for the integrin binding. DLC1 is recruited to the mature focal adhesions and negatively regulates actomyosin 
contraction (Li et al., 2011). 
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1.4 - Nascent adhesion formation The formation of the nascent adhesions is 
dependent on the activation of integrin. Integrins are activated by the multi-domain 
protein talin (Calderwood et al., 2003). Talin is recruited to the inactive integrin by the 
adaptor protein RIAM in a Rap1A-GTP dependent manner (La Fuente et al., 2004; Jenzora 
et al., 2005; Han et al., 2006; Watanabe et al., 2008; Lee et al., 2009; Goult et al., 2013; Lee 
et al., 2013). Figure 4 shows the sequence of events resulting in integrin activation; Wynne 
et al (2012) demonstrated that mCherry tagged Rap1A is localised to the cell membrane, 
while RIAM (GFP) has both membrane and cytosolic distribution. Han et al (2006) elegantly 
reconstructed the integrin activation cascade, demonstrating that talin, Rap1A and RIAM 
form an “integrin activation complex”, and that talin recruitment requires the N-terminus 
of RIAM (a short amphipathic helix 6-30) (Lee et al., 2009). Current data have established 
the importance of RIAM-talin interactions, structural basis of which is address in this study. 
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Figure 4 - The early events of the integrin activation are governed by an integrin initiation complex (talin, integrin and RIAM). RIAM recruits talin to the cell membrane through direct 
interactions with Rap1A and talin (Lee et al., 2009). Talin binds to the β-integrin tail, inducing a conformational change and activating the integrin heterodimer. As the cell continues to 
migrate talin binds actin (Gingras et al., 2010) and vinculin. This leads to the adhesion maturation and stress fibre linkages. 
 
Figure 4 
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1.5 - The Integrin clutch mediates adhesion stabilisation F-actin nucleation 
at the leading edge under the regulation of Arp2/3 complex creates a retrograde flow 
(Mullins et al., 2000; Winter et al., 1997) (figure 5). Talin-vinculin complexes at the nascent 
adhesion capture retrograde flow, concentrating actin at the nascent adhesion (Ponti et al., 
2004; Thievessen et al., 2013). Retrograde flow is a continuous process from the leading 
edge; and talin-vinculin interactions provide a mechanism of slippage variation (Mitchison 
and Kirschner et al., 1988; Wang 2007; Gingras et al., 2010). The capture and arrest of the 
retrograde flow by talin generates a counterforce clutch; this clutch uses the initial force 
from nucleation to drive the membrane forward, inducing lamellipodial protrusion. 
Additionally, actin binding induces talin stretch and formation of talin-vinculin complex, as 
well as a recruitment of other adhesion proteins. 
 
As the cell continues to migrate the nascent adhesions increase in size and change 
composition. The adhesion is always stationary, so as the cell migrates the adhesion enters 
a transition zone between lamellipodium and lamellum (Abercombie et al., 1970; Franz et 
al., 2005; Thievessen et al., 2013). Inside this zone some adhesions stabilise into rich multi-
protein complexes, and at this stage actin linkages have developed into cell stress fibre 
linkages. These linkages provide connections to the actomyosin contractile machinery and 
contribute to adhesion maturation (figure 5).  
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1.5.1 - Focal adhesion disassembly   Focal adhesion disassembly is the final stage 
of adhesion turnover.  At the trailing edge, integrins are required to be internalised via 
clathrin dependent endocytosis (and then migrate back to the leading edge via lateral 
diffusion (Bretscher 1992)). Image correlation spectroscopy methods show that integrin is 
clustered at the leading edge, and that lateral diffusion (upon disassembly) of integrin is 
relatively random (Wiseman et al., 2004). For many years the working hypothesis of 
integrin cycling assumed the re-excocytosis of vesicles that were internalised from the 
trailing edge of adhesion.  Recent evidence however suggests that the recycling of integrins 
may be far more specific to the leading edge, and regulated by the Rab family of GTPases. 
Caswell et al (2007) showed the GTPase Rab25 directly associates with α5β1 integrin and 
creates a localised pool of integrin at the leading edge.   
Adhesion disassembly would require the displacement of talin from integrin tails. The exact 
mechanism of this process however remains unknown.  Cytoskeletal microtubule (Nagano 
et al., 2012) networks are believed to deliver and recruit proteins that mediate the 
disassembly process. Disassembly requires the eventual displacement of talin from the 
integrin tail, and multiple proteins are implicated in this process. The first is SHARPIN 
(Rantala et al., 2011). SHARPIN binds α-integrin tails and inhibits the binding of talin to β-
integrin in vivo. SHARPIN recruitment to the cell membrane could be involved in a 
mechanism where talin is displaced in favour of a SHARPIN-integrin complex. Talin is 
further targeted for degradation by calpain cleavage of the talin head, and ubiquitination 
through proteins such as Smurf1 (Franco et al., 2004; Huang et al., 2009, Critchley 2009). 
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1.5.2 - Focal adhesions link to cell stress fibres Linkages between the 
adhesion complexes and actomyosin stress fibres are established within the transition 
zone.  Cell-stress fibres are composed of 10–30 actin filaments bundled in a bi-polar 
arrangement (Tojkander et al., 2012); these bundles are stablised by the cross-linking 
protein α-actinin and non-muscular myosin II (NMII). Myosin rich cell-stress fibres are 
regularly anchored to mature focal adhesions; and provide force for stabilisation 
(Tojkander et al., 2012; Naumanen et al., 2008; Cramer et al., 1997; Pellegrin and Mellor 
2007; Choi et al., 2008). NMII contraction (figure 5B) reveals binding sites in talin and 
induces formation of the talin-vinculin complex (Del Rio et al., 2010).  
The neural growth cone is a migrating, actin-regulated outgrowth of a neuron in response 
to extracellular chemokines, thus actomyosin networks also play a part in the migratory 
process. Retrograde F-actin flow is witnessed both in neural growth cones and during 
growth cone formation, and functions in directed chemotaxis. The myosins (non-muscular 
myosin II) organise actin at the growth cone transition zone, and provide a boundary 
between the lamellipodium and the developing axon (Medeiros et al., 2006). Inhibition of 
myosin II (using the specific inhibitor blebbistatin) decreases retrograde flow by 51% 
(Medeiros et al., 2006). The protrusive polymerising actin-end filaments at the leading edge 
accounting for the remaining actin flow.  
Under inhibition (blebbistatin), filopodial actin bundles elongate, with substantially 
increased actin polymerisation at the leading edge. This is due to decreased rates of actin-
bundle severing near their pointed ends that are located in the transition zone of the 
growth cone (Medeiros et al., 2006). 
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Figure 5 
 
                                                         
 
 
 
 
 
 
Figure 5 - Links between actin networks and adhesion. A) Arp2/3 mediated F-actin nucleation is caught by 
talin. This generates counterforce that induces lamellipodial protrusion. B) Transition zone maturation is 
mediated by the adaptor protein connections to the actomyosin. Cell stress fibres are bundled by 
connections to α-actinin. Non-muscular myosin (NMII) drives actin contraction in an ATP dependent manner. 
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1.5.3 - Rho-GTPase and myosin regulation Non-muscular myosin II is regulated 
by the members of the Rho-GTPase family.  Active Rho-GTPases (RhoA and RhoC-GTP) have 
diverse cellular functions, and are the primary regulators of ROCK (Rho associated Protein 
Kinases) mediated actomyosin contractility (Totsukawa et al., 2004; Tcherkezian and Vane 
2007; Van Aelst and D’Souza-Schorey 1997). The RhoA and RhoC family members act to 
promote actomyosin force generation through ROCK (ROCK1&2), and actin-end 
polymerisation through formin. ROCK phosphorylates myosin light chains and the LIM 
kinases (figure 6) (Rath and Olsen 2012; Gardel et al., 2010), simultaneously promoting 
actin filament stability through inactivation of the cofilin family proteins (Totsukawa et al., 
2004). This process leads to increased actin filament bundling and myosin-driven 
contraction; contractility contributes directly to tension dependent adhesion maturation 
(Itoh et al., 1999; Riento et al., 2003; Ridely 2003). Inhibition of the Rho-signalling cascade 
results in decreased adhesion maturation and shorter adhesion life times (Totsukawa et al., 
2004). 
Figure 6 
 
             
 
 
Figure 6 Rho-GTPases regulates cell stress fibre formation through the regulation of ROCK and formin. 
ROCK kinase phosphorylates myosin light chains, leading to stress fibre formation and contraction. 
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1.5.4 - Focal adhesion kinase and paxillin The activity Rho-GTPases and actin 
dynamics are indirectly regulated by the recruitment of tyrosine kinases to the focal 
adhesion (Parsons et al., 2010). One such tyrosine kinase is focal adhesion kinase (FAK); 
FAK is a FERM (4.1 protein, Ezrin, radixin and moesin) domain containing protein, recruited 
to focal adhesions through interactions with talin or the β-integrin tail  (Parsons et al., 
2003; Lawson et al., 2012).  
FAK and paxillin form a complex at the focal adhesion (Choi et al., 2011); and 
phosphorylation of paxillin by FAK on Y31 and Y118 regulates and enhances lamellipodial 
protrusions (Zaidel-Bar et al., 2007). Overexpression of phosphomimetic FAK (tyrosine to 
glutamate substitution) increases lamellipodial protrusion and nascent adhesion formation. 
Phenylalanine (Y31F, Y118F) mutations result in fibrillar large focal adhesions, consistent 
with a phenotype of contractile cells (Zaidel-Bar et al., 2007).  FAK binds to paxillin via a 
conserved hydrophobic LD motif LDxLLxxL (Hoellerer et al., 2003). In vivo data are in 
agreement with the recruitment of paxillin being responsible for the activation of Rac-
GTPase that controls actin polymerisation (Parsons et al., 2010). 
Interestingly, recent evidence challenges the conventional model of integrin activation. In 
MEF (Mouse Embryonic Fibroblasts) cells cultured on a fibronectin matrix, talin, FAK and 
paxillin colocalised in mature focal adhesions after 15 minutes. In FAK-null cells, talin was 
not localised in the early paxillin rich focal adhesions. In addition talin colocalised with FAK 
in cells expressing integrin Y783A mutant that abolishes talin interactions. This suggests 
that talin can be recruited to adhesions through FAK, independently of integrin 
(Calderwood et al., 2013; Lawson et al., 2012). 
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1.5.5 - The DLC1 Rho-GAP domain    The Rho-GTPases are regulators actin 
dynamics and cell proliferation (Tcherkezian and Vane 2007; Van Aelst and D’Souza-
Schorey 1997). The crucial role of GAPs (GTPase Activating Proteins) lies in their ability to 
negatively regulate the GTPases and promote hydrolysis from GTP to GDP (Hall et al., 
2002). This hydrolysis induces a conformational change, leading to the inactivation of the 
GTPase. The focal adhesion protein DLC1 is held in an autoinhibitory complex between the 
N-terminal SAM (Sterile Alpha Motif) and a C-terminal GAP domain (Cao et al., 2012). Once 
activated by the adhesion protein tensin (Cao et al., 2012) the GAP domain of DLC1 
negatively regulates actomyosin contraction through the change of myosin light chain 
phosphorylation (figures 6 and 7). 
Figure 7 
 
 
 
 
              
 
Figure 7 - The GAP domain of DLC1 is held in the autoinhibitory complex with the SAM domain. 
Autoinhibition is relieved by the DLC1 binding simultaneously to the tensin ABD (Actin Binding Domain) 
and SH2 (Serine Homology) and PTB (Phosphotyrosine Binding) domains. Once active, the GAP domain 
promotes GTP hydrolysis and inactivation of Rho (Li et al., 2004). 
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1.5.6 - Conformational changes in adhesion proteins Over the past decade 
there have been multiple studies characterising proteomic transitions within the focal 
adhesion complex (Schiller and Fassler 2013). Rho-GTPase regulation of the contractile 
machinery and nucleation from the leading edge provide the tension required for talin-
vinculin mediated adhesion stabilisation. Eventual linkages to cell stress fibres provide the 
force required for maturation. This force gradually alters the conformation of talin and 
vinculin within the nascent adhesion (Del Rio et al., 2010; Fillingham et al., 2005; 
Thievessen et al., 2013).   
Talin is composed of an atypical FERM domain, and a rod domain composed of a linear 
array of helical bundles (Winkler et al., 1997) (for more detail see chapter 3). There are 12 
of the rod domains (R1-R12) and the first 6 domains contain multiple vinculin-binding sites 
(VBS), adopting a compact “spring like” arrangement. VBSs are peptide like motifs that 
decorate the inside face of the helical bundles (held cryptic). The compact N-terminal 
arrangement of R1-R6 and the cryptic nature of vinculin binding suggest that talin may act 
as a tensile spring that opens up and reveals VBSs upon stretch. This would amplify vinculin 
binding upon the actin-clutch engagement. 
Single molecule measurements utilising magnetic tweezers to stretch the R1R2 double- 
domain of talin increases vinculin binding (Del Rio et al., 2010; Gingras et al., 2005). 
Furthermore, talin is subjected to cycles of actomyosin contractility, and vinculin 
recruitment to focal adhesions is partially dependent on NMII (Pasapera et al., 2010; 
Margadant et al., 2011). Blebbistatin (a known inhibitor Myosin II ATPase) inhibition of 
NMII prevents adhesion complex maturation, whereas NMII over-expression in CHO 
(Chinese hamster ovary) cells has the opposite effect, with increased mature focal 
adhesions relative0to0nascent0adhesions (Vicente-Manzanares et al., 2008; Vicente-
Manzanares et al., 2009). 
Various recent studies have quantified the levels of tensile force at focal adhesion. Grashoff 
et al., (2010) demonstrated using a FRET (Forster Resonance Energy Transfer) calibrated 
force sensor, that vinculin is both elongated and under tension at the mature focal 
adhesion (Grasshoff et al., 2010).  Du Roure et al., (2005) measured this force by culturing a 
monolayer of MDCK (Madin-Darby canine kidney cells) on elastomeric pillars; force 
measurements at the migratory edges of the cell were in a range between 5 nN and 20 nN 
(Du Roure et al., 2005), the deflection of elastomeric pillars beneath cultured cells allowing 
the force to be calculated. 
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1.6 - Structural aspects of integrin activation The initial events of nascent 
adhesion formation have recently been characterised in vivo and in vitro (discussed section 
3.1.4) (Lee et al., 2009; Han et al., 2006; Watanabe et al., 2008). This section will discuss 
the events of integrin activation beginning with the activation of talin and its recruitment to 
integrin. The key events in this process are shown in figure 8. 
Figure 8 
                                                                                                                                  
  
 
 
 
 
 
 
 
Figure 8 – Integrins are held in their autoinhibitory-closed state by interactions of the α and β sub-units. GTPase 
Rap1A recruits RIAM-talin complex to the cell membrane. This brings the talin head domain (green oval) in 
proximity to the β-integrin tail. PIP2 (Phosphatidylinositol 4,5-bisphosphate) at the cell membrane activates 
talin, and the talin head binds to the β-integrin tail. This induces the conformational change that activates 
integrin. As the focal adhesion matures, proteins such as vinculin and DLC1 may be recruited, securing actin 
networks that bind proteins such as SHANK3. SHANK3 and DLC1 promote direct and indirect interactions that 
help regulation of the Rho-GTPases. 
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1.6.1 – The Rap1A effector RIAM mediates talin recruitment   Recent 
evidence has placed the small GTPase Rap1A (Nagata et al., 1989) central to the regulation 
of integrin activation. Fibroblasts deficient of the Rap1A GEF (Guanine nucleotide Exchange 
Factor) C3G show impaired adhesion and accelerated cell migration. This phenotype can be 
reversed by over-expression of the Rap1A GEF EPAC (Ohba et al., 2001). Cells transfected 
with the Rap1 AE63 activation mutant show similar levels of integrin activation as cells 
overexpressing RIAM when cultured on a fibronectin matrix (La Fuente et al., 2004). 
Activation is inhibited by treatment of cells with the VLA β1 inhibitory antibody, suggesting 
that RIAM and Rap1A share a common interaction pathway (La Fuente et al., 2004). RIAM 
knockdown in primary leukocytes using shRNA depletes Rap1A dependant cell adhesion (La 
Fuente et al., 2004).  
Han et al (2006) and Lee et al (2009) demonstrated that RIAM creates a link between talin 
and Rap1A and is required for the focal adhesion formation (more detail will be given in 
chapter 3). Wynne et al (2012) suggests a mechanism whereby the PH domain of RIAM is 
recruited by Rap1A-GTP and lipid microdomains of PtdIns (4, 5)P2 (PIP2). This establishes 
membrane anchorage of RIAM that subsequently recruits talin to the membrane. 
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1.6.2 - Integrin activation   Integrin activation includes increased integrin 
extracellular ligand affinity, and increased clustering; both of which are dependent on the 
intracellular integrin-talin interaction (Shattil et al., 2010). Integrins are heterodimeric type 
one transmembrane proteins consisting of one α and one β subunit (Hynes 1987). In 
mammalian biology there are currently 18 α-subunits, and 9 β-subunits (Humphries et al., 
2006). Integrin heterodimers are held in the inactive closed state stabilised by the packing 
of α-β transmembrane helices. Point mutations and structural analysis of the integrins 
reveal that the salt bridge between D723 of the αII and R995 of the β3 integrin tails 
stabilises the α-β complex (Lau et al., 2009). 
Talin head binding to the β-integrin cytoplasmic tail is the final event of integrin activation, 
demonstrated both in vitro and in vivo (Han et al., 2006; Lee et al., 2009). Integrins are 
engaged and activated by the talin N-terminal atypical FERM domain. Usually FERM 
domains contain three sub-domains F1-F3; the talin N-terminal FERM domain is atypical as 
it contains four sub-domains F0, F1, F2 and F3 (Elliott et al., 2010). F0 and F1 domains have 
ubiquitin-like fold, F2 and F3 is a phosphotyrosine-binding domain (PTB). 
When talin F3 binds to the membrane proximal region of the β3-integrin tail, a 
conformational change is induced. This conformational change sees the closed in-active 
ecto-domain proverbially open up, thus increasing integrin affinity for extracellular ligands. 
This is considered to be the active state, and the process referred to as inside-out 
activation (Bledzka et al., 2012; Calderwood et al., 2002; Tadokoro et al., 2003; Lau et al., 
2009; Xiong et al., 2001). Conversely, integrins can also participate in the outside-in 
signalling, and the activation can be induced by divalent cations (Ca2+, Mg2+, Mn2+) or 
fibronectin.  Divalent cations and fibronectin bind the integrin ecto-domain and induce the 
same conformational change as induced by the inside-out signalling (Hynes et al., 2002; 
Adair et al., 2005; Nishida et al., 2006; Tiwari et al., 2011).  
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1.6.2.1 - Kindlin and focal adhesion assembly The kindlin family proteins 
(kindlins 1-3) directly bind the membrane distal region of β-integrin cytoplasmic tails, and 
inhibitory kindlin-integrin mutations reduce talin dependent integrin activation 
(Calderwood et al., 2013). This implies that the kindlin–integrin interaction is required for 
the optimal integrin activation (Calderwood et al., 2013). Like talin, kindlins contain a FERM 
domain; kindlin FERM domains differ to talin by the presence of a PH (Pleckstrin Homology) 
sub-domain, adjacent to the F2 sub-domain (Hyvonen et al., 1995) (Figure 9). The kindlin F3 
sub-domain binds to the membrane distal NITY sequence of β-integrin (Bledzka et al., 
2012), whereas the talin F3 sub-domain has higher affinity for the membrane proximal 
NPLY sequence (Calderwood et al., 2013). Current models suggest that kindlin and talin 
may form a ternary complex with β-integrin (Calderwood et al., 2013). Ye et al., (2013) in 
fact demonstrated that kindlins do not affect the affinity of αIIbβ3 for extracellular ligands, 
nor is activation by talin synergistically increased. Membrane distal integrin-kindlin 
interactions increase clustering of the activated integrin heterodimers, thus strengthening 
the focal contact. 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
Figure 9 
 
 
 
 
 
Figure 9 - Schematic representation of the integrin heterodimer. The integrin ectodomain region forms a 
compact inactive complex regulated by interactions of the transmembrane helices. Upon engagement of 
the cytosolic β-integrin NPxY motif by talin, a conformational change is induced. The resulting 
conformation is the open integrin active state. β3 integrin contains two sites that contain the NPxY 
motifs (highlighted in red). These are located in region 760-790 of the human β3 integrin sequence. The 
crystal structure of talin F2F3 in complex with the β3 integrin tail containing the membrane proximal 
NPLY sequence is shown (3G9W). 
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1.6.3 - Talin activation Talin has been shown by cryo-EM to be a globular doughnut 
shaped dimer (Goult et al., 2013). In addition, gel filtration and other electron microscopy 
(EM) studies have shown that talin can have an extended conformation (Kanchanawong et 
al., 2010; Molony et al., 1987). This led to a model that a globular cytosolic talin is recruited 
to the cell membrane where it becomes elongated under tension (Kanchanawong et al., 
2010; Isenberg 1998).  Goult et al (2009) and Goksoy et al (2008) show that talin is held in 
an autoinhibitory complex between the F3 sub-domain and the rod domain R9. The F3-R9 
complex sterically restricts F3-integrin binding, thus inhibiting integrin activation (Goult et 
al., 2009). This complex can be abolished by mutagenesis, and doing so results in increased 
focal adhesion assembly (Kopp et al., 2010). 
The second messenger PIP2 (PtdIns (4, 5) P2) activates talin (Martel et al., 2001); PIP2 binds 
to the talin head F2 sub-domain, and disrupts the F3-R9 autoinhibitory complex (Martel et 
al., 2001; Goksoy et al., 2008). This event could occur at the cell membrane surrounding 
the integrin tail (figure 10) by localised PIP2 synthesis. Tolias et al (1997) showed a direct 
interaction between α3β1 integrin and PI 4-kinase, an intracellular enzyme that controls 
PIP2 synthesis, demonstrating PIP2 regulatory proteins are recruited to integrin. PIP2 
production is catalysed by PtdIns kinase Iγ, and cells lacking PtdInsP kinase Iγ (the talin 
binding isoform) have reduced nascent adhesion formation and reduced talin-vinculin 
recruitment (Legate et al., 2011).  PIP2 interactions with talin are localised to the F2 sub-
domain and the charge reversal mutation (K274E) is inhibitory. Introduction of this 
mutation induces a similar phenotype as the ablation of PtdinsP kinase Iγ; demonstrating 
diminished nascent adhesion formation and reduced talin-vinculin recruitment (Legate et 
al., 2011).   
A secondary effect of the localised increase of PIP2 concentration is the induced formation 
of helical structure in the large insert of the talin F1 sub-domain (Goult et al., 2010). In 
isolation the F1 loop is predominantly unstructured with only a small population in a helical 
state. Upon the binding to the PIP2 enriched membranes, the loop adopts an α-helical 
conformation, with positive charges concentrated on one side of the helix, shortening the 
F1 loop and drawing the talin head to the cell membrane. This interaction re-orientates the 
FERM domain in complex with integrin; the torsional force generated by re-orientation 
disrupts the inner membrane salt bridge of the αIIβ3 integrin and β3 integrin inducing 
activation (Lau et al., 2009; Wegener et al., 2007; Elliott et al., 2010). 
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Figure 10 -  Cartoon representation of inactive talin. Talin is held in an inactive conformation between the N-terminal atypical FERM (consisting of four subdomains F0-F3) domain and the 
R9 talin rod domain. PIP2 activates talin (Martel et al., 2001), and talin is localised to the cell membrane in proximity to integrins. RIAM recruits talin to the leading edge, bringing the 
FERM domain in proximity to both the β-integrin tail and membrane localised pools of PIP2. This activates talin, revealing the F3 sub-domain to engage the integrin tail. 
Figure 10 
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1.7 – The Post-synaptic density The postsynaptic density (PSD) is a signallosome 
mediating the transmission of neuronal signals from the presynaptic density. The PSD can 
be around 200nm-800nm in diameter with a depth of 50nm (Cohen et al., 1977; 
Blomberg0et al., 1977; Carlin0et0al.,01980). This large signallosome, like the focal 
adhesion, links extracellular processes with the actin cytoskeleton.  Figure 11 shows the 
ultrastructure of the postsynaptic density; the density is composed of membrane receptors 
and scaffold proteins. The postsynaptic membrane contains NMDARs (N-methyl-d-
aspartate receptors) and AMPARs (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
receptors). 
Scaffold proteins such as PSD95 and the SHANK proteins are part of a protein network 
beneath the cell membrane receptors (Boeckers et al., 1999; Lim et al., 1999; Naisbitt et al., 
1999; Gerrow et al., 2006); these proteins are amongst the first localised to the 
postsynaptic density with actin (Gerrow et al., 2006), providing the PSD cell surface 
receptors an indirect link to the cytoskeleton through the passive scaffold SHANK3. 
SHANK3 also helps to regulate dendritic spine formation; overexpression of SHANK3 
induces spine head hypertrophy (Sala et al., 2001) and spine formation in spiny cerebellar 
neurons (Roussignol et al., 2005). 
1.7.1 – SHANK family proteins SHANKs (1-3) are multidomain proteins consisting 
of an N-terminal unstructured region, ankyrin repeat domain, SH3 domain, PDZ domain 
and a proline rich linker followed by a C-terminal SAM domain. In vivo there are a plethora 
of tissue specific isoforms; and diversity arises due to multiple intragenic promoters (Wang 
et al., 2011). Mameza et al (2013) demonstrated that mutations within N-terminal 100 
residues of SHANK3 have an effect upon SHARPIN binding, suggesting a regulatory 
mechanism. Pathogenic mutation within the region, L68P, increases the levels of SHARPIN 
binding detected by in vitro pull down. This region was dubbed as the SPN (SHANK Pro/Sap 
N-terminal) region and has been identified previously to be functionally significant by 
Durand et al (2012). Durand et al (2012) demonstrated that the distribution of SHANK3 is 
dispersed between the cell membrane, and large cytosolic pools in COS-7 (a fibroblast like 
cell line) cells. Membrane recruitment of SHANK3 is diminished by the mutations R12C and 
R300C, these residues are also contained within the SPN region and ankyrin repeats 
respectively (Mameza et al., 2013). Structural information on the N-terminal region of 
SHANK is critical for the understanding of SHANK interactions with ligands, and the effects 
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of mutations. 
1.8 – Conclusions and perspectives   Linkages to the actin cytoskeleton provide 
the cell with the means to induce morphological changes in response to extracellular cues. 
In neuronal complexes and adhesions cytoskeleton remodelling is regulated through 
Rap1A. Rap1A provides the ability to recruit talin and subsequently concentrate actin 
linkages at the leading edge through talin-vinculin interactions. In this case, actin binding by 
the talin-vinculin complex provides the cell with an immediate clutch to induce protrusive 
lamellipodia, in a self-perpetuating method of tension dependent self-stabilisation. 
It is clear that SHANK3, like talin, provides a link to actin through downstream signals of the 
PSD. SHANK proteins do not directly signal intracellularly, instead they recruit proteins to 
fulfil this function. In this respect they act as a scaffold in a multi-tiered 
PSD0linking0NMDA0receptors0to0actin. A common feature of both SHANK3 and talin is 
their mutual recruitment of GAP proteins to negatively attenuate stress fibre formation. 
The central actin-binding region of talin binds DLC1, and SHANK3 binds the Rho-GAP 
protein Rich 2 (Raynaud et al., 2013). Thus both scaffolds have the potential to both 
directly0or0indirectly, recruit0and0regulate0actin.00000000000000000000000000000000 
This thesis will elucidate the molecular interactions that govern the leading edge 
recruitment of talin and the stabilisation of the nascent adhesion. Furthermore this thesis 
will study the details of molecular interaction of talin-DLC1, suggesting inhibitory talin 
mutations that may disrupt the binding. SHANK3 binds the integrin regulator SHARPIN, and 
the unstructured SPN region inhibits binding. The structural and biophysical 
characterisation of SHANK is required for the understanding its function.
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Figure 11 
                                  
                       Figure 11 - SHANK proteins act as scaffolds at the postsynaptic density, facilitating the linkage to actin. PSD proteins shown are NMDA (N-methyl-D-aspartate receptor), AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor), PSD-95 (Post synaptic density protein), CamKII (Calmodulin kinase II), Homer and the mGlu (metatropic glutamate receptor). SHANK3 
domain boundaries are shown and are referenced from Pfam (Punta et al., 2012). PDB accession codes (Sterile alpha motif-2F3N) SH3 (Serine homology domain 3-1WA7), PDZ (Post 
synaptic density zonuna occludin- 3O5N) and SPN (SHANK3, ProSap N-terminal domain).  
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1.9 - Aims   Preliminary data demonstrate talin contains multiple binding sites for RIAM 
(see chapter 3); and these binding sites coincide with vinculin binding sites. As of yet the 
extent and affinity of RIAM interactions are unknown, as are the mechanisms of RIAM 
displacement as adhesions stabilise. Thus the aims of chapter 3 are to -  
                         - Characterise the binding sites and stoichiometry between RIAM and talin. 
                         - Characterise the affinities of intermolecular complexes. 
                         - Analyse competition between vinculin, RIAM and talin. 
                        -  Structurally characterise RIAM-talin complexes.   
At the mature focal adhesion Rho-GAP proteins are recruited to negatively regulate the 
contractile actomyosin machinery.  DLC1 is recruited to focal adhesions, and interacts with 
the central actin-binding region of the talin rod. The aims of this chapter 4 are to- 
                         - Determine the specificity of talin-DLC1 interactions. 
                         - Determine the structure of DLC1 complexes. 
                         - Design mutants to abolish the interaction in vivo. 
SHANK3 binds to SHARPIN (a competitive inhibitor of α-integrin); and the unstructured N-
terminal region (1-100) may pack against the ankyrin domain acting as an autoinhibitory 
sub-unit. Thus the purpose of chapter 5 is to - 
                        - Determine the structural basis of SHANK3 autoinhibiton. 
                        - Based upon the structure, test for potential intermolecular             
                          interactions. 
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2 - Materials and methods. 
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2.1.1 - Media   Assume all recipes made up to 1litre (except for antibiotics). 
SOC medium -  20g Bacto Tryptone 
 
                            5g Bacto Yeast Extract 
 
                            2ml of 5M NaCl. 
 
                            2.5ml of 1M KCl. 
 
                            10ml of 1M MgCl2 
 
                            10ml of 1M MgSO4 
 
                            20ml of 1M D-Glucose (after autoclaving) 
  
2YT medium  -  16g  Tryptone, 10g Yeast extract and 5g NaCl. 
2M9 medium, solution  A -  14.6g of Na2HPO4, 5.4g of KH2PO4 and 1g of N
15 ammonium 
chloride (autoclave). 
                       B - 0.1M Magnesium Sulphate 
 
                             7.5 mM CaCl2 
 
                             0.75 mM MnCl2 
 
                             0.25 mM FeSO4 
 
                                             4g Glucose  (2g C
13 D-Glucose) 
  
Solution B was filter sterilised (0.2μM filter) and added to solution A. To avoid isotope 
dilution, the labelled medium was used for the starter culture. 
Luria-Bertani broth - 10g Tryptone, 5g Yeast extract, 5g NaCl. 
Luria-Bertani agar plates- 10g Tryptone, 5g Yeast extract,  5g NaCl, 15g of Agar (antibiotic 
of choice). 
Antibiotics - Chloramphenicol -34mg/ml (1000 times stock), Ampicillin 54mg/ml (1000 
times stock) and Kanamycin 32mg/ml (1000 times stock). 
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 2.1.2 - Buffer recipes 
          Low Imidazole Buffer-       20 mM Na2HPO4, pH 7.4, 0.5 M NaCl , 25 mM Imidazole 
          High Imidazole Buffer-      20 mM Na2HPO4 ,pH 7.4 ,0.5 M NaCl , 0.5 M Imidazole            
          Anion exchange buffer-    20 mM Tris pH 8 (DTT if necessary) 
          Cation exchange buffer-   20 mM PO4 pH 6-6.5 (DTT if necessary). 
          Gel filtration buffer-          20 mM Tris pH 7.4 ,150 mM NaCl (DTT if necessary) 
          NMR sample buffer-          20 mM PO4 pH 6.5, 50 mM NaCl (DTT if necessary) 
                                                          20 mM MES pH 6.5, 50 mM NaCl (DTT if necessary) 
          Crystallisation buffer-        20 mM Tris pH 7.4, 50 mM NaCl (DTT if necessary) 
DTT (Di-thiothreitol (Sigma)) was used to prevent cysteine oxidation and potential 
disulphide bond formation In ITC experiments Tris- (2-Carboxyethyl) phosphine (TCEP) was 
used as an alternative to DTT to improve baseline stability. GTP (Guanosine-5'-
triphosphate), GMPnP (5'-Guanylyl imidodiphosphate) and GDP (Guanosine 5’ 
Diphosphate) were used at 95% purity. 
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2.1.3 - Columns and membranes  5 ml and 1 ml His-Trap (Ni), Hi-trap (QFF and 
SPFF) affinity columns, and analytical gel filtrations (Superdex 75/10 300GL and Superdex 
200/10GL) columns were purchased from GE healthcareTM. For buffer exchanges Hi-Trap 
desalting and Hi-Prep 26/10 desalting columns were used (GE Healthcare). 
2.2 - Molecular biology 
 2.2.1 - Primer design All PCR fragments were integrated into the OPPF (Oxford 
Protein Production Facility) vector suite; all of the vectors share the same restriction sites 
and were linearized using KpnI and HindIII (NEB) restriction enzymes. Primer extensions 
(table 1) were added in the 3’ direction to facilitate integration in the same open reading 
frame as the fusion tag. Primers were designed to enable synchronous primer annealing to 
the template DNA with minimal CG content to prevent secondary structure DNA formation. 
The primers were required to have melting temperatures within 5oC of each other. 
Additionally, primers were required to be non-complementary to prevent “primer dimer” 
formation. Primers for mutagenesis are discussed later. 
 
Table 1 
 
 
 
 
 
 
 
 
 
Vector Name Forward Primer extension Reverse Primer extension 
pOPINS 5’-GCGAACAGATCGGTGGT- 3’ 3’-ATGGTCTAGAAAGCTTTA-5’ 
pOPINF/M/J 5’-AAGTTCTGTTTCAGGGCCCG-3’ 3’-ATGGTCTAGAAAGCTTTA-5’ 
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2.2.2 - Polymerase chain reaction PCR steps were performed using KOD hot start 
polymerase (Novagen) with the following reagents. 
 
    
 
 
 
 
  
Hot start polymerases are bound by an antibody and inactive, the initiation of the PCR 
reaction required pre-incubation for 98oC for 2 minutes, then 95oC for 30 seconds, 47oC 
annealing temperature for 30 seconds (this varied usually 3oC below the lowest melting 
temperature of the annealing primer), and a final 72oC extension cycle. The cycle was then 
repeated 29 times exponentially multiplying the desired DNA fragment. PCR products 
samples were visualised using 1% (w/v) agarose gel (8µg/ml-1 SYBR safeTM made with TAE 
buffer 40 mM Tris-acetate, 1 mM EDTA).  Samples were loaded in a 1:1 ratio with 5× 
Sample buffer (final concentration of 25 mM Tris pH 7.5, 20 mM NaCl, 30% glycerol, 0.1% 
Orange G). Primers are detailed in table 2 and were designed manually from the cDNA 
sequence of a codon-optimised template purchased from Geneart. 
 
 
 
 
 
 
 
Ingredient Volume (µl) 
Q 31.5 
10* Buffer (KOD Hot start). 5 
25 mM MgSO4 3 
dNTP’s(2 mM Each) 5 
30µM Forward Primer 2 
30µM Reverse Primer 2 
Template DNA 0.5 
Polymerase 1 
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Table 2 
Name Sequence 
Melting 
temp 
RIAMF-1Fwd AAGTTCTGTTTCAGGGCCCGATGGGTGAAAGCAGCGAAGA 52 
RIAMF-Tyr1Fwd AAGTTCTGTTTCAGGGCCCGTATATGGGTGAAAGCAGCGAAGA 52 
RIAMF-174Rev ATGGTCTAGAAAGCTTTATTTGGCTTCTTTCAGTTTTTCCA 50 
RIAMF-127Rev ATGGTCTAGAAAGCTTTAGTCATCATCTTCATACTGGCT 50 
RIAMS-1Fwd GCGAACAGATCGGTGGTATGGGTGAAAGCAGCGAAGA 52 
RIAMS-Tyr1Fwd GCGAACAGATCGGTGGTTATATGGGTGAAAGCAGCGAAGA 52 
RIAMS-45Fwd GCGAACAGATCGGTGGTTATAGCGTGGGCTTCAAAGATC 53 
RIAMS-147Fwd GCGAACAGATCGGTGGTGAACCGCTGAGCCAAGAA 50 
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2.2.3 - Site directed mutagenesis Mutations within DNA fragments were 
introduced using overlap extension PCR. Initially 2 PCR fragments were generated with a 
mutation introduced in two complementary overhangs. Complementary primers are shown 
in diagram 1 as Mut-Fwd and Mut-Rev. These two primers overlap in their respective 3’ 
directions with a 12-15bp overhang. The mutation was usually central in this design 
allowing 6 bp either side of the codon mutation to ensure successful hybridisation.  
If the initial PCR was successful, the two fragments were extracted via gel extraction and 
purified using electrophoresis (to remove primers, enzyme and template DNA). The two 
fragments were annealed using wild type forward and reverse primers in a PCR reaction 
under identical conditions as their original PCR. This fragment was then verified by 
electrophoresis and subsequently used for infusion. Primer designs for mutation are shown 
in diagram 1. After successful integration plasmids were sequenced to verify the 
introduction of the mutation. 
Figure 1 
 
 
 
 
 
 
 
 
 
Name Sequence Tm 
MesD4TyrFwd-S GCGAACAGATCGGTGGTTATGGACAGCAAGGACTGGT 52.4 
MesdD4Rev-S ATGGTCTAGAAAGCTTTACTCAGGGTTGGAGGCAAA 50 
MesD4TyrFwd-f AAGTTCTGTTTCAGGGCCCGTATGGACAGCAAGGACTGGT 52.4 
Arginine1523AlanineFwd CCC ACT GCC AAG GCA CAGTTTGTACAGTCAGCCAAGG 55 
Arginine1523AlanineRev CTGTACAAACTGTGCCTTGGCAGTGGGATTGGC 53 
Lysine1530AlanineFwd GTACAGTCAGCCGCAGAGGTGGCCAACAGTACAG 53 
Lysine1530AlanineRev CTCTGCGGCTGACTGTACAAACTGGC 53 
Figure 1 – Overlap extension PCR method primers are listed in accompanying table, the generation of two 
complementary DNA fragments is followed by hybridisation visible on accompanying 1% agarose gel. 
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All plasmids were verified by independent sequencing by either Source bioscience™ of 
GATC ™ using both T7 forward and T7 reverse reads.           
2.2.4 - Restriction double digest Non-linear vector was produced by growth of 
200ml of culture grown to an optical density of 1@600nm at 37oC in LB. This was treated 
with Chloramphenicol (to inhibit protein synthesis) and subsequently maxi-prepped 
(Qiagen). DNA was digested with KpnI and HindIII (NEB); and was purified using gel 
extraction and concentrated. A control blue white screen tested efficacy of digested vector. 
2.2.5 - Ligation independent cloning The method of plasmid generation used in 
this thesis was the ligation independent cloning system developed by ClontechTM. pOPINS is 
derived from pET28a (Invitrogen), generating N-terminal His-tagged Sumo fusion protein 
(Sun et al., 2008). Sumo enhances solubility (Mossessova et al., 2000) substantially 
increases protein yield (Sun et al., 2008). pOPINF is derived from the pTri-ex2 (Novagen) 
series of vectors and contains T7, CMV (cyto magelovirus) and P10 promoter for 
baculovirus expression.  pOPINF encodes an N-terminal His-tag followed by a 3C protease 
cleavage site, and is part of a series of vectors that all share the same infusion site pOPINM 
is an MBP (MalE Maltose binding protein), pOPINJ is an N-terminal His-tagged GST 
(Glutathione-S-transferase) fusion  (Berrow et al., 2007).  
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 A) Overview of the ligation independent cloning procedure using the Infusion advance HD kit 
(Clontech) in combination with OPPF vectors. B) Fusion proteins designs used in this thesis pET151D encodes 
a TEV cleavage site. pOPINS and pETSUMO  both encode an N-terminal Hexa-histidine tagged Sumo fusions,  
and pOPINM an N-terminal hexahistidine Maltose binding protein fusion cleavable by 3C protease. 
A 
B 
36 | P a g e  
 
2.2.6 - Transformation Plasmid DNA (2µl) (purified by mini-prep QIAGEN) (at 
100ng/µL) was added to a vial of chemically competent cells (BL21*(DE3) (Invitrogen) (for 
pOPINS/pET151/15b) and Rosetta 2 pLacI (Invitrogen) (pOPINF/J/M)). pOPINF/J/M cannot 
be transformed into BL21* (DE3) due to the lack of the pLacI element in the plasmid. This is 
compensated for by the presence of the chloramphenicol resistant plasmid within the pLacI 
strain. This plasmid also provides rare tRNAs making this strain ideal for eukaryotic 
proteins. Additionally 1% glucose was added to transformation plates to assist in 
suppression of toxic protein expression. For blue white screening XL1Blue (Novagen) or 
Stellar competent cells (Clontech) were used. Cells were incubated on ice for 30 minutes 
and heat shocked at 42oC for 30 seconds and then cooled on ice for 30 seconds. Cells were 
then incubated with SOC media for 1 hour, spun down at 3000rpm for 30 seconds and 
plated onto agar containing the desired antibiotic resistance selection pressure. 
2.2.7 - Plasmids Talin and vinculin Vd1 were kindly provided by the Prof.D.Critchley’s 
lab at the University in Leiceste. All talin fragments mentioned in this thesis are in 
pET151/D. The vinculin Vd1 domain was provided in pET15b. SHANK3 was kindly provided 
in pETSUMO by Dr Hans Kreinkamp (University Hospital Eppendorf Hamburg). 
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2.3 - Protein expression and purification 
2.3.1 - SDS-PAGE electrophoresis SDS-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) was performed using gels cast using the Bio-Rad Mini-PROTEAN™ III system. 
Generally 10-15% acrylamide gels were poured and consisted of a resolving and stacking 
gel. The resolving gel was formed of 750 mM Tris pH 8.5, 0.1%w/v SDS, 10-15 %v/v 
acrylamide, 0.1 % w/v ammonium persulphate, 0.0004%v/v TEMED. Once poured a layer of 
water saturated isobutanol was added, and removed after polymerisation. The stacking 
gels were formed of 125 mM Tris pH 6.8, 0.1%w/v SDS, 4%v/v acrylamide, 0.02%w/v 
ammonium persulphate, 0.0002%v/v TEMED. TEMED was always added at the end of the 
mixing process to begin polymerisation. Samples were prepared prior to electrophoresis by 
adding sample buffer (10x SDS-running buffer, 3%w/v Tris base, 14%w/v glycine or tricine, 
1%w/v SDS). Samples were boiled for 3 minutes prior to loading and gels were calibrated 
using NEB (10-250kDa) pre-stained protein marker. Gels were stained using 0.4%w/v 
Coomassie Brilliant Blue R250, 50%v/v methanol and 10% v/v acetic acid. Gels were 
subsequently destained in 50% v/v methanol and 10%v/v acetic acid and 40%v/v H20. 
2.3.2 - Protein expression Plasmid DNA was transformed into E.Coli by heat shock. A 
single colony was then taken and grown overnight in a 10ml overnight culture at 37oC.  This 
culture as then grown in 1 litre of 2YT media to an optical density of 0.6@ 600nm at 30oC 
and induced using IPTG at 18oC.  For isotopically labelled proteins 1 colony was taken and 
grown for 8 hours in a 1ml LB culture to an optical density of 1@600nm. 150μl of this was 
then used in a 10ml overnight culture containing 2M9 media. To note this small volume 
was used to avoid the dilution effect of isotopes. This 10ml culture was then grown in 1 
litre of culture at 37oC and induced overnight using 300 IPTG at 18oC. 
2.3.3 - Protein purification Cultured cells were harvested at 5000 rpm for 10 
minutes.  Cells were resuspended in the desired buffer (30ml per litre of culture) of their 
respective purification protocol.  For nickel affinity chromatography cells were 
homogenised at 1000 psi using French press containing cocktail VII protease inhibitors 
EDTA free (Calbiochem) and bovine deoxyribonuclease (Sigma) 20 mM Na2HPO4 pH7.4, 500 
mM NaCl, 25 mM Imidazole (Low imidazole buffer). Cells were then centrifuged at 18,000 
rpm for 30 minutes and subsequently filtered using a 0.22µM filter for FPLC (Fast protein 
liquid chromatography). Proteins were purified on an AKTA purifier FPLC (Fast Protein 
Liquid Chromatography) systems equipped with triple wavelength and peristaltic pump. 
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2.3.4 - Nickel affinity chromatography Cell lysate was loaded on to a 5ml His-
trap HP (GE healthcare) using a peristaltic pump, and loaded at a flow rate of 4ml/min. 
Once bound, the protein was eluted over 10 column volumes using a linear gradient (10 
column volumes) of 20 mM Na2HPO4 pH 7.4, 500 mM NaCl, 500 mM Imidazole (High 
imidazole buffer).  Protein was then dialysed overnight into low imidazole buffer and the 
fusion tag was cleaved at the same time as TEV cleavage. Proteins expressed in pET151/D 
all contained N-terminal His-tags followed by a V5 epitope and TEV protease cleavage site. 
TEV/Sumo/3C proteases were produced recombinantly and removed by a reverse pass 
through the nickel column.  
Sumo protease cleavages differ slightly; the protein and protease mixture was exchanged in 
20 mM Na2HPO4 pH 7.4, 50 mM NaCl, and 2mM DTT. Sumo protease is highly processive; 
theoretically a 3-hour cleavage can be used at room temperature. However to maintain the 
integrity of the protein product proteins in this thesis were incubated at 4oC overnight still 
achieving complete cleavage as judged by SDS-PAGE. Once Sumo has been cleaved the 
sample was exchanged into low imidazole buffer and further purified by reverse pass 
through the nickel column. 
2.3.50- Ion exchange chromatography For anion exchange (QFF) 
chromatography protein was exchanged into 20 mM Tris pH 8-8.5 (2 mM Dithiothreitol if 
cysteines are present). Protein was loaded on to a QFF fast flow (GE Healthcare) column at 
a flow rate of 4ml/min and eluted after a 3CV (column volumes) wash, over a linear 
gradient of 10CV using 20 mM Tris pH 8-8.5 1M NaCl.  When using a cation (SPFF) column 
(GE Healthcare) protein was loaded in 20 mM PO4 pH 6-6.5 (2 mM Dithiothreitol if 
cysteines are present). The column was washed for 3CV and then protein was eluted using 
a linear gradient (10CV) with 20 mM PO4 pH 6-6.5, 1M NaCl.   
2.3.6 - Size exclusion chromatography Gel filtration was always performed using 
20 mM Tris pH 7.4, 150 mM NaCl and 2 mM DTT. Depending on the molecular weight of 
the protein either a Superdex 75 26/60 or Superdex 200 26/30 was used at a flow rate of 
2ml/min. A Superdex 75/26 60 column can resolve proteins ranging from 10-75kDa, a 200 
column can resolve 10kDa and 600kDa (GE healthcare). In analytical experiments buffer 
conditions were kept the same except using a Superdex 75/10 300GL or 200/10 300GL 
column was used at a flow rate of 0.75 ml/min. 
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2.3.7 - Protein concentration Protein concentration was determined by A280nm 
using a nano-drop 3000, and calculated extinction coefficient of respective proteins 
determined by Prot-Param (Gasteiger et al., 2005). For proteins where this method is 
ineffective a Bradford assay was used and calibrated using a control curve of Bovine Serum 
Albumin (0.2mg - 1mg/ml). To confirm Bradford estimates molar concentrations were 
compared with the 1H spectrum of proteins of a similar molecular weight (and tertiary 
fold). 
2.3.8 - Proteases   Recombinant TEV/Sumo/3C proteases were produced from 
plasmids and glycerol stocks provided from Dr Paul Elliott in BL21*(DE3). Cells were grown 
to OD 0.6@600nm and induced using 500µM IPTG at 18oC overnight. Cells were pelleted 
and re-suspended in low imidazole buffer containing 10% glycerol. After nickel affinity 
chromatography protein was exchanged into 20 mM Tris pH 8, 150 mM NaCl, 3 mM DTT, 5 
mM EDTA, 20% glycerol and flash frozen. Activity of each protease was tested with control 
sample and verified using SDS-PAGE. 
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2.4 - Multi-angle laser light scattering SEC-MALLS data in this thesis were 
collected at the SEC-MALLS facility at the University of Manchester. Data was collected 
using a Wyatt Dawn HELEOS-II 18-angle light scattering detector and Wyatt Optilab rEX 
refractive index monitor linked to FPLC system (Amersham). This detector was coupled to a 
FPLC system using a Superdex 75/10 300GL analytical column at a constant flow rate of 
0.75ml/min. SEC-MALLS couples gel filtration with the measurement of molar mass, as 
shown in figure 3.  
Figure 3 
 
         
 
 
 
 
 
 
 
Figure 3 – Experimental set up of SEC-MALLS, analytical gel filtration of a sample is recorded via a MALLS 
detector. Laser light scattering provides information of the molar mass across peak (Mw) and intensity 
(Refractive units). 
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2.4.1 - Isothermal titration calorimetry A standard isothermal calorimeter (ITC-
2000-Microcal) is composed of two identical cells made of a highly efficient thermal 
conducting, and chemically inert material surrounded by an adiabatic jacket (Leavitt and 
Freire 2001). Sensitive inert materials detect the thermal differences between reference 
cells and sample cells, and compensat by reverting to the baseline (figure 4). 
 
Figure 4 
 
                                                                                   
 
 
 
 
 
 
 
 
 
 
 
ITC has been extensively used to study protein-protein interactions and it is considered to 
be the gold standard in the determination of binding constants (Leavitt and Freire 2001). It 
is the only technique that determines directly the thermodynamic parameters of an 
interaction (ΔH and ΔS). Protein-protein interactions induce a change in the solution 
temperatures that is compensated for by the calorimeter in a feedback loop (Leavitt and 
Freire 2001). The stepwise injection of one titrant into the calorimetric cell containing the 
second protein allows measurement of the heat of the reaction for both exothermic and 
endothermic processes (Figure 4). ITC relies on the kinetic measurement of a dynamic 
equilibrium between two interacting proteins (Leavitt and Freire 2001). 
 
                                                                                 
 
The strength of the interaction is reflected in the absolute value of dissociation constant 
which is calculated from Ka and given by 
Figure 4 – Diagram of the isothermal titration calorimeter with accompanying example of an isotherm. The ITC 
machine detects thermal difference between the sample and the reference cells (ΔT). 
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                                                                  and           
 
The free energy of complex formation can then be calculated by  
 
                                                                             
 
Thus both binding constant and thermodynamic parameters and are calculated from the 
ITC data. 
 
2.5 - Crystallisation accessories For the vinculin-RIAM complex, manually 
dispensed 96 well plates designed for sitting drop vapour diffusion were used (MRC plates 
Molecular dimensions). Plates used on the 96 dispensive Inovadyne screen maker were 96 
well intelliplates purchased from ARI. All plates were set up with 80µL of buffer within the 
vapour well. Plate seals were purchased from Starlabs as well as 96 deep well blocks and 
block seals.  Sparse matrix screens employed were always Wizard I and Wizard II (Emerald 
Biosystems), PEGRX I and PEGRX II (Hampton research), JCSG+, AmSO4, PACT, Classics I, 
Classics II, Cryo and Classics Lite (Qiagen).  
2.5.1 - Crystallisation screening  
    2.5.1.1 - The crystal structure of RIAM-vinculin The vinculin Vd1 domain 
was exchanged into 20 mM Tris pH 7.4, 50 mM NaCl and 2 mM DTT. Protein was 
concentrated to 9mg/ml (300µM). RIAM peptide was purchased from Genic BioTM 
1MGESSEDIDQMFSTLLGEMDLLTQSLGVDTLY32 and dissolved in 20 mM Tris pH 7.4, 50 mM 
NaCl and 2 mM DTT. Crystal screens were set up with RIAM in 2-1 molar excess at 21oC and 
4oC. Crystals were optimised as described in chapter 3. 
    2.5.1.2 - The crystal structure of R7R8 and DLC1 R7R8 was exchanged into 
20 mM Tris pH 7.4, 50 mM NaCl and 2 mM DTT. Protein was concentrated to 10mg/ml 
(300µM). The peptide 467PELDDILYHVKGMQRIVNQWSEK489 was synthesised by Genic BioTM 
and dissolved in 20 mM Tris pH 7.4, 50 mM NaCl and 2 mM DTT.  Initial crystal screens 
were set up with peptide in a 4-1 and 8-1 molar excess (1.2 mM) at 21oC and 4oC.  Crystals 
were optimised as described in chapter 4. 
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2.5.1.2.3 - The Crystal structure of the SHANK3 N-terminus SHANK 1-348 
was exchanged into 20 mM Tris pH 7.4, 150 mM NaCl and 2 mM DTT. Screens were set up 
in a 96 well Intelliplate (AIB) designed for sitting drop vapour diffusion 21oC and 4oC. No 
optimisation was required. 
2.5.2 - Data collection Data were collected at Diamond light source on I24 (λ0.97Å), 
I04 (λ0.97Å) or I04-1 (λ0.92Å).  Collection was performed at 100k in a stream of boiled off 
nitrogen to reduce radiation damage. For cryo-crystallography crystals were mounted using 
either litholoops (Molecular Dimensions) or Mitegen micro-loops. For vinculin-RIAM and 
R8-DLC1, crystals were instantly cooled in liquid nitrogen and transferred to magnetic vials 
(Hampton). Cooled vials were transferred to canes and at the synchrotron samples were 
transferred into pre-cooled pucks, which were then transferred to the data collection 
dewar.  For the SHANK structures crystals were stored in pre-cooled pucks that could be 
instantly loaded on to synchrotron robotics without sample transfer thus reducing the 
chances of humidity effecting crystal quality. 
2.6 - NMR experiments NMR experiments were performed on a Bruker avance 
600Mhz and 800MHz spectrometers equipped with cryoprobes. Experiments were 
performed at 298K in 20 mM P04 pH 6.5, 50 mM NaCl. Precompiled pulse sequences for 
HSQC (Bodenhausen et al., 1980) HNCACACB (Grzesiekt et al., 1992), CBCACONH (Grzesiek 
et al., 1992), HAHBNH and HBHACONH (Clubb 1992), HNCO and HNCACO (Clubb 1992) 
were used and data was processed using Topspin 2.1 and CCPN analysis 2.2 (Vranken et al., 
2005). The process of assignment is described chapter 3.  For the calculation of Δδ shift 
values all resonances were arbitrarily assigned and tracked through titration points. 
Combined chemical shift was calculated as Δδ=√ (ΔδH
2+ (ΔδN*0.15)
2) (Williamson et al., 
2013). The top 20 shifts were used to produces the ranges quoted. 
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2.7 - Servers, databases and Programs used in this thesis 
2.7.1 - Sequence analysis 
Uniprot - Used as the source for reference sequences. 
Psi-pred - Secondary structure prediction software (Buchan et al., 2010) 
Phyre 2 - Fold prediction based on PDB depositions (Kelley et al., 2007). 
2.7.2 - Structure validation 
Molprobity - Produces Ramachandran plots and provides bond statistics prior to PDB 
deposition (Chen et al., 2010, Ramachandran et al., 1966). 
POLARFN - Patterson self-rotation function generator.  
2.7.3 - Structure comparison 
PDBefold - Compares supplied structure with existing structure on the PDB for structural 
homology (Krissinel and Hendrick 2004). 
CCP4mg - Generation of diagrams (Mc Nicholas et al., 2011). 
2.7.4 - Data Processing 
Topspin 3.1 - Data collection and processing (Bruker). 
CCPN - (Collaborative computing project NMR) NMR data analysis (Vranken et al., 2005) 
CCP4 6.3 - (Collaborative computing project 4, references individually given in chapters). 
PHENIX 1.2 - Crystallographic data processing suite (Adams et al., 2012). 
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Chapter 3 – Competitive interaction between talin, RIAM and vinculin. 
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3.1. - Introduction Focal adhesions are multi-protein complexes that link the cell to 
the extracellular matrix (ECM). These adhesions are transient with initiation and growth 
phases followed by disassembly. Once mature the adhesions link the ECM to the actin 
cytoskeleton. The linkage to the extracellular matrix is mediated through integrin 
heterodimers, these heterodimers switch between open (active) and closed (inactive) 
states that regulate activity. Integrins are activated by talin the 250kDa cytoskeletal 
scaffold protein. Cytoplasmic pools of talin need to be recruited to the integrin at the cell 
membrane to induce activation.  At the early focal adhesion the GTPase Rap1A recruits the 
adaptor protein RIAM (Rap1 Interacting Adaptor Molecule) and RIAM recruits talin to 
integrins resulting in activation. As the focal adhesion matures actin linkages are 
strengthened by recruitment of the talin-actin bridging protein vinculin.  In vivo data shows 
RIAM is not found at the mature focal adhesions and our data shows that both RIAM and 
vinculin occupy the same binding sites on talin (Goult et al., 2013; Lee et al., 2013; Han et 
al., 2006). Thus the goals of this chapter were to first structurally characterise talin-RIAM 
interactions and then the switching to the talin-vinculin complexes. 
 
3.1.1 - Talin Talin is a 250kDa cytoskeletal scaffold protein containing an N-terminal 
atypical FERM domain (Elliott et al., 2011). The FERM domain is connected via a flexible 
linker containing an unstructured calpain cleavage site to a C-terminal rod domain. The rod 
domain is composed of 62 helices arranged into 4 and 5-helix bundles. The 4-helix bundles 
adopt a left handed up-down twist topology, and the 5-helix bundles follow an up-down 
anti-parallel topology, with the helices typically 23-30 residues in length. The peptide 
sequence of talin is largely alanine and leucine rich with low content of aromatic residues. 
This has the result of facilitating the packing of the 62 α-helices into the compact helical 
bundles that define the rod structure. The six N-terminal domains of the rod are unusual 
given their predicted compact N and C-terminal connections and their high concentration 
of vinculin binding sites (figure 1). The highest concentration of vinculin binding sites are 
localised in the R2R3 double domain and in vivo evidence shows that focal adhesion 
formation requires R2R3 to mature (Goult et al., 2013).  Preliminary analysis by Goult et al., 
2013 shows that RIAM binds to R2, R3, R8 and R11, and figure 1 demonstrates that these 
coincide with vinculin binding sites. 
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Figure 1 
 
 
 
 
 
 
 
 
3.1.2 - Vinculin   Vinculin is a 1066 amino acid protein with 4 N-terminal head (Vh1) 
domains held in an autoinhibitory complex with the C-terminal tail region (Winkler et al., 
1996; Gilmore et al., 1996; Miller et al., 2001). Disruption of this interaction activates 
vinculin (Izard et al., 2004) and this disruption is induced by talin VBS (vinculin-binding 
sites) peptides (Izard et al., 2004). The vinculin Vd1 domain is formed of two consecutive 4-
helix bundles formed of 7 helices (figure 2).  The vinculin tail is a 4-helix bundle and binds to 
the open face of the vinculin head (Vd1 domain) sustaining the autoinhibitory complex. 
Talin disrupts the interaction between the two domains by altering the domain topology of 
the N-terminal bundle of the head into a 5-helix bundle. This is referred to as helical bundle 
conversion and experiments show the binding of talin is enough to induce this process 
(Izard et al., 2004).   
Figure 1 – Schematic representation of the talin rod. The talin rod region domain consists of 13 distinct helical 
bundles with a C-terminal dimerisation domain. The models shown are based on the crystal and solution 
structures of the talin rod fragments. Vinculin binding helices are highlighted in red. RIAM binding domains 
are highlighted in blue (Goult et al., 2013). 
Compact N-terminus                               Extended N-terminal region 
RIAM binding sites 
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Figure 2 
 
 
Figure 2 – Full-length vinculin (1TR2) (Borgon et al., 2004) is held in an autoinhibitory complex between the Vd1 domain (shown in blue), and the vinculin tail shown in orange. Full-
length vinculin is shown in spectrum colours, and highlights the tail domain. When talin binds, the head and tail complex is disrupted and the N-terminal 4-helix bundle becomes a 5-
helix bundle. Topology diagram shows the connections between adjacent helices in the Vd1 domain and the location of the α0 helix. The α0 helix represents one of any of the talin VBS 
helices shown in figure 1 and all bind in the same way (Papagrigoriou et al., 2004). 
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3.1.3 - The MRL proteins The MRL proteins (Mig-10/RIAM/Lamellipodin) are a family 
of adaptors containing Mig-10, Lamellipodin (Lpd) and RIAM (and the Drosophila 
orthologue of RIAM Pico).  Characteristically the MRL proteins contain a central RA-PH (Ras 
Association-Pleckstrin Homology) double domain (Wynne et al., 2012; Depetris and 
Hubbard 2009). This RA-PH (Wynne et al., 2012; Hyvönen et al., 1995) domain shown in 
figure 3 interacts with PIP2 within the cell membrane contributing to recruitment (Wynne 
et al., 2012). The N-terminus of the MRL proteins has no tertiary structure, but instead is 
predicted to contain amphipathic helices (Lee et al., 2009).  The C-terminus of MRL proteins 
contain proline rich repeats (FPPPP) that interact with Ena/VASP homology 1, profillin and 
SH3 binding motifs (La Fuente et al., 2004).  
Figure 3 
 
   
                           
 
 
 
   
 
Figure 3 – Schematic representation of the MRL proteins.  All members of the MRL family contain a tandem 
RA-PH double domain followed by a C-terminal proline rich sequence. The crystal structure of the RIAM RA-
PH domain is shown (Wynne et al., 2012). The RA domain is shown in yellow and PH domain (orange/red). 
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3.1.4 - RIAM is a Rap1A adaptor La Fuente et al., (2004) showed that RIAM over-
expression induces adhesion formation, and that RIAM knockdown decreases Rap1A 
dependant adhesion formation. Han et al (2006) reconstructed the integrin activation 
pathway in cells using αIIbβ3 integrin as the principle receptor.  In that study expression of 
constitutively active Rap1A (G12V) activated integrins independent of PKC (Protein kinase-
C), suggesting that Rap1A is downstream of PKC.  Rap1A dependant integrin activation is 
talin dependent; cells expressing defective talin fail to activate αIIbβ3 integrin (Han et al., 
2006). Rap1A dependent integrin activation is mediated by recruiting RIAM, and this is 
verified by siRNA knockdown that abolishes integrin activation (Han et al., 2006). Therefore 
the MRL proteins RIAM and, possibly, Lamellipodin (Lpd) function as scaffolds connecting 
Rap1A to talin (Lee et al., 2009). 
Lee et al., (2009) showed that the RIAM-talin interaction is dependent on RIAM residues 1-
30. RIAM induced integrin activation is dependent on both the Rap1A-RIAM interaction and 
the RIAM-talin interaction. In this study, integrin activation was assessed using flow 
cytometry measuring PAC1 binding (active integrin antibody).  Integrins were only active 
when both the RIAM RA domain and N-terminus were co-expressed, confirming that both 
regions are required for integrin activation. The 1-30 region of RIAM was identified as the 
principal talin-binding site and was subsequently linked to the membrane targeting CAAX 
motif of Rap1A (by use of a chimera). This fragment was sufficient to localise talin to the 
membrane and activate integrins, bypassing Rap1A dependence. The ability to activate 
talin is shared across the MRL family, as the analogous experiment using Lpd was also 
sufficient to activate integrin (Lee et al., 2009). 
3.1.5 - Chapter Aims RIAM is required and significant for Rap1A dependant focal 
adhesion formation. However there is no structural data on talin-RIAM interactions. Thus 
the first aim of this chapter is to structurally characterise the talin-RIAM interaction, as 
there may be contributions from other regions of RIAM. Furthermore as the focal adhesion 
matures the composition of the focal adhesion changes with RIAM not being present in the 
mature form (Lee et al., 2013). Thus the aims of this chapter will be to biochemically assess 
the competition between RIAM and vinculin for talin. 
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3.2 - Results  
3.2.1 - Design of RIAM fragments TBS1 is a predicted amphipathic helix that is 
required for Rap1A dependant focal adhesion formation (Lee et al., 2009). RIAM fragment 
1-30 (TBS1) contains a region that binds to R2, R3, R8 and R11 (Goult et al., 2013). The 
RIAM N-terminal region (1-174) is unstructured but includes 3 fragments with high helical 
propensity, one of which coincides with TBS1 (figure 4).  Similar to TBS1, helices formed in 
the other two-regions (53-88 and 151-173) would be amphipathic. Therefore these regions 
are good candidates for additional interactions with talin. To test this hypothesis we 
expressed a range of fragments from the RIAM N-terminus. RIAM 45-127 was chosen as it 
includes two potential helical regions and a large region of random coil in the case of 
incorrect prediction. RIAM 1-127 was also selected as it contains all helical regions up until 
147-174. RIAM fragment 147-174 was expressed, as it corresponds to the third helix. The 
location of the hydrophobic residues are shown in figure 4 and highlighted in red.  
Figure 4 
                        
Conf- 987425699999998975442101369999999999999875432246342010013477 
Pred- CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC 
  AA- MGESSEDIDQMFSTLLGEMDLLTQSLGVDTLPPPDPNPPRAEFNYSVGFKDLNESLNALE 
              10        20         30        40        50        60 
 
 
 
Conf- 889999999875545899997653113553356887675578688887789888867667 
Pred- CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC 
  AA- DQDLDALMADLVADISEAEQRTIQAQKESLQNQHHSASLQASIFSGAASLGYGTNVAATG 
              70        80        90       100       110       120 
 
 
 
Conf- 888889999999999999999999999999379999766777889999875511420799 
Pred- CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCEEEE 
  AA- ISQYEDDLPPPPADPVLDLPLPPPPPEPLSQEEEEAQAKADKIKLALEKLKEAKVKKLVV 
             130       140       150       160       170       180 
 
 
N 
C 
Figure 4 - Psi-pred (Buchon et al., 2010) secondary structure predictions of the RIAM N-terminal regions 
1-180. α-helices are represented by cylinders and TBS1 is marked. Hydrophobic residues are highlighted 
in red. 
TBS1 
45 
127 147 174 
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3.2.2 - Expression and purification of RIAM fragments RIAM fragments 
were cloned from a codon optimised template purchased from Geneart to increase yield in 
E.Coli. To increase the chances of successful expression, N-terminal Sumo and MBP fusions 
were used. RIAM fragments 45-127 (8.2kDa) and 147-174 (3.3kDa) were expressed in 
pOPINS that introduces the N-terminal His-Sumo fusion tag. Expressions of Sumo fusions 
proteins have the added advantage of a flush cleavage site with no cloning artefacts, as 
well as increased solubility.  Once fully purified, RIAM 45-127 yielded 8mg/litre from a 
1litre culture grown in 2YT media. RIAM 147 -174 yielded 4mg/litre of a 1litre culture 
grown in 2YT medium. In both cases expression levels provided enough protein to use in 
titration studies.  
RIAM 1-127 was expressed with an N-terminal MBP fusion (pOPINM). MBP is the most 
soluble of the fusion tags and often improves the stability of unstructured proteins. RIAM 
1-127 (13.82kDa) was exceptionally low yield with 1mg/litre in 2YT medium. This protein 
often required the purification of >20 litres of culture to attain a usable yield. Expression in 
2M9 media usually resulted in a 40% reduction in yield. Proteins were shown to be >95% in 
purity as visible by SDS-PAGE electrophoresis, using Tris-tricene gels to improve isoelectric 
focusing of low molecular weight unstructured peptides (figure 5). The data in this section 
established the expression and purification protocols of RIAM fragments for subsequent 
structural analysis. 
Figure 5 
          
 
 
 
 
 
 
 
Figure 5- SDS-PAGE electrophoresis of the purified RIAM fragments using 15% Tris-Tricene gels – RIAM 147-
174 (3.3kDa), RIAM 45-127 (8.2kDa) and RIAM 1-127(13.82kDa). Molecular weight was predicted using 
Prot-param (Gasteiger et al., 2010). Samples were independently verified by mass-spec courtesy of Dr 
Mark Wilkinson (University of Liverpool). The sample of RIAM 45-127 shown in this figure was fully 
assigned in section 3.4. 
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3.2.3 - NMR analysis of RIAM fragments   15N- 1H-HSQC data provides detail on 
the environment of both protons and nitrogen atoms in a macromolecule. The resonance 
distribution on a 1H-N15 2D-HSQC (Bodehausen et al., 1980) experiment provides data on 
the folded state of the protein as well as revealing potential artefacts of protein expression 
including truncations or degradation.  
Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - 
1
H-
15
N HSQC spectra of RIAM fragments. All RIAM fragments are at 100µM and in 20mM PO4, pH 
6.5, 50mM NaCl, 2mM DTT. A) Spectrum of RIAM 147-174, B) Spectrum of RIAM 1-127 shown in blue 
overlaid with Spectrum of RIAM 45-127 in red. Characteristic regions of chemical shifts are indicated by the 
dashed lines. Green lines mark the region corresponding to structured proteins, black lines correspond 
peaks associated with random coils. Spectra were collected at 298k at field strength of 600MHz. 
1H 
1H 
N15 
N15 
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Figure 6 shows the 1H-15N HSQC spectra of RIAM (45-127), RIAM (1-127) and RIAM (147-
174). The HSQC spectra of all fragments show well-dispersed resonances with 1H chemical 
shifts distributed between 7ppm and 9ppm. Well-dispersed NH resonances that have 
diverse chemical shift values are consistent with a folded protein. Wishart et al (1998) and 
Wang et al (2002) show that random coil NH resonances usually have a chemical shift of 
between 8ppm and 8.4ppm (black staggered lines). In an α-helix the hydrogen bonding 
stabilising the helix and the values of Phi and Psi angles will result in an up-field (low ppm 
values) deviation of the 1H resonances from the corresponding random coil values (Wang et 
al., 2002). A significant number of the HN-resonances shifted to the low field are observed 
for all three RIAM fragments (figure 6), suggesting the presence of helical structures within 
the fragments. This correlates well with the secondary structure prediction of figure 3. 
More accurate analysis of the secondary structure within the fragments requires the use of 
13C chemical shifts. 
Comparison of HSQC spectra of RIAM (45-127) and RIAM (1-127) (Figure 6B) shows that 
practically all cross-peaks of RIAM (45-127) either superimpose or are close to cross-peaks 
of RIAM (1-127). This similarity of the cross-peaks positions demonstrates that free RIAM 
(45-127) has a similar conformation as the corresponding fragment within a larger 
polypeptide RIAM (1-127). Small differences between the chemical shifts are likely caused 
by the free amino-group at the N-terminal of RIAM (45-127), which is replaced by the 
peptide bond in the longer fragment. The lack of significant chemical shift differences 
between RIAM (45-127) and the corresponding cross-peaks of RIAM (1-127) demonstrate 
that the 1-44 region does not make any contacts with the 45-127 region in RIAM (1-127). 
The additional cross-peaks in the RIAM (1-127) spectrum correspond to the N-terminal part 
1-44, absent in RIAM (45-127). These resonances have a wide distribution of chemical 
shifts, in agreement with the presence of a helical structure in the TBS1 region (Figure 4).  
In combination, the spectra of RIAM (45-127), RIAM (1-127) and RIAM (147-174) 
demonstrate that all three predicted helical structures (Figure 4) are likely to be stable 
within the polypeptides. These helical regions are independent within the complete N-
terminal region of RIAM, in agreement with the prediction of long stretches of random-coil 
structures between the helical regions (Figure 4).   
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3.2.4 - Multi-site interactions of talin The focus of this study are the talin N-
terminal rod domains R2, R3 and R2R3 (in their native double domain).  This region of talin 
is of particular interest as it contains two RIAM binding domains and four vinculin-binding 
sites (VBSs), two vinculin binding sites in each of the domains. R2 and R3 are linked by a 
short flexible linker (5 residues); their close proximity may suggest a cooperative 
interaction with RIAM. The presence of several regions at the RIAM N-terminus that can 
form stable amphipathic helices suggest a possibility of additional talin binding sites in 
RIAM that could further enhance the interactions.  The overlap with vinculin sites could 
also lead to competitive interactions.  We will address this question by a comprehensive 
analysis of the RIAM interaction with the talin R2R3 region. 
3.2.5 - Talin expression Talin fragments (R2, R3, vinculin and R2R3) were expressed 
and as described in Materials and Methods. Plasmid DNA was supplied by Dr Ben Goult 
(University of Leicester). The proteins were readily soluble and expressed both in nutrient 
rich (2YT) and minimal conditions M9 media. All proteins were expressed with an N-
terminal hexa-histidine tag cleavable by TEV protease.  R2 and R3 gave expression levels of 
30mg/litre per culture and R2R3 yielded 50mg/litre.  
3.2.6 - HSQC experiments in binding studies The 1H-N15 HSQC spectrum 
(Bodenhausen et al., 1980) has multiple advantages for use in binding studies. The chemical 
shift value of a nucleus is sensitive to the surrounding chemical environment. When the 
chemical shift of a nucleus changes in response to a ligand this is the result of a direct 
contact and/or conformational change in the protein on ligand binding. The process of 
binding is dynamic and the involved nuclei are exchanging between different 
environments; this process is referred to as chemical exchange and can be used to describe 
the affinity of interactions.  Consider half-spin nuclei (e.g. 1H or N15) in an amino acid that is 
switching between two isotropic chemical shift values of A (the free form) and B (the 
protein- peptide) complex.  
If the rate of the inter-conversion is slow relative to the differences in the resonance 
frequencies measured in Hz (usually corresponding to exchange rates on a second –high 
millisecond time scales) between free protein and the complex then there will be two sets 
of resonances with different chemical shift values. These resonances correspond to the free 
form of the protein (δA), and the complex (δB). This exchange condition is referred to as 
“slow exchange”. As the system is in dynamic equilibrium then the addition of the ligand 
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will increase the population of the bound state and the intensity of the signals of the 
complex. Normally “slow exchange” regimes correspond to high affinity interactions and at 
equimolar protein-ligand ratio all protein is in the bound state and signals of the free form 
disappear. This is referred to as saturation and further ligand addition has no effect on the 
protein signals. 
In intermediate exchange, the affinity is reduced and inter-conversion becomes more 
frequent and so on the time scale of the pulse sequence there is no favoured 
conformation. In this regime the exchange induces significant resonance broadening and 
line-shape distortion.  If the exchange rate is sufficiently high a single line is observed at the 
chemical shift value defined by wδA+ (1-w)δB ,where w  is the relative  population of A. 
Fast exchange causes spins to experience an effective local field being the average of free 
and the bound states.   A single signal is observed with minimal resonance broadening with 
the chemical shift of wδA+(1-w)δB. In the fast exchange regime where the binding constant 
Kd is relatively high the weighted chemical shift values change can be tracked and fitted 
using the following equation and provide an estimation of Kd. Where y=Δδobs, A=Δδ∞/2, 
B=1+Kd/a and x=b/a. 
 
 
 
        √           
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3.2.7 - HSQC analysis of RIAM fragments The definitions of the exchange 
regimes described can be applied to the talin-RIAM interactions. 15N labelled R2 and R3 
were titrated with RIAM fragments. TBS1 was progressively titrated into 15N labelled R2 and 
15N labelled R3 domains (figures 7 & 8). The progressive titration of TBS1 into R2 resulted in 
low-level overall chemical shift changes with many intensities remaining unaffected. 
However, some peaks have shifted significantly, with additional broadening in some cases. 
TBS1 induces overall low level chemical shift changes ranging from Δδ0.02-0.07ppm. These 
shift changes display low-level intensity changes, and the shift changes increased linearly 
with concentration even at higher peptide excesses (4:1 and 8:1).  In fast exchange the 
deviations from the linearity occurs at ligand concentrations that are close to Kd. The 
maximum RIAM concentration in titrations was 800 μM; linear shift dependence even at 
the end of titration signifies a weak interaction with a Kd > 800μM. 
TBS1 was progressively titrated into 15N labelled R3; addition of the peptide resulted in 
broadening at a 1:1 ratio and the broadened resonance failed to re-appear at higher ligand 
ratios (1:2, 1:4 and 1:8). Figure 7B shows this titration at the 1:2 ratio of R3-TBS1; the 
spectral changes induced by TBS1 binding to R3 are comparable to R2 Δδ=0.04-0.07ppm. 
However, the level of exchange broadening is significantly greater than R2, with many 
resonances becoming undetectable. Initially, the resonances are broadened because the 
corresponding nuclei are exchanging quickly between free and bound forms, corresponding 
to the intermediate exchange. The persistent broadening at the high ligand concentrations 
may be due to the low degree of the binding site saturation, increase of the molecular 
weight of the complex or intrinsic exchange between different bound states. Since the slow 
exchange requires relatively high affinity, the concentrations used at the end of the 
titration should be sufficient to achieve high level of the saturation. The relatively high 
affinity is also supported by the strong broadening detected at low ratios of ligand to 
protein. The increase of the molecular weight would affect all protein signals, while the 
broadening is observed only for a subset of cross-peaks. These considerations suggest that 
the broadening at high ligand ratios is cause by the exchange between different bound 
forms, which persists even at high ligand concentrations. A likely reason for this is the 
peptide binding at different orientations, supported by a nearly symmetric distribution of 
the charged and hydrophobic residues in the RIAM TBS peptide. Significant broadening is 
induced at the peptide concentrations as low as 20 µM and R3 concentration 100 µM, and 
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at 1:1 ratio very strong broadening effect was observed. This demonstrates significant 
population of the bound state, which can only be achieved at with Kd < 100 µM. 
15N R2 and 15N R3 were subsequently titrated to excess with RIAM (45-127) (figure 8). The 
spectral changes induced on R2 are diminished in comparison with TBS1. Figure 8A shows 
R2 in a 1:2 complex with RIAM 45-127, the addition of peptide has induced shift changes 
still relatively that are small Δδ=0.04-0.064ppm.  Many of the resonances do not change in 
intensity with linear shift changes, and some resonances are unaffected by ligand binding. 
Thus we can conclude that RIAM (45-127) is in fast exchange with R2 and the interaction is 
relatively weak with a binding constant Kd>800μM. 
Interactions of R3 with RIAM (45-127) induce similar chemical changes to the TBS1 
interactions. RIAM 45-127 induces similar shift changes to TBS1 of Δδ0.1-0.13ppm. The 
resonance broadening observed suggests intermediate exchange similar to the effects of 
TBS1 with a binding constant Kd<100 μM, similar to TBS1.Although with both TBS1 and 
RIAM 45-127 spectra resonances broaden, some central peaks remain in intensity and are 
subject to no chemical shift changes; these are highlighted (boxes) in figures 7 and 8. As 
these peaks remain unchanged this suggests both domains are still folded on ligand 
binding. 
The above experiments identify the second talin-binding site (TBS2) within the RIAM N-
terminus. Proximity between TBS1 and TBS1 may lead to co-operative or competitive 
interactions between the two domains. 
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Figure07        
       
 
 
 
 
 
 
Figure 7- Superposition of 
1
H-
15
N HSQC spectra of (A) R2 (100µM) and (B) R3 (100µM) (red) 
and spectra in the presence of 2-fold excess of TBS1 peptide (black). Chemical shift changes 
are highlighted with arrows. Peaks with minimal chemical shift changes are marked with 
boxes. Data were collected in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT. Data was collected 
on 600MHz (R2) and 800MHz (R3) spectrometers at 298k. 
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1H 
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Figure 8 
     
 
 
 
 
 
 
Figure 8 - Superposition of 
1
H-
15
N HSQC spectra of (A) R2 (100µM) and (B) R3 (100µM) (red) and 
spectra in the presence of 2-fold excess of TBS2 peptide (black). Chemical shift changes are 
highlighted with arrows. Peaks with minimal chemical shift changes are marked with boxes. Data 
were collected in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT. Data was collected on 600MHz (R2) and 
800MHz (R3) spectrometers at 298k. 
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3.2.8 - RIAM 147-174 does not bind to talin RIAM fragment 147-174 wastested 
for binding to R3 and showed no resonance changes when the ligand was in a 2-1 excess 
(figure 9). There are no resonance shift changes on ligand addition therefore there is no 
interaction and this fragment does not bind to talin. As a consequence the fragment was 
ruled out of subsequent analysis. 
Figure 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Superpositition of 
1
H-
15
N- HSQC spectra of the free R3 (100µM) in red in with the presence of 1:1 
concentration of RIAM (147-174) (black). Spectra were collected in 20mM PO4 pH6.5, 50mM NaCl, 2mM DTT 
at a field strength of 800MHz at 298k. 
1H 
N15 
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3.2.9 - The TBS1&2 does not enhance binding to R2 or R3    So far this 
thesis has described two talin binding sites that have a seemingly higher affinity for R3 than 
R2. As TBS1 and TBS2 are in close proximity, it is possible both regions could act 
simultaneously or cooperative in R3 interactions. If simultaneous, this could imply that 
both sites engage R3 at the same time, either cooperatively (TBS1 and TBS2 are involved in 
allostery), or competitively. To answer these questions both TBS1 and 2 were expressed in 
the same construct (TBS1&2) and titrated into molar excess of both 15N labelled R2 and R3. 
In the TBS1&2 titration to 15N labelled R2 (figure 10A) the resonances shifted to a greater 
extent than for the single RIAM TBS interactions with R2.  Overall, resonances are broader 
and larger shift changes have been induced on ligand addition.  The average weighted shift 
changes Δδ in this interaction range between 0.036 and 0.072 ppm. These shift changes 
(marked) small intensity change relative to the background noise. As general intensity is 
not significantly reduced and the chemical shift changes progress in a linear fashion over 
the full titration range, the exchange is fast exchange and the binding is weak. 
Figure 10B shows the resonance shift changes for the R3-TBS1&2 interaction. The 
progressive addition of TBS1&2 to 15N R3 induces greater exchange broadening at lower 
ligand ratios than the individual TBS1 and TBS2 peptides. The resonances in this interaction 
broadened completely at a 1:0.5 protein: ligand ratio. As the resonance broadening 
observed in this case is significantly enhanced relative to single RIAM fragment interactions 
the chemical shift changes cannot be followed. Some resonances however do remain 
relatively intense and are well defined in low field regions suggesting the domain is still 
folded. Although the more extensive broadening represents a higher affinity interaction, 
the number of the binding sites in TBS1&2 fragment is twice the number of the sites in a 
single TBS, which accounts for the overall affinity increase. Two binding sites in TBS1&2 
could also contribute to the additional broadening due to the presence of a mixture of 
states in exchange with each-other (figure 12). Therefore R3 in a 1:1 complex with TBS1&2 
was compared (figure 11) with R3 in a 1:2 complex with TBS1, and R3 in a 1:2 complex with 
TBS2.  As TBS1&2 contains 2 binding sites one would expect the broadening effects to be 
comparable at 1:1 to a single fragment at 1:2.  Comparison of the spectra reveals the levels 
of spectral changes induced are comparable with selected peaks highlighted showing 
similar shift changes. 
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One can conclude, given the similarity of the changes in the HSQC spectra, that TBS1&2 is 
not binding R3 with higher affinity, rather the R3 binding sites are in exchange with R3 as 
explained in figure 12. 
Figure 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 10 - Superposition of 
1
H-
15
N
 
HSQC spectra of (A) R2 (100µM) and (B) R3 (100µM) (red) and spectra in 
the presence of 2-fold excess of TBS1&2 peptide (black). Chemical shift changes are highlighted with arrows. 
Peaks with minimal chemical shift changes are marked with boxes. Data were collected in 20mM PO4 pH 6.5, 
50mM NaCl, 2mM DTT. Data was collected on 600MHz (R2) and 800MHz (R3) spectrometers at 298k.  
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  Figure011                
 
 
Figure 11 – Superposition 
1
H-
15
N
 
HSQC spectra of R2 (100µM) and R3 (100µM) shown in red.  A) TBS1&2 interaction screen with R3, free protein is shown in red and the 1:1 complex 
shown in black B) 100µM TBS1 (i) and TBS2 (ii) (red) in a 2:1 excess (black) of R3. Similarities in chemical shift change are shown in boxes. Data was collected on 800MHz spectrometer at 
298k in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT.  
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Figure 12 
   
         
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 12 – Possible interactions of TBS1&2 with R3 molecules. Solid lines represent binding and dashed line 
dissociation. 
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3.3 - Chemical shift mapping of TBS2 interactions on R3   One of the 
advantages of the 1H-N15 spectrum is in its use with a full resonance assignment of the 
protein. Protein labelling with 13C and 15N allows transfer of magnetization through peptide 
bonds to reveal the connectivity between the adjacent nuclei. This allows the resonances of 
the backbone atoms of a protein to be traced from the C to the N terminus, and the 
residues assigned based on distinctive chemical shift values and sequence information. In a 
ligand binding experiment this allows the mapping of chemical shift changes to the specific 
residues, providing information on ligand binding. 
The BMRB (Biological Magnetic Resonance Bank) provides a library of both solution 
structures and assignments that are downloadable to users and interpreted using popular 
programs such as CCPN analysis 2.2 (Vranken et al., 2005). The chemical shift values of the 
R3 domain (PDB-2L7A, BMRB 17332) were downloaded. This provides a chemical shift list 
of all assigned spin systems and analysis generates a synthetic HSQC spectrum. These 
artificial peaks are mapped onto the corresponding spin systems of a user acquired HSQC. 
In most cases (and in this case) this was relatively straightforward as the peak lists were 
super-imposable.  Using the data from section 3.6.2, the TBS2 interactions with R3 were 
mapped on to the assigned R3 domain (figure 13). 
The largest chemical shift perturbations (figure 13) are localised to the α2-α3 face of the 4-
helix bundle; as chemical shift changes are the result of a change in the environment then 
this region likely corresponds to the TBS2 binding site. The largest chemical shift changes 
with Δδ > 0.09ppm correspond to Asn811, Glu831 Lys841, F813, I839, A860 and A866. 
Smaller values of shift change with Δδ > 0.05ppm correspond to Gln825, Arg82, Thr833, 
Leu848, Asp865, Glu872 and Lys875. Exchange broadening effects were localised to Ser858, 
Ser859, Ala868, Asp799, Leu836, Gly845 and Glu851. This data show that the α2-α3 face of 
R3 is the RIAM binding site, as chemical shift perturbation is localised to this site and 
dispersed across it with differential values of chemical shift changes and broadening. 
Similar mapping has been observed for the R3 interaction with TBS1 (Goult et al., 2013). 
This demonstrates that both TBS1 and TBS2 bind to the same area on R3, consistent with 
their sequence similarity. In the double TBS1&2 fragment the two-talin binding sites 
compete, causing additional broadening due to the exchange between R3-TBS1 and R3-
TBS2 complexes. 
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Figure 13 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 – Chemical shift mapping for 100µM of R3 titrated with TBS2. Combined weighted shift changes 
are mapped on to the NMR structure; Δδ > 0.11 are shown in black, Δδ > 0.05are shown in red. Residues 
shown in orange have broadened out on the first peptide addition. Residues 794 and 881 are prolines. 
Spectra were collected at 298k in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT with a field strength of 800MHz. 
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3.4 - Sequential assignment of RIAM 45-127    Besides chemical shift mapping 
nuclear assignments can be used for the accurate secondary structure identification based 
on the carbon chemical shifts (Wang et al., 2002). The RIAM 45-127 peptide is large, and 
secondary structure prediction implies that much of the fragment may be a random coil.  
Data of the carbon chemical shift in combination with 15N and 1H shifts will elucidate the 
likelihood of the corresponding spin system to be coil or structured (Wang et al., 2002).  
To assign the amino acid residues of a molecular system a HSQC spectrum is first used to 
initialise what are termed “root NH resonances”.  The corresponding Cα and Cβ within the 
spin system share the same NH shift values. Thus the two are correlated using the through 
bond experiment HNCACB.  Resonances from this spectrum reveal the α and β carbons of i 
(the NH spin system), and these correlate to i-1 resonances and i detected in the 
CACBCONH spectra. The i-1 peaks observed in CACBCONH correlate to observed i 
resonances in a different carbon plane in HNCACB. Eventually you construct a proverbial 
chain connecting all residues from the C-terminus of a protein or peptide. This same 
principle is shared across other spectra. HNCO spectra provide data on i and HNCACO i-1 
and i-1 (of the backbone carbonyls). HBHANH i and HBHACONH i-1 (α and β protons). Once 
the connections between the spin systems are accurately identified then from sequence 
information we can reconstruct the sequence.  
Figures 14, 15 and 16 show characteristic spectra for RIAM 45-127, all of the spin systems 
are well resolved and show intense peaks relative to the noise. The connection between 
Gln79 and Ser 78 is easy to figure out. Serines always have characteristic chemical shifts as 
the β carbon resonance has a larger shift value (ppm) than the α resonance (due to de-
shielding of the β carbon resonance). As the sequence contains only one linkage of this 
type this combination can only be Gln79 and Ser 78 and thus they are assigned.  
92% of TBS2 spin systems were assigned, the remaining 8% are the N-terminal 3 residues 
that typically broaden out due to solvent exange with water. A central 50HHS52 motif was 
not resolvable in the final assignment, figure 17 shows the decrease in intensity 
approaching S52 from the adjacent A53; peak intensity is restored from residue 49 where 
the carbon resonances have returned (figure 17). Intensity decrease and resonance 
broadening in the 50-52 region suggests intermediate exchange between different 
conformational states, most likely due to the histidine rings forming transient hydrogen 
bond configurations. This effect is common is poly-His stretches.  
69 | P a g e  
 
Chemical shift index (CSI) suggests a largely helical polypeptide with regions of helical 
propensity in agreement with secondary structure prediction (Wang et al., 2002, BMRB, 
Psi-pred). The main helical region from CSI are residues 30-49, the carbon chemical shift 
values of these residues show distinct deviation from random coil values (Wang et al., 
2002). There is another predicted helix from residues 20-24, this helix is in proximity to the 
helical region 30-49 and may contribute to the secondary structure. 
 
 
70 | P a g e  
 
Figure 14 
           
 
Figure 14 - 
1
H, C
13
,
 
N
15
 Heteronuclear assignment of RIAM 45-127 showing CBCACONH and HNCACB spectra at their respective 
15
N planes. CBCACONH spectra are shown in purple, 
positive HNCACB peaks are in blue and negative peaks shown in green. Spectra were collected at 298k at field strength of 600MHz in 20mM PO4 pH6.5, 50mM NaCl, 2mM DTT. 
Experimental descriptions are shown adjacent to assignment panel. Connections between i and i-1 are shown highlighted with arrows. Transfer diagrams show observed resonances 
(pink) and indirect resonances (blue) and were taken from Protein NMR.org 
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Figure 15 
1
H, C
13
,
 
N
15
- Heteronuclear assignment showing HNCACO and HNCO spectra at their respective 
15
N planes. HNCO spectra are shown in red, positive HNCACO peaks are shown 
in purple. Data was collected at 298k at a field strength of 600MHz in 20mM PO4 pH6.5, 50mM NaCl, 2mM DTT. Experimental descriptions are shown adjacent to assignment panel. 
Connections between i and i-1 are shown highlighted with arrows. Transfer diagrams show observed resonances (pink) and indirect resonances (blue) and were taken from Protein 
NMR.org. 
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Figure 16 
Figure 16 
1
H, C
13
,
 
N
15
- Heteronuclear assignment of RIAM 45-127 showing HBHANH and HBHACONH spectra at their respective 
15
N planes. HBHANH spectra positive peaks are shown in brown 
negative in cyan. HBHACONH peaks are shown in blue. Data was collected at 298k at field strength of 600MHz in 20mM PO4 pH6.5, 50mM NaCl, 2mM DTT. Experimental descriptions are shown 
adjacent to assignment panel. Connections between i and i-1 are shown highlighted with arrows. Transfer diagrams show observed resonances (pink) and indirect resonances (blue) and were 
taken from Protein NMR.org 
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Figure 17 
Figure 17-Heteronuclear assignment of RIAM 45-127 showing secondary structure prediction based on ΔδH, ΔδC deviations from the random coil values (Wang et al., 2002). Only 
92% of the sequence could be successfully assigned. The stretch 
50
HHS
52
 could not be assigned and are missing.  Decrease in intensity is shown in CBCACONH and HNCACB spectra 
from alanine 53 to the point of return at Gln49. 
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3.5 - RIAM-talin binding is synergistic  
    3.5.1- RIAM binding restricts relative motion of R2 and R3 domains 
The data presented thus far has identified sequential talin binding sites in RIAM, and these 
sites bind both R2 and R3 with comparable affinity (TBS1&2). These talin-binding sites 
cause enhanced broadening effects with either R2 or R3 alone when titrated. Although low 
affinity, R2 does interact with RIAM thus may contribute to an interaction involving both R2 
and R3 in their native double domain. 1H- N15 R2R3 was titrated with TBS1&2 gradually to 
molar excess. The HSQC spectrum of R2R3 is well dispersed with resonances coming from 
both R2 and R3 domains (figure 18).   
Figure 18 
            
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 – Superposition of 
1
H-
15
N- HSQC spectra of 100 μM R2R3 (red) in complex with RIAM 1-127 (black).  
A) 1:0.4 complex of R2R3 with RIAM (TBS1&2); B) 1:2 complex with RIAM (TBS1&2) (black). Spectra were 
collected at 298k at a field strength of 800MHz.  Data was collected in 20mM PO4 pH6.5, 50mM NaCl, 2mM 
DTT. Resonance peaks that have shifted are highlighted. 
1H 
1H 
N15 
N15 
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At a 1:0.4 ratio most of the resonances of the double-domain have broadened out, 
although to a very different degree (figure 18A). A significant number of peaks are 
broadened beyond detection or just visible above the noise level. These signals correspond 
to the R2 peaks with the largest shift changes in R2 or exchange-broadened peaks in R3.  
For the peaks that can be detected, the broadening is accompanied by chemical shift 
change. This group of peaks corresponds to the residues at the binding sites in R2 and R3. 
The second set of peaks shows no shift change and a limited broadening, suggesting that 
the change is caused by the overall reduction in the mobility and not by the conformational 
change or direct contact with RIAM.  
 At 1:1 and 1:2 ratios all cross-peaks show severe broadening effect, with the majority 
below the detection level (figure 18B). This uniform effect on all cross-peaks suggests a 
strong reduction in the rate of overall motion of the R2 and R3 in the R2R3 fragment. If the 
domains retained their relative independent motion, the increase in the molecular weight 
on the complex formation would be insufficient to account for the degree of broadening. 
This suggests that TBS1&2 binding to R2R3 either restricts the relative mobility of the 
domains or cross-link R2R3 fragments. The lack of significant spectra changes after 1:1 ratio 
demonstrate the saturation of the binding sites at the equimolar concentration, 
corresponding to a higher affinity of the interaction than that for the isolated R2 and R3 
domains. 
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3.5.2 - Analytical gel filtration of RIAM-talin complexes – TBS1&2 
interactions with R2R3 enhanced resonance-broadening effects visible by HSQC. As both 
domains broadened out this suggests both R2 and R3 are contributing to an overall 
interaction with TBS1&2.  To test the hypothesis that R2 could contribute to an interaction 
with RIAM analytical gel filtration was first employed.  
If a protein complex is formed with high affinity then it will co-elute with its binding 
partner. The co-elution volume depends on the concentration of the constituent binding 
partners. When a complex is loaded onto FPLC it is diluted 3 to 4 fold. Thus the complex 
eluted is more dilute than the sample loaded, as a result proteins in a complex will 
dissociate during this process.  At a higher concentration there will be less dissociation so 
the complex will have a smaller elution volume. At lower concentration there will be more 
dissociation so the complex will form but have a larger elution volume. 
RIAM-talin complexes were mixed assuming a stoichiometry of 1:1 and were subsequently 
loaded at decreasing concentrations (beginning at 75μM then 37.5 μM and then 18μM) to 
observe complex dissociation.  R2R3-TBS1&2 was the most stable with co-elution observed 
even at 18μM concentration.  At the same concentration R3 and RIAM dissociated and R2 
does not even significantly shift on gel filtration with RIAM (at 75μM). Protein complexes 
are visualised using SDS-PAGE gels that accompany elution traces (figure 19). The data 
reveals that the presence of the R2 domain is reducing the dissociation between talin and 
RIAM TBS1&2. Thus the presence of R2, a domain with low affinity for RIAM is significantly 
increasing the affinity for RIAM in the R2R3 double domain.  
This data thus raises a possibility that perhaps R2 and R3 are required for high affinity 
interaction with RIAM. This is in agreement with HSQC data leaving only stoichiometry and 
the binding constant to be determined. 
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Figure 19 
   
 
      
 
Figure 19 - Analytical gel filtration performed on a Superdex 10/200GL column using 20mM Tris pH 7.4, 150mM NaCl, 2mM DTT. A) R2R3 with TBS1&2 absorbance shown at 280nm 
B) R3 with TBS1&2 absorbance shown at 220nm C) R2 with TBS1&2 absorbance shown at 260nm. 15% SDS-PAGE gels of complex elution profiles are shown and were scanned at 
various levels of de-staining.  Elution fractions are labelled accordingly. In figure C control run of RIAM is shown in green and R2 brown. 
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3.5.3 - Stoichiometry and affinity of talin-RIAM interaction The data in the 
above sections has described how not only does a TBS1&2-R2R3 interactions increase 
broadening by HSQC, but the presence of R2 reduces dissociation on gel filtration. To 
determine both stoichiometry and binding affinity between RIAM fragments ITC 
(Isothermal titration calorimetry) was used as it provides thermodynamic information on 
intermolecular interactions. The binding affinities determined by ITC show R3 binds to TBS1 
with a Kd of 36μM (figure 20), whereas interactions with R2 are at least an order of 
magnitude weaker as determined by the relative chemical shift changes observed in 
section 3.2.7.  In contrast, TBS1&2 has a binding constant observed to be >10 times greater 
than this, Kd=1.82±0.2 μM. The stoichiometry of binding inferred from the data is 1:1 
(n=0.8).  
This stoichiometry was confirmed by use of SEC-MALLS (Size Exclusion Chromatography-
Multi Angle Laser Light Scattering) in figure 20A.  SEC-MALLS provides accurate data on the 
molecular weight of protein complexes in solution, not biased by the shape of the 
molecule.  The molar mass distribution across the peak is 40kDa and this is consistent with 
a 1:1 complex being the sum of the predicted molecular weights of RIAM (TBS1&2) (14kDa) 
and R2R3 (26kDa).  The HSQC broadening observed in section 3.5.1 showed broadening of 
both domains and this is consistent with a hypothesis suggesting both domains are 
involved in the interaction. The interaction between R2R3 is endothermic, with an enthalpy 
increase (ΔH=2.5±0.5kcal/mol) compensated for by the change in entropy (TΔS=10.1±0.6 
kcal/mol); this is consistent with the engagement of a hydrophobic interface. 
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Figure020                      
 
 
 
 
 
 
 
 
 
 
 
 
The data presented here show that the double-domains of RIAM and talin form a high 
affinity complex with a 1:1 stoichiometry. Importantly, the data shows that both domains 
in each fragment (TBS1&2 and R2R3) are required for the high affinity interaction and that 
the interactions between single domains are much weaker.  
 
 
 
 
 
 
Figure 20 - A) SEC-MALLS of 50µM measurements of RIAM (TBS1&2) (red) and R2R3 (green). The complex was 
loaded at 250µM in a 1:1 ratio; the predicted molecular weight is 40kDa. 15% SDS-PAGE gels show the control 
runs and the protein complex. SEC-MALLS was performed on Superdex 75/10 300GL column in 20mM Tris pH 
7.4, 150mM NaCl, 2mM DTT. B) 5mM TBS1 titrated into 500μM of R3 C) 180μM TBS1&2 titrated into 18μM of 
R2R3. All ITC experiments were performed in 20mMPO4 pH6.5, 50mM NaCl and 0.05mM TCEP; titration was 
conducted with 2µL injections with 180-second intervals. Experiment C was performed in duplicate for error 
estimates. 
Kd=1.82µm 
n=0.8 
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3.6 - Regulation of the talin-RIAM interaction by vinculin  RIAM and 
vinculin both bind to the same domains on the talin rod. Del Rio et al., (2010) showed that 
the unfolding of the R1R2 double domain increases vinculin binding. This unfolding of the 
tertiary structure is believed to reveal the VBSs buried in the hydrophobic core of the 
helical bundle. The individual helices then engage the Vd1 domain, inducing helical bundle 
conversion (Goult et al., 2013; Gingras et al., 2010; Del Rio et al., 2010; Izard et al., 2004). 
Goult et al., (2013) showed through stabilisation (by introduction of hydrophobic residues) 
of the R3 domain, vinculin binding is reduced; yet RIAM binding is unaffected. These data 
suggest that the modes of binding are incompatible - RIAM requires a folded domain, and 
vinculin needs an unfolded domain. 
The R2 and R3 domains contain 2 vinculin bind sites (Patel et al., 2006; Gingras et al., 2010). 
The residues involved in vinculin interactions are part of the hydrophobic core of R2 and R3 
(Gingras et al., 2010). This concept is explained in figure 21; vinculin-binding helices must 
form hydrophobic contacts with vinculin, and not the core of cognate bundle. 
 Figure 21 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 – To reveal VBS R3 helices need to be extracted from the 4-helix bundle they form. In the folded 
domain they form part of the hydrophobic core. But these residues (labelled in red) also mediate vinculin 
binding. The vinculin Vd1 domain is shown in blue. 
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Therefore, in this study SEC-MALLS was used to examine how R2R3 stability relates to VBS 
availability. The vinculin Vd1 domain was expressed in BL21*(DE3) and gave a yield of 
60mg/litre of culture in 2YT medium and was expressed and purified as described by 
(Papagrigoriou et al., 2004).  
 SEC-MALLS provides the opportunity to detect the molecular weight of a complex as it 
elutes from an analytical gel filtration column (Superdex 75 10/300GL in this case). 
Molecular weight is observed as the molar mass distribution across the elution peak, and 
this allows the real time determination of molecular weight. The vinculin Vd1 domain has a 
molecular weight of 31.5kDa and R2R3 26kDa. SEC-MALLS was performed with the Vd1 
(125µM) in 5 molar excess of R2R3 (25µM) both at room temperature (21oC, black line) and 
again with 10 minutes pre-incubation at 40oC(red line). All elution profiles were visualised 
using SDS-PAGE electrophoresis (figure 22).  
At 21oC the molar mass distribution across peak 2 shows an 80kDa complex, this 
corresponds to a 2:1 Vd1 (63kDa)/ R2R3 (26kDa) complex. This implies that two of the four 
VBS in R2R3 are available for binding. Excess of vinculin is visible as a 31.5kDa protein (3). 
After the pre-incubation at 40oC there are two dominant peaks (1 and 2).  Peak 1 has a 
molar mass distribution of 160kDa and peak 2 80kDa. The 160kDa complex represents a 4:1 
complex between Vd1 (126kDa) and R2R3 (26kDa).  
One of the most engaging trends of research regards the nature of vinculin binding to talin. 
Although there is a correlation between instability and binding (Del Rio et al., 2010), the 
exact mechanism of this binding remains to be determined. If we use R2R3 as an example 
this point is highlighted. The α1 and α4 helices of R2 bind vinculin as do the α2-α3 helices 
of R3, with residues key to the interface held cryptic within the hydrophobic core of the 
protein.  
Figure 21 illustrates that vinculin binding involves unfolding, thus in the 2-1 complex (2) 
either R3 is saturated by Vd1, or R2 is (as to achieve 2-1 one domain must be unfolded). 
The 2-1 complex still remains intense at both 40oC and 21o. Thus it could be hypothesised 
that the saturation of one domain results in the reduced stability of the other. Combined 
with thermal denaturation the 2-1 complex may have a priming effect facilitating the 
formation of the 4-1 complex. 
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Figure 22 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
Figure 22- SEC-MALLS measurements performed on Superdex 75/10 300GL in 20mM Tris pH 7.4, 150mM 
NaCl, 2mM DTT, Samples were loaded at 25µM R2R3  with the Vd1 in 5 molar excess. The black line 
represents the experiment at room temperature and in red pre-incubated complex at 40
o
C. The 
accompanying SDS-PAGE gels show R2R3 (26kDa) and Vd1 (31.5kDa). 
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3.7 - RIAM and vinculin compete for talin RIAM and vinculin are not found at 
focal adhesions simultaneously (Lee et al., 2013; Goult et al., 2013). RIAM and vinculin also 
bind to R2R3 (Goult et al., 2013). Thus there may be a structural mechanism of switching 
between the two complexes.  To examine the hypothesis of competition between the three 
ligands, analytical gel filtration was used.   
To provide the control elution volumes for each component, 50 μM of each individual 
protein was used. These control elution profiles are shown in figure 23, RIAM (TBS1&2) 
(red), R2R23 (black) and Vd1 (Green). Next binary complexes were tested for and these are 
formed between R2R3-RIAM (TBS1&2) (pink), R2R3 and Vd1 (light blue).  
To test for competitive interactions an equimolar sample of all three proteins was loaded 
(blue). This shows an elution profile consistent with a lower molecular weight complex. If 
there was a ternary complex then the elution profile would be consistent with a complex 
larger than R2R3 and Vd1 (light blue). If RIAM was displaced there would be a peak 
corresponding to free RIAM (TBS1&2) (red) and the R2R3-Vd1 (light blue) complex.  As 
there is no direct displacement then it may be the case that all three proteins within the 
sample bind to each other with a relatively high affinity. Therefore the peak may be a 
mixture of talin-RIAM complexes and RIAM-vinculin complexes. As there is no displacement 
in favour of a vinculin-talin complex, then this experiment also implies that vinculin is 
binding talin weaker than RIAM. 
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Figure 23 
                     
  
 
 
 
 
 
Figure 23 - Analytical gel filtration using a Superdex 75/10 300GL in 20mM Tris pH 7.4, 150mM NaCl, 2mM 
DTT. Analytical gel filtration of RIAM (TBS1&2), talin and vinculin (Vd1), all were loaded at 50 μM, the R2R3-
Vd1 domain complex is shown (light blue), vinculin (green), TBS1&2(red), R2R3 (black), R2R3 and TBS1&2 
(Pink), equimolar complex of proteins (dark blue). 15% SDS-PAGE gel accompanying showing the elution 
profile of the talin-RIAM-vinculin complex. 
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3.7.1 - RIAM and vinculin interaction   Section 3.7 shows that talin, RIAM and 
vinculin compete with each other for interactions. Therefore the analytical gel filtration of 
vinculin and RIAM (TBS1&2) was performed. The elution profile of the proteins in an 
equimolar sample shows a shift in elution profile consistent with an increase in molecular 
weight. SDS-PAGE electrophoresis confirms that this peak contains a vinculin-RIAM 
complex.  
The vinculin binding helices in talin are amphipathic, as shown in figure 20 (Gingras et al., 
2010; Izard et al., 2004). Thus they may have similar structural properties as TBS1, another 
predicted amphipathic helix. Thus TBS1 was tested using ITC to confirm binding to the Vd1 
domain. The ITC for vinculin-RIAM (TBS1) interaction was performed, showing a Kd =3.7µM. 
In comparison, Vd1 domain interacts with the VBS from R3 with a Kd = 800nm.  
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Figure 24 
 
               
 
Figure 24 – A) Analytical gel filtration using a Superdex 75/10 300GL column in 20mM Tris pH 7.4, 150mM 
NaCl, 2mM DTT. Proteins were loaded at 50μM and visualised using 15% Tris-tricene SDS-PAGE gels. ITC was 
performed in 20mM Tris pH7.4, 150mM NaCl, 0.05mM TCEP at 35
o
C B) Vd1 (40μM) was titrated with a talin 
R3 VBS peptide (820‐844) (2mM) using 0.75 μL injections. C) TBS1 (800µM) from RIAM at 35
o
C titrated in 60 
µM of the Vd1 domain using 2µL injections. Data were fitted with a 1-site model. 
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Comparison of the isotherms reveals a substantial difference in binding constants. The talin 
VBS (820-844) engages the vinculin Vd1 domain with 5 fold high affinity than the RIAM 
(TBS1&2) peptide. The RIAM TBS1-Vd1 interaction shows ΔG= -7.5kCal/Mol with an 
entropy driven interaction (ΔH=-1.5 kCal/Mol and TΔS=5.8 kCal/Mol). The VBS peptide 
binds Vd1 with the interaction that have comparable contributions from both enthalpy and 
entropy with (ΔH=- 5.8 kCal/Mol and TΔS=2.7kCal) and ΔG =-8.5kCal/Mol. This data suggest 
that the Vd1-R3 peptide is a more favourable interaction than TBS1-Vd1. In the R3 domain 
however the VBS are cryptic and an energy barrier of unfolding must be breached before 
engagement of the interface. Therefore a comparison of peptide binding curves is not a fair 
comparison between the competing binding partners. 
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3.8 - The crystal structure of the RIAM-vinculin complex To examine the 
hypothesis that TBS1 may be amphipathic and bind the Vd1 domain in an analogous 
manner to talin the structure of the complex was resolved. 
 3.8.1 - Protein crystallisation For crystallisation two drops were set up one of the 
vinculin-RIAM (TBS1) complex and the other free of peptide (TBS1). This would provide a 
negative control against false hits and maximise the chance of crystallising the complex. 
Crystals were achieved in 1.2M Ammonium sulphate, 0.05M Tri-sodium citrate 3% 
Isopropanol after 3 weeks at room temperature (figure 24A). Optimisation varying 
ammonium sulphate concentration (0.8-1.2M Ammonium sulphate) attempted to achieve 
less clustered crystals. This yielded crystals again in 3 weeks under identical conditions as 
the initial crystal screen with a slight variation in morphology (figure 24B). 
Figure 24 
  
 
 
 
 
 
    
 
3.8.2 - Data collection The crystals were vitrified in 20% glycerol and 10% 
Isopropanol; this was the only successful cryo-conditions all others attempted failed to 
yield high quality data.   Data were collected to 2.3Å at a λ0.97Å; data were collected over 
180o with a non-overlapping 0.25o oscillation width on a PILATUS 6M detector. The crystals 
shown in figure 24B provided data that could not be integrated. The crystals from figure 
24A provided data used for structural determination. The data is of high quality showing 
respectable Rmerge values (0.87) and I/σ (3). 
Figure 24- Diffracting crystal form of the vinculin-RIAM comple. Both crystals A and B were grown in 1.2M 
Ammonium Sulfate, 0.05M Tris Sodium citrate, 3% Isopropanol. 
p21212 2.3Å 
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3.8.3 - Structural determination  Data were integrated in MOSFLM (Elmsely et al., 
2007), processed using POINTLESS (Evans and McCoy et al., 2006) and, based on systematic 
absences data, were indexed in P21212.  Molecular replacement in PHASER (Mc Coy et al., 
2007) used the non-bound Vd1 fragment from the template 1XWJ.pdb and the solution 
was found in P21212 (Gingras et al., 2010). Data were re-integrated and scaled in P21212 and 
yielded PHASER scores of TFZ=25.0 and LLG = 1281, indicating the correct solution.  
 The un-refined F0-FC   map showed the presence of the RIAM peptide in the same binding 
site as the VBS3 peptide from the template structure (figure 25). Upon refinement and 
model building at 1σ the entire peptide was visible (figure 25). Atomic models were built 
using COOT (Elmsely and Cowtan 2004) which on refinement revealed side chain detail of 
the peptide. The presence of the C-terminal flexible loop (highlighted) confirmed the 
registry of the peptide.  
 Data was refined using PHENIX.refine (Adams et al., 2002). Water molecules were added 
using COOT (Emsley and Cowtan 2004) and PHENIX at positions where peaks were greater 
than 1.0 σ in the 2Fo-Fc weighted map and greater than 3.0 σ in the mFo-Fc weighted 
difference map. Model validation was performed as part of the refinement using PHENIX 
and the Molprobity (Chen et al., 2010) web servers. The refined crystal structure was 
deposited to the PDB (ID 3ZDL) prior to publication. Data collection and refinement 
statistics are shown in table 1.   
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Figure025 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1σ 
Figure 25 - Difference mapping of RIAM 1-32 on the vinculin head domain A) 2F0-FC map at 1σ shown in blue 
and F0-FC map at 3σ of molecular replacement solution B) Refined 2F0-FC map of RIAM 1-32 in complex with 
the Vd1 domain. The Vd1 domain is shown with a surface charge representation blue showing positive 
charges and red negative, white regions are uncharged. C) Refined 2F0-FC map of RIAM 1-32 in complex with 
the Vd1 domain. The C-terminal flexible region is resolved confirming registry of the peptide. 
 
 
C 
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Table 1 
Data Collection                          
Beamline I24(0.97Å) 
Space Group p21212 
Cell Dimension 
                     a,b,c (Å) 51.73,70.03,95.6 
                    α ,β,γ (o) 90,90,90 
Resolution (Å) 56.49-2.3 
Rmerge 0.151(0.872) 
 
0.989(0.656) Mn(I) half-set correlation 
CC(1/2) 
I/σI  15.4(3.1) 
Completeness (%) 100 
Redundancy 5.6(5.5) 
Refinement   
No. reflections 16055 
No. atoms 
                      Protein 2261 
                     Water 57 
B factors (Å2) 
                      Protein 28.9 
                     Solvent 27.3 
RMSD(bonds Å) 0.008 
RMSD(angles o) 1.09 
Rwork 18.81 
Rfree 22.98 
 
 
                          
 
 
 
 
 
Table 1 - Summary of data reduction statistics for Vinculin-RIAM in p21212 . Rmerge = hkl[ i Ihkl,i - 
<Ihkl> ]/ hkl,i<Ihkl>, where Ihkl,i is the intensity of an individual measurement of the reflection 
with Miller indices h, k, and l and <Ihkl> is the mean intensity of that reflection. R =Σhkl ||Fo (h, 
k, l)| - |Fc (h, k, l)||/ Σhkl |Fo (h, k, l)|. Rfree is defined as R calculated on a random 5 % non- 
refined data 
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3.8.4 - The RIAM-vinculin complex in P21212 The crystal structure of RIAM- 
vinculin complex was solved with one Vd1 domain and one RIAM peptide in the 
asymmetric unit (solvent content 55.6%). Residues 1-256 of the Vd1 domain were resolved 
excluding the N-terminal his-tag and two C-terminal residues. This is also the case for the 
N-terminal six residues of the RIAM peptide.  The RIAM peptide is occupying the same 
region on the Vd1 as all other established Vd1 binding partners (Izard et al., 2004, Gingras 
et al., 2010).  The peptide inserts into a hydrophobic groove between the α1-α2 helices on 
the Vd1 domain. The C-terminal helical bundle remains identical in both free and bound 
structures of vinculin and as to date has no established binding partners. 
Figure 26 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 – The crystal structure of RIAM with vinculin, surface charge representation of vinculin head in 
complex. Red represents negative charge, blue positive charges and in white no charge. 2F0-FC (blue) at 1σ 
map of the RIAM peptide that contact the Vd1 domain. 
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Figure 27 
 
 
 
 
 
 
 
 
               
 
Figure 27 – RIAM induces a conformation change in the Vd1 domain. PDB-1RKE (Izard et al., 2004) shows the crystal structure of the Vd1 domain from the vinculin head-tail complex. In 
this form the N-terminal 4-helices form a bundle bundle between the α1-α2-α3 and α4 helices, upon RIAM binding there is a conformation change in this 4-helix bundle facilitating the 
engagement of the RIAM peptide. 
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RIAM changes the conformation of the Vd1 domain upon binding by forming hydrophobic 
contacts with the Vd1 domain.  Figure 27 shows this conformational change, the α1-α2-α3 
and α4 helices that in the Vd1-vinculin tail (blue) complex adopt a 4-helix bundle. Upon 
RIAM binding, the conformation changes, with the pitch of helices (of the initial 4-helix 
bundle) changing facilitating the formation of a 5-helix bundle. 
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3.8.5 - Comparison of vinculin-RIAM with the vinculin-VBS3 complex 
Superimposition with the template structure of the Vd1 domain in complex with VBS3 
demonstrates positional differences talin and RIAM in complexes with vinculin.  Figure 28 
shows a structure of the Vd1 domain in complex with the VBS3 helix from talin. As with 
VBS3 there are 8 residues involved in the hydrophobic contacts that engage the core of the 
Vd1 domain. Structural based sequence alignment of RIAM and VBS3 highlight sequence 
similarity and differences. Marked in yellow are differences between the vinculin binding 
consensus sequence, and in green are residues that are similar. RIAM is different to VBS3 as 
it contains large hydrophobic side chains such as F12 and M19 in positions that in talin are 
occupied by A1954 and V1961. The large hydrophobic moieties displace the RIAM helix 
from the surface of the Vd1 domain relative to the VBS3 peptide (figure 28). It is possible 
that the lengths of the hydrophobic side chains are the cause of differences in the binding 
constants; however this hypothesis needs verification by mutagenesis (figure 28). 
 Figure 28 
  
 
Figure 28 – The crystal structure of RIAM (Cyan) with vinculin (Green) structurally aligned using PyMol with 
template structure PDB-1XWJ, with the VBS3 peptide shown in purple. RIAM is displaced from Vd1 by a large 
phenylalanine side chain. Structural alignment of VBS3 and RIAM is shown; residues that follow VBS 
consensus are highlighted in green and differences in yellow.  
RIAM 
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3.9 - Discussion and conclusion The data presented in the chapter show that the 
talin binding site within the RIAM N-terminus is extended, this extended binding site 
contains two amphipathic helices that engage the talin rod domains R2R3 synergistically. 
Synergistic interactions mechanically provide a convenient mechanism for the 
displacement of proteins. If we consider the example in this chapter, the presence of R2 
drastically increases overall affinity for RIAM. Therefore any forced based change in 
orientation of R2 would result in a reduced binding affinity. 
These data show that RIAM and vinculin and talin interaction are competitive. This is 
consistent with in vivo data that show RIAM and vinculin are not co-localised at the mature 
focal adhesion (Goult et al., 2013), and in vivo evidence showing the direct displacement of 
RIAM in favour of a vinculin rich focal adhesion (Lee et al., 2013). Vinculin, RIAM and talin 
interactions are competitive, and the binding mechanisms are fundamentally incompatible 
(Del Rio et al., 2009; Gingras et al., 2010). Talin-vinculin binding requires rod domain 
unfolding, RIAM only binds to the folded R2 and R3 domains and binding will be disrupted 
by the domain unfolding either induced by force or by vinculin binding (Goult et al., 2013). 
This is verified experimentally by our SEC-MALLS showing R2R3 destabilisation induces 
vinculin binding. The opposite of this is true with respect of RIAM-R3 binding; introduction 
of stabilising mutations in R3 reduces vinculin binding and does not affect RIAM 
interactions (Goult et al., 2013).  
Cryo EM (Electron Microscopy) and SAXS (Small Angle X-ray Scattering) studies have shown 
that talin exists in a cytosolic globular form (Goult et al., 2013). In vivo studies have also 
shown that RIAM exists in a cytosolic auto-inhibited form (Wynne et al., 2012). A potent 
activator of talin is the second messenger PIP2 (Martel et al., 2001). This binds the PH 
domain of RIAM with a relatively weak Kd of 16µM (Wynne et al., 2012), and is considered 
significant as PIP2 is at high concentrations at the nascent adhesion. PIP2 can directly 
activate talin, therefore both talin and PIP2 could disrupt the autoinhibitory complex 
between the RIAM RA-PH and N-terminal domain (Wynne et al., 2012), resulting in a 
synergistic activation. 
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       Figure 29      
 
   
 
 
 
 
 
 
  
Figure 29 – Focal adhesion growth in the migrating cell. At nascent adhesions RIAM (TBS1&2) binds talin, and Rap1A recruits RIAM to the cell membrane, facilitating integrin activation. 
At the transition zone integrins cluster and vinculin is recruited by talin. The central actin-binding region of talin captures retrograde F-actin (Gingras et al., 2005; Gingras et al., 2010). 
This force results in the displacement of RIAM in favour of vinculin. At the mature adhesion adaptor proteins are recruited to the focal adhesion to signal intracellularly. Actomyosin 
polarises talin, inducing conformational changes increasing vinculin binding, strengthening connections to the actin cytoskelton. 
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The data presented in this thesis propose a model of binary switching between talin-RIAM 
nascent adhesions to talin-vinculin adhesions. These vinculin rich adhesions thus provide a 
route to focal adhesion stabilisation.  
In the absence of force, the data propose a model where R2R3 synergistically bind to TBS1 
and TBS2 in RIAM (figure 28). This recruits talin to the cell membrane where it is activated. 
Here the talin FERM domain engages the NPXY motif in the β-integrin cytoplasmic tail. 
From this position the FERM domain binds PIP2, providing the torsion to activate the 
integrin dimer (Elliott et al., 2010; Calderwood et al., 2003). The C-terminal actin binding 
domains of talin then bind leading edge F-actin from retrograde flow (Gingras et al., 2010); 
this will affect the compact N-terminal region and disrupt the packing of domains R1-R6. 
This will also destabilise the N-terminal rod domains, progressively revealing vinculin-
binding sites and simultaneously reducing affinity for RIAM. Vinculin also binds to RIAM, 
augmenting the transition process. The overall effect regulates the transition from the 
transient RIAM rich nascent adhesion to more the stable vinculin rich adhesions (Goult et 
al., 2013). On progression through the transition zone (figure 29) one would expect 
actomyosin contraction to progressively reveal more VBSs, increasing the connection to F-
actin (figure 30).  
Figure 30 
 
 
 
Figure 30 – Layers of the mature focal adhesion, a talin rich layer binds to actin and to vinculin. Vinculin 
and talin provide the linkages to actin. This layer of proteins transmits force bi-directionally through the 
cell membrane (based on diagram from Kanchanawong et al., 2010). 
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Chapter 4 – The structure of the talin R8-DLC1 complex. 
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4.1 - DLC1 (Deleted in Liver Cancer 1) DLC1 is a Rho-GAP containing (GTPase 
activating protein) tumour suppressor protein localised to focal adhesions (Yuan et al., 
1998). DLC1 is found deficient in HCC (Human Hepatocellular Carcinoma) primary cell lines 
(Zimonjic  et al., 2012; Lahoz et al., 2008) and has been deleted or mutated in almost as 
many cancers as p53 (Kim et al., 2009). Several studies have demonstrated that 
reintroduction of DLC-1 into liver, lung or breast cancer cell lines results in decreased 
neoplastic growth (Yuan et al., 2004; Yuan et al., 2003; Zhou et al., 2004).  
 
 The DLC1 gene encodes a 1092 amino acid protein with an N-terminal SAM (Sterile Alpha 
Motif) domain and a Rho-GAP-START double-domain.  The Rho-GAP-START double domain 
is the defining characteristic of the DLC family and is conserved across DLC 1-3. The DLC1-
GAP domain is a negative regulator of the Rho GTPases and actin stress fibre formation 
(Durkin et al., 2007; Bishop et al., 2000; Li et al., 2011). DLC1 also binds to PLCδ1 and 
enhances the hydrolysis of PIP2 (Homma & Emori 1995); therefore DLC proteins may act 
synergistically to negatively regulate Rho-GTPase function and inhibit talin activation.   
 
Figure 1 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Domain organisation of the DLC1 family of proteins. The N-terminus contains SAM (Sterile Alpha 
Motif) domain and a C-terminal GAP (GTPase activating protein)/START (Star-related lipid transferase) 
domain. The talin-binding site is shown in red and is located between residues 460-490. 
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4.1.1 - The R7R8 talin rod domains The R7R8 domains are sequential helical 
domains in the talin rod. R7 is a 5-helix bundle and R8 is a 4-helix bundle.  The R7R8 double 
domain is unique in the respect that double-domain is composed of non-sequential alpha 
helices. Helices 1,2,3,8 and 9 form R7 and helices 4, 5, 6 and 7 form the R8 domain (figure 
2). An anti-parallel linker connects R7 and R8, and hydrogen bonding in this linker caps the 
R8 domain thus increasing stability (Gingras et al., 2010). Figure 2 shows the position of 
R7R8 within the talin rod. The R7 domain is connected by both termini to R6 and R9 
respectively; this potentially makes the R7 domain more susceptible to force generated 
from the leading edge than R8.  The unusual nature of this connection also makes the R8 
domain protrude from the talin rod, with as yet no known functional consequence. 
Figure02
Figure 2 - Domain structure of talin (red). R7R8 coloured in blue are located centrally within the talin rod region 
and provide connection from R6 to R9. 
R6 R9 
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4.1.2 - DLC1 binds to talin Li  et al (2008) showed by yeast two-hybrid screens that 
human DLC1 residues 260-630 binds to talin R7R8. This region of DLC1 was already 
demonstrated to be a region required for DLC1 localisation to focal adhesions (Liao et al., 
2008). In vitro pull down assays of GST (Glutathione-S-transferase)-talin 1288-1646 (R7R8) 
show complex formation with full length GFP (Green fluorescent protein)-DLC1. DLC1 
fragments of GFP-1-492 and GFP-448-500 form a complex with GST talin-1288-1646. DLC1 
fragments 1-461 or 500-1091 failed to form a complex and showed that the intervening 30-
residue stretch is required for talin binding. Sequence analysis showed that this region 
contained the LD domain consensus motif LDxLLxxL that is shared by the focal adhesion 
protein paxillin (Brown et al., 1996) 
 To determine if this region was required for the interactions deletion analysis was 
performed on the region 467PELDDILYHVKGMQRIVNQWSEK489.   Deletion of residues 469-
474 resulted in deficient localisation to the GST-talin (R7R8) fragment, suggesting that this 
region encompassed the talin-binding site. Section 4.1.1 described residues 1288-1646 
contain the R7R8 double-domain and this double-domain binds to DLC1. Shorter GST-talin 
fusions of various lengths (1500-1646, 1453- 1580 and 1380-1646) were tested via pull 
down and all bound to wt DLC1. Talin regions GST-1288-1510 and GST-1288-1400 do not 
bind, and when considered within the context of the domain architecture of the talin rod, 
these are sub-optimum constructs that result in disruption of key helical bundles. In vivo 
experimentation reveals that the talin interactions do not influence Rho-GTPase activity, 
and deletion of the LD-motif failed to reduce Rho-GTP or Rho dependant activities. This is 
consistent with a hypothesis that talin localisation, and not Rho-GAP function are required 
for tumour suppressor activity (Li et al., 2009).  
 Qian et al (2007) demonstrated that introduction of a point mutation DLC1 Y442F (in the 
tensin binding region) substantially decreased DLC1 adhesion localisation; in a double 
mutant of both LD deletion and Y442F, adhesion association was decreased relative to 
either single mutant alone (Li et al., 2009). Thus tensin and talin make different 
contributions to DLC1 adhesion localisation. Given the sequence homology to paxillin LD 
domains, it could be speculated  (though not confirmed) that paxillin and DLC1 compete for 
FAK, or one of the two sites on FAK that are capable of LD domain interactions (Hoellerer et 
al., 2003). Li et al (2011) tested this hypothesis and showed that there was LD-domain 
dependent competition. Thus the structural basis of this interaction remains a pertinent 
question. 
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4.1.3 - Structural basis of LD domain interaction DLC1 binds to talin through 
an LD-like motif. This small peptide motif is defined from the consensus sequence LDxLLxxL. 
This motif is present in the paxillin super-family and orthologues such as Hic-5 and leupaxin 
(Brown et al., 1996). The structural basis of LD interactions is of interest due to specificity 
of intermolecular interactions. The LD motifs specifically bind to multiple proteins, 
including FAK, GIT, vinculin, actopaxin, and integrin-linked kinase (Hoellerer et al., 2003; 
Brown et al., 1999; Nikolopoulos 2000; Nikolopoulos 2001, Brown et al., 1996). The vinculin 
tail binds to paxillin LDs 1, 2 and 4, whilst FAK only binds paxillin LDs 2 and 4 (Brown 1996; 
Brown et al., 1999). The specificity of LD motif interactions is even maintained when LD 
motifs are displayed in the context of full-length paxillin (Manetti et al., 2012).  The β-
integrin binding protein merlin binds to paxillin LDs 3-5 and is responsible for membrane 
recruitment (Manetti et al., 2012). LD domains have been shown by crystallographic and 
NMR studies to be amphipathic alpha helices. The structural basis of LD-domain 
interactions demonstrates the formation of a 5-helix bundle with the LD peptide, occupying 
the open face of a 4-helix bundle (Hoellerer et al., 2003). Thus the DLC1 LD-like motif would 
be expected to bind talin via a similar mechanism. 
4.1.4 - Aims The aim of this study is to structurally evaluate DLC1 talin interactions. No 
evidence currently maps the contribution of either R7 or R8 in the double domain. 
Additionally the extent of the talin binding site in DLC1 is unknown. Thus this chapter will 
map the binding sites of both talin and DLC1. Once characterised, the structure of the 
complex will be determined. This will provide the basis of talin-LD domain interactions and 
provide details of the interface that will allow subsequent design of talin  mutations that 
selectively disrupt DLC1 binding.  
.
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4.2 Results  
  4.2.1 - Protein expression and purification Both talin R8 and R7R8 
polypeptides were expressed in pET151D. Plasmids were supplied courtesy of Dr Ben Goult 
(University of Leicester). Protein was expressed in BL21*(DE3), cells were grown at 37oC 
and induced using 500 μM IPTG at 18oC overnight. Protein was purified by nickel affinity 
chromatography and the hexa-histidine tag was removed by TEV-protease. The protein was 
further purified by reverse purification and anion exchange chromatography. The yield for 
1 litre of culture grown in 2YT medium was 85mg/litre (culture) for R7R8 and 42mg/litre of 
R8. Isotopic labelling of protein resulted in a 40% reduction of yield when expressed in 2M9 
medium. Typical protein purity of R7R8 and R8 is above 95% as shown by SDS-PAGE 
electrophoresis shown in figure 3. 
Figure 3 
                                     
 
 
 
 
 
 
 
Figure 3 – Purification of R7R8 and R8 A) 12%-SDS-PAGE gel of R7R8 post ion exchange chromatography, 
R7R8 is shown in lane 2 and unrelated protein in lane 1 B) Analysis 15% SDS of R8 post ion exchange 
chromatography. R8 is shown in lane 1 and unrelated sample in lanes 2 and 3. Gels shown are at various 
levels of de-stain. 
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4.2.2 - Secondary structure prediction of the LD domain Li et al (2011) 
showed the deletion of a 469LDDILYHV476 region in the central region of DLC1 abolished talin 
interactions. Multiple studies reveal that the average length of an LD motif is around 12-14 
residues (Brown et al., 1996; Hoellerer et al., 2003). Furthermore Hoellerer et al (2003) 
showed that LD interactions are dependent on the engagement of an α-helix.  To ensure 
the full α-helical region was used in subsequent binding and crystallographic studies, 
secondary structure prediction was performed on the region 450-521 using Psi-pred 
(Buchan et al., 2010) (figure 4).  This prediction showed that the full helical region may be 
larger and contains 23 residues 467PELDDILYHVKGMQRIVNQWSEK489.  Construct design was 
stopped at the K488 as this could provide a helical cap, and also the addition of a terminal 
phenylalanine could result in peptide instability. 
Figure 4 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- Consensus secondary structure prediction of the DLC1 region 469-489 shows helical propensity. 
Secondary structure prediction was performed by the PSI-PRED online server (Buchan et al., 2010). 
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4.2.3 - DLC1 engages the R8 domain Li et al (2011) showed via pull-down that 
talin 1453-1580 (R8) binds to DLC1 with similar efficacy as 1288-1656 (R7R8). This suggests 
binding is specific to the R8 domain (as both constructs contain R8). This does not strictly 
rule out R7, however, as GST based pull downs are not as sensitive as 1H-N15 HSQC 
measurements in detecting potential weak intermolecular interactions. 1H-N15 labelled R8 
was titrated at various ligand ratios of the 467PELDDILYHVKGMQRIVNQWSEK489   peptide.   
1H-15N HSQC spectra show resonance shift changes with DLC1-R8 binding.  
The resonance shift changes associated with the ligand binding reflect an intermediate 
exchange regime between the free and the bound state (see chapter 3 for more 
information on exchange regimes).  Figure 5 shows the effect of the peptide addition on 
the R8 resonances at different titration points.  The addition of the peptide results in 
combined shift changes between Δδ=0.1-0.19ppm.  Between titration points (1:1 and 1:2) 
intensity of resonances are reduced. This reduction reflects the exchange broadening 
arisen due to chemical shift differences between the free and the bound states.  At 1:4 and 
1:8 ratios the resonances representing the complex are increasing in intensity and the 
degree of shift changes between points is becoming smaller. This shows that the effects of 
peptide addition are non-linear and approaching saturation. At a 1:8 (protein-peptide) ratio 
the entire population of labelled material in the sample is in a complex with the ligand, thus 
the resonance shifts detected are resonating from the complex.  
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5- Changes in the 
1
H-N
15
 HSQC spectra of 
15
N-labelled R8 (100 µM) on addition of DLC1. A) Free R8 (red) in a 1:1 R8-DLC1 mixture (Sky blue), 1:2 (green), 1:4  (orange) and 1:8 (black) 
and accompanying zoom of the selected spectral regions to illustrate peak changes on DLC1 addition. Spectra were collected at 298k with field strength of 800MHz. Protein and the 
peptide were in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT Δδ=(ΔδH
2
+(ΔδN*0.15)
2
). 
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4.3 - Crystal structure of the R8-DLC1 complex. 
    4.3.1 - Crystallisation Crystallisation screens were set up using the talin R7R8 
region. The R7R8 structure has been previously solved (Gingras et al., 2010) and the 
unbound fragment readily crystallised in multiple conditions, maximising chances of 
successful crystallisation. Two drops were set up for R7R8 alone and R7R8 mixed with a 4-
fold excess of the LD peptide. This initial screen failed to yield any complex crystals; only 
amorphous aggregation and quasi-crystals were detected. It is possible that the dilution of 
a 1:1 drop may drive equilibrium away from complex formation. Thus the complex was re-
screened at a high ligand ratio of 8:1, as NMR suggests that this ratio is the saturation point 
(2.4mM). These screens typically yielded crystals overnight in 1 condition, 15% Ethanol, Tris 
pH 7.4 at 4oC, and were optimised using a variety of alcohols and pH. Optimisation screens 
varied pH (6.8 - 7.4) and alcohol concentrations (12% - 20%), testing ethanol, methanol and 
isopropanol. Crystals adopted a hexagonal rod morphology with the size of 80µm - 300µm 
(figure 6). No crystals were observed in drops not containing peptide or at room 
temperature, indicating that the complex had likely crystallised. However, this is not 
verified until diffraction data is collected. 
Figure 6 
 
  
 
 
 
 
 
    
 
 
Figure 6 - Crystals yielded through optimisation of DLC1-R7R8 complex crystal at 4
o
C optimisation varied 
alcohol type and concentration (v/v). Crystal varied in size and morphology. In ethanol, crystal size 
increased at lower alcohol concentrations. Large 300 micron crystals were observed in Tris pH 7.4 20% 
Methanol. Under the same pH and buffer conditions using 20% Isopropanol smaller hexagonal crystals were 
observed. 
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4.3.2 - Data collection   Crystals grown in 15% Ethanol, Tris pH 7.4 at 4oC were 
prepared for cryo-crystallography by vitrifying both crystals in sodium malonate pH 7 prior 
to data collection. Various other cryo conditions were tested (Paratone-N-Oil, Silicone Oil, 
Mother Liquor + 20% glycerol or ethylene glycol) and these all resulted in 6-8Å diffractions 
data. Sodium malonate was the only successful condition and diffraction data were 
collected on I04 (Diamond light source 0.975Å fixed wavelength) to 1.8Å. Owing to the high 
quality of the diffraction images, a 0.2o  non-overlapping oscillation width was used per 
image and a total of 180o of data were collected on a PILATUS 6M-F detector.  The 
integration statistics show that the data is 100% complete within the resolution range with 
respectable Rmerge (0.654) , I/σ(3.1) values with high redundancy. 
4.3.3 - Structural determination in p3121   Diffraction data were integrated 
using MOSFLM (Powell et al., 2007). POINTLESS (Evans et al., 2006) suggested a p3121 space 
group owing to systematic absences and re-indexed the data accordingly before the 
intensities were scaled using SCALA (Evans et al., 2006). Using PHASER (McCoy et al., 2007) 
a search of all space groups and enantiomorphs yielded the solution in p3121.  Data was 
then re-integrated in p3121 and scaled; the scaled data were then used for molecular 
replacement again. The initial molecular replacement using only R7 yielded scores of 
LLG=363 TFZ=22.7 indicating a correct solution. R8 was visible in the weighted difference 
map and subsequently positioned and refined (figure 7). 
 Once the R8 domain had been built into the structure molecular replacement performed 
again yielded more favourable statistics LLG=7467 TFZ=60.8 and an R value of 29, 
confirming the correct solution (once all features of the search model are included). 
Models were built using COOT (Emsley and Cowtan 2004), which on refinement revealed 
side chain detail of the DLC1 peptide. This is shown in figure 8 demonstrating the molecular 
replacement solution and refined electron density of W486 and H475. These residues 
provided the markers required for determining the registry of the peptide and its 
subsequent assignment. Data were refined using PHENIX  (Adams et al., 2002), for TLS 
refinement rigid bodies encompassed the DLC1 peptide (body 1) and the R7 and R8 
domains (bodies 2&3). Water molecules were added using COOT (Emsley and Cowtan, 
2004) and PHENIX.refine at positions where peaks were greater than 1.0 σ in the 2Fo-Fc 
weighted map and greater than 3.0 σ in the Fo-Fc weighted difference map. Model 
validation was performed as part of refinement using Molprobity (Chen et al., 2010). Data 
collection and refinement statistics are shown in table 1. 
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Figure 7 
 
      
Figure 7 – Positioning and refinement of the R8 domain post molecular replacement. In blue is the 2F0-FC weighted map (1σ) and in green is mF0-Fc weighted difference map (at 3σ). On 
the left hand side of the panel is the molecular replacement solution, after modelling and refinement the full DLC bound R8 domain was visible in the electron density map Rwork=18.15 
Rfree=23.1. 
Molecular replacement solution Refined structure. 
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Figure 8 
    
 Figure 8 – COOT images of refinement of DLC1 peptide in complex with R7R8 in blue is the 2F0-FC weighted map (1σ) and in green is mF0-Fc weighted difference map (at 3σ). In the left 
hand panel is the initial electron density of W486 on molecular replacement, and in the adjacent panel is the refined electron density map at the end of refinement. In the right hand 
panel is H475 and both initial and refined solutions. H475 is in a hydrogen bond and this allowed correct placement of the rotamer. 
W486 H475 
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Table 1  
Data Collection                          
Beamline      I04 (λ0.975Å) 
Space Group     p3121 
Cell Dimension 
                     a,b,c (Å) 86.76 , 86.76 , 158.73 
                    α ,β,γ (o) 90 , 90, 120 
Resolution (Å) 55.26-2.1 
Rmerge 0.128(0.654) 
Mn(I) half-set 
correlation CC(1/2) 
0.998(0.92) 
I/σI 10.3(3.1) 
Completeness (%) 100(100) 
Redundancy 7.8(7.6) 
Refinement   
No. reflections 20874(2991) 
No. atoms 
                      Protein 2456 
                     Water 203 
B factors (Å2) 
                      Protein 31.6 
                     Solvent 36.2 
RMSD(bonds Å) 0.007 
RMSD(angles o) 1.055 
Rwork 18.15 
Rfree 23.19 
 
 
 
 
 
 
 
 
 
Table 1- Summary of data reduction and refinement statistics for 
DLC1-R7R8 in p3121. Rmerge = hkl[ i Ihkl,i - <Ihkl> ]/ hkl,i<Ihkl>, 
where Ihkl,i is the intensity of an individual measurement of the 
reflection with Miller indices h, k, and l and <Ihkl> is the mean 
intensity of that reflection. R =Σhkl ||Fo (h, k, l)| - |Fc (h, k, l)||/ 
Σhkl |Fo (h, k, l)|. Rfree is defined as R calculated on a random 5 % 
non refined data 
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4.4 - The crystal structure of R7R8 in complex with DLC1  
    4.4.1 - Changes in the talin structure on complex formation The crystal 
structure of the complex resolves both R7 and the R8 domain. There is one R7R8 and one 
DLC1 molecule within the asymmetric unit and a corresponding solvent content of 55%. 
The structure shows that the DLC1 peptide is bound to the R8 domain; all of the residues of 
R7R8 were visible in the crystal structure apart from the flexible cloning artefacts of the 
TEV cleavage site.  The R7 five-helix bundle follows the standard up-down topology 
observed in the non-bound crystal structure of R7R8 (Gingras 2010). R8 follows the 
standard left handed up-down twist topology consistent with all 4-helix bundles within the 
talin rod (Goult et al., 2013;Goult et al., 2009; Goult et al., 2010). These two helical bundles 
are linked by a flexible inter-domain linker that due to hydrogen bonding remains stable 
and well resolved in this crystal structure at 1σ (Gingras et al., 2010). The DLC1 peptide lies 
across the α2-α3 of R8 and thus the complex forms as a new 5-helix bundle. 
 
Figure 9 shows a structure-based sequence alignment using CCP4MG (Mc Nichols et al., 
2011) between bound and un-bound structures. Analysis of the backbone RMSD of R8 
values reveals there is no significant change in the R8 domain (figure 10). The minor change 
in RMSD (2Å) is characteristic of LD-domain interactions with 4-helix bundles (Hoellerer et 
al., 2003) and is suggestive of a pre-existing binding site. Furthermore, as there is no 
change in RMSD, the conformational change between domains is a result of crystal packing, 
the saturated complex facilitating the change in space group (P3121 bound, P212121 
unbound). 
 
The R7 and R8 domains are connected through a flexible linker (1452-1461 and 1579 -1589) 
that adopts a pseudo anti-parallel beta sheet that is stabilised by hydrogen bonds (figure 
10). L1461 and F1581 in the apo-form have a hydrogen bonding distance of 2Å. These two 
residues rotate in the bound structure and the hydrogen bond distance remains intact 
capping the termini of R8. 
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Figure 9 
 
 Figure 9 – Comparison of the crystal structure of free R7R8 (blue) and the R7R8-DLC1 complex (red) the peptide of DLC1 is shown in cyan. A) The crystal structure of R7R8-DLC1. B) 
Superimposition of free and bound forms of R7R8. Helices in the double domain are labelled in their order from the N-terminus of the sequence. 
α1 
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α4 (α1) 
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  Figure 10 
                                                                           
Figure 10 – The crystal structure of the R7R8-DLC1 complex, R7R8-DLC1 is shown in red and PDB-2X0C is shown in blue. Rotation of F1581 and L1461 occurs in the bound form with 
hydrogen bonding distances remaining constant. 2F0-FC map at 1σ shows electron density of the region in blue of the inter-domain linker between R7 and R8. 
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Figure 11 - Crystal structure of the 
467
PELDDILYHVKGMQRIVNQWSEK
489 
peptide. Surface charge 
representation of the charged (A) and non-charged (B) faces of the DLC1 peptide. Secondary structure 
prediction from the Psi-pred online server of the residue 450-521 of DLC1 (Buchan et al., 2010), 2F0-FC map 
is overlaid on the crystal structure of the peptide at 1σ and shown in blue. W486 and H475 are highlighted 
and were used as markers to assign the registry of the peptide. In surface charge representation the colour 
blue represents positive charges and red negative, no charge is shown in white. 
Figure 11 
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4.4.2 - The DLC1 peptide structure in the complex   The DLC1 peptide forms 
an α-helix and this is consistent with the secondary structure prediction of the region 
(figure 4). Secondary structure prediction shows that the helix may include a C-terminal 
phenylalanine residue that could stabilise the C-terminus of the alpha helix. In the crystal 
structure of the complex the C-terminal region of the peptide becomes non-helical 
approaching W486 and then appears to be unstructured.  The overall secondary structure 
is consistent with the LD domains from paxillin that also form α-helices (Hoellerer et al., 
2003). The two faces of the peptide are shown in figure 11 using surface charge 
representation of both faces of DLC1.  If we examine the sequence of the peptide shown in 
figure 11 then we can observe certain sequence characteristics of the peptide. Short 
hydrophobic residues are found at the N-terminus of the DLC1 peptide and these form an 
interface to the talin R8 domain. Whereas bulkier residues (W486, M479) dominate the C-
terminus of the peptide, defining specificity for the DLC1-talin R8 interaction (described 
below). 
4.4.3 - The peptide protein interface   The DLC1 peptide lies across the α2-α3 
face of the R8 domain helical bundle (figure 12). The hydrophobic contacts that form the 
DLC1 binding site on talin α2-α3 faces are shown in figure 12. The binding site on talin 
comprises hydrophobic residues exposed on the surface of R8 (leucine, alanine and valine) 
residues (figure 12).  DLC1 binding specificity is mediated by a C-terminal 486WSEK489 motif 
on the DLC1 peptide. E488 engages in a mid-range electrostatic network with R1523 and 
K1530, W486 appears to engage the hydrophobic Cδ 1510 of R1510. Li et al (2011) showed 
that the talin-DLC1 interaction requires the 469LDDILYHV476 region and deletion of this 
region reduces interactions (Li et al., 2011). Thus the N-terminal residues of the peptide 
could0contribute0to0the0stability0of0binding0helix.
B 
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               Figure 12                                                 
      
Figure 12 – A) Ribbon representation of the R8 bundle (red) with hydrophobic residues highlighted in magenta; B) Surface charge representation of the R8 bundle with the DLC1 peptide 
(cyan). 2F0-FC map at 1σ is shown with zoom of W486 shown in C and zoom of E486 shown in D. Blue patches are positively charged and red are negatively charged, uncharged are 
shown in white. 
         α2                                    α3 
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4.4.4 - Site directed mutagenesis The crystal structure of the R8-DLC1 complex 
reveals that the interaction between DLC1 and R8 has electrostatic contributions from 
K1530 and R1523. These residues were individually mutated to alanine to investigate 
whether insertion of a short hydrophobic side chain may disrupt the interaction and 
remove hydrogen bonds. Expression levels, purification and purity were identical to those 
achieved in figure 3 section 4.2.1. The effect of these mutations on the R8 structure has 
been assessed using HSQC spectra.   
The K1530A single mutant exhibits well-distributed resonances in the low and high field 
regions associated with a folded protein. Many resonances superimpose and show that the 
presence of the mutation has not affected the integrity of the fold (figure 13A). 
Experiments were carried out in identical conditions as the initial R8 titration with the same 
experimental parameters. With K1530A resonances intensities were diminished compared 
to noise level. The reduced intensity (relative to the wild type spectra at the same 
concentration) indicates that the total amount of correctly folded protein is reduced in the 
sample relative to intense disordered central resonances. These intense central peaks (6-8 
ppm) are consistent with degraded or truncated forms of the protein that may be an 
artefact of the expression system.  Nevertheless, when titrated in a 1:0.5 (figure 14) ration 
to DLC1, the resonances corresponding to native sample attenuate suggesting protein and 
peptide still bind to each other. Due to material constraints and the inconsistent nature of 
the sample, determination of the exchange regime was not confirmed. 
In contrast, the R1523A single mutant reveals peaks of similar intensity to the wild type 
protein (under identical conditions). Thus, the protein is not degraded to the same extent 
and provides valuable binding data (figure 15). Unlike the wild type titration, where 
resonances disappear and then return, the maximum broadening of this titration is 
observed at a 4:1 ligand excess. During the titration the shift changes are linear and 
resonance broadening is less extensive and shifted to the higher protein to peptide ratios 
(figure 15). This suggests that the protein is far from saturation and the exchange regime 
significantly faster than for the wild type titration. These two factors indicate a reduced 
affinity of the R1523A mutant. However, comparable changes in the NMR spectra between 
the mutant and the wild-type protein imply that the affinity reduction is relatively small 
and is unlikely to cause a biologically significant effect.  
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 Figure 13 
                    
Figure 13- Changes in the 
1
H-N
15
 HSQC spectra of 100µM R8 (red) in comparison with mutants A) Spectra 
of i) 100µM of K1530A (black) B) 100µM of R1523A (black) C) Shows position of mutations on the α3 helix 
of R8. Spectra were collected in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT at field strength of 600MHz at 
298k. Central unfolded peaks are in-between black staggered lines. Up and down field dispersed 
resonances are in between green staggered lines (Wishart et al., 1998). 
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         Figure 14 
 
A
a 
B
a 
Figure 14 - Changes in the 
1
H-N
15
 HSQC spectra of 
15
N-labelled 100µM R8 K1530A. A) Spectra of 100 µM K1530A (red) mutant overlaid with 1:0.5 complex (black).  B) 
Selected dispsersed resonances are shown of spectra A. Data was collected at 298k with a field strength of 800MHz. Protein and peptide were in 20mM PO4 pH 6.5, 
50mM NaCl, 2mM DTT. 
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Figure 15
 
                                                
 
 
 
 
 
 
 
 
 
 
 
Figure 15- Changes in the 
1
H-
15
N HSQC spectra of 
15
N-labelled R8 and R8-1523A (100 µM) on addition of DLC1 with zoom of selected peaks A) Spectra of the free R8 (red) in a 1:1 R8-DLC1 
mixture (Sky blue), 1:2 (green), 1:4  (orange) and 1:8 (black) B) 
1
H-
15
N HSQC spectra of 
15
N-labelled R8 R1523A (100 µM) on addition of DLC1, Free R8 (red) in a 1:1 R8-DLC1 mixture (Sky 
blue), 1:2 (green), 1:4 (pink). Data was collected at 298k with field strength of 800MHz. Protein and peptide were in 20mM PO4 pH 6.5, 50mM NaCl, 2mM DTT. 
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The crystal structure of the complex revealed that the binding is mediated through 
electrostatic interactions between R1523, K1530 on R8 and E488 on DLC1. Mutation of 
R1523 to alanine reduced the affinity between R8 and DLC1 and changes the exchange 
regime from intermediate to fast. Thus charge reversals may be introduced to abolish 
interaction completely in this region. Acidic charges should be introduced across the face of 
the helical bundle. This charge reversal would have the effect of repulsion rather than the 
removal of hydrogen bonds (figure 16) 
 
Figure 16 
 
                                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 – Suggested mutations that will be introduced to abolish R8 interactions with DLC1. Suggested 
mutations have blue surface surrounding them and this signifies the potential mutations on the surface. 
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4.4.5 - Comparison of R8 with focal adhesion kinase The LD domains of 
paxillin bind to several proteins, including the FAT domain of focal adhesion kinase 
(Hoellerer  et al., 2003).  Like the talin R8 domain the FAT domain of FAK is a 4-helix bundle. 
If we look at figure 17 we can see that both follow the left hand up-down twist topology, 
common to the talin 4-helix bundles (Gingras et al., 2010; Goult et al., 2010).  This topology 
sees the α2 helix follow α1 in an anti-clockwise manner (figure 17). Both of these structures 
are similar and superimpose with an RMSD of 2Å. 
The paxillin LD4-helix binds to both α1-α4 and α2-α3 faces of the FAT domain and this is 
shown in figure 18. Thus it would be structurally interesting if R8 could achieve this dual 
occupancy. To examine the hypothesis, the surface charges of R8 were compared with FAK. 
Figure 18 uses the same structural alignment from figure 17 and shows the surface charge 
distribution of the α1-α4 and α2-α3 of both R8 and FAK. Both α2-α3 face on FAK and talin 
contain large hydrophobic patches capable of engaging hydrophobic helices.  If we 
compare the α1-α4 faces, however, there are differences. The R8 α1-α4 face contains 
multiple negative charges; this will repel any hydrophobic moieties. Thus we can conclude 
from structural comparison that the α1-α4 face on talin is unlikely to bind an LD domain. 
DLC1 also binds to FAK (Li et al., 2011) thus DLC1 may bind to the analogous α2-α3 face on 
the FAT domain. Thus structure based sequence alignment using CCP4mg was performed, 
Figure 19 shows this alignment with surface charges of FAK; we can observe in this 
structure that although R8 and FAK follow the same topology and that DLC1 is orientated in 
an opposing direction to the LD domain.  It is possible that the DLC1 peptide may occupy 
two sites on FAK, however this hypothesis needs to be verified structurally. 
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Figure 17          
 
 
Figure 17 – Like talin, the FAT domain of focal adhesion kinase adopts a left-handed up down twist topology, and 
these two domains superimpose. R8 is shown in red and FAK is shown in blue. In the left-handed twist topology the 
α1, α2 helices follow each other in an anti-clockwise manner.  Structural superimposition was performed using 
CCP4mg.  
 
RMSD =2Å 
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Figure 18 
 
            
 
Figure 18 – Surface charge representation of R8 and Paxillin LD-domain binding sites. A) Surface charge representation of the R8 α2-α3 DLC1 binding site and the R8 α1-α4 non-binding 
face. B) Surface charge representation of the α2-α3 and α1-α4 LD4 complexes of paxillin and FAK (PDB-10W7). In the surface charge distribution blue is positive, red is negative and no 
charge is shown in white. 
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Figure 19 
                                             
 
 
 
Talin is composed of 62 helices and early domain mapping of the rod region proved 
challenging. One of the challenges was the incorrect prediction of domain boundaries and 
this led to the structure of the helical bundle R10 initially being thought of as a 4-helix 
bundle (Gingras et al., 2006). Closer examination of the sequence then led to this domain 
actually being classified as a 5-helix bundle and the structure was solved (Goult et al., 
2010).  
This additional helix (α0) (figure 19) adopts a position on the α2-α3 face on R10, if we 
perform a structural based alignment with the R8-DLC1 complex we can observe some 
interesting similarities. The α0 helix is orientated in the same direction and binds to the 
analogous site as DLC1. The presence of the α0 helix in R10 increased relative stability of 
the bundle by concealing a hydrophobic patch. Thus this may represent a general 
mechanism of 4-helix bundle binding interactions. 
 
 
Figure 19- Structural superimposition using CCP4mg of the R8 domain and FAK (PDB-10W7). Both domains 
share the same left handed up down twist topology. The DLC1 peptide (cyan) is orientated in an opposite 
direction to LD4 on the α2-α3 face of the 4-helix bundle. Positive charges are shown in blue, negative 
charges in red and no charge is show in white. 
 
A 
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Figure 20 
 
 Figure 20- Structural superimposition using CCP4mg of the R8 domain in red and R10 in blue (PDB-2L7A) 
with accompanying topology diagrams. DLC1 peptide is shown in cyan. α0 denotes an amphipthatic helix 
capable of engaging the α2-α3 face of a helical bundle. 
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4.5 - Discussion and Conclusion  LD domain interactions regulate focal adhesions 
through multiple interactions with vinculin, focal adhesion kinase and other proteins.  In 
this chapter we solved the structure of R8 in complex with the LD-like motif of DLC1, 
identifiying talin-R8 as a DLC1 binding protein, through a combination of NMR and X-ray 
crystallography. Using NMR a high affinity interaction with the R8 domain was measured, 
and using X-ray crystallography the structure was resolved to 2.1Å by molecular 
replacement. Although LD domain interactions are traditionally associated with paxillin, in 
this thesis the identification of the DLC1 LD-like motif reveals this motif is more widespread 
than previously thought.  
 
R8 engages the DLC1 peptide on its α2-α3 face, and the DLC1 peptide engages talin with 
uncharged moieties from its N-terminal region and a specific WSEK motif approaching its C-
terminus.  The DLC1 peptide is coordinated to the surface of R8 by electrostatic contacts 
between E488 (DLC1) and K1530 and R1523 from the R8 surface. Mutation of R1523 results 
in a diminished interaction. Unfortunately this interaction is not disturbed to the point of 
no binding, and will require further negative mutations to abolish. 
 
The LD domain interactions of paxillin tend to be mediated by short chain hydrophobic 
residues with no side chain engagement of the helical bundles (LD4 and focal adhesion 
kinase).  In this structure we show the insertion of a tryptophan into the hydrophobic cavity 
on the R8 surface; this suggests a potential specificity of the DLC1 LD-like motif derived 
through a 486WSEK489 motif. This differs from canonical LD motif interactions, as they can be 
promiscuous with their orientations due to hydrophobic-hydrophobic patch binding (Lorenz 
et al., 2006). Multiple assays (Brown et al., 1996; Brown et al., 1999) imply that there is a 
specificity of the LD domains in their interactions.  However given high sequence similarity 
the degree specificity of the LD domain interactions is startling (figure 21). The vinculin tail 
can engage paxillin LDs 1,2 and 4 whereas FAK can only engage LDs 2 and 4 (Brown et al., 
1996; Brown et al., 1999).   
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Figure 21 
 
 
 
 
 
 
 
Paxillin is ubiquitous in focal adhesions (Brown and Turner 2004), and currently there is no 
in vivo data revealing the specific localisation of DLC1 (Li et al., 2009). As DLC1 negatively 
regulates stress fibre formation, it stands to reason that DLC1 recruitment may be one of 
the initiation events of focal adhesion disassembly, or rather the inhibition of further 
maturation through actomyosin dependent tension. There may also be a competition 
between talin-DLC1 and DLC1-FAK complexes. The recruitment of DLC1 may provide a 
switch between focal adhesion maturation (associations with talin), through to FAK 
interactions that begin the processes of adhesion disassembly (Hamadi et al., 2005; Ezratty 
et al., 2005). This would be consistent with in vivo data that shows deletion of the DLC1 LD-
like motif increases levels of anchorage independent growth (Li et al., 2011). 
In conclusion this thesis has structurally elucidated the intermolecular interactions 
between talin and DLC1, providing the structural basis for binding specificity. In the context 
of LD domain interactions, this thesis has contributed to the field showing LD helices can be 
significantly larger. The structure of the DLC1-LD domain complex provides the first 
structure of a talin rod domain in complex and shows the DLC1 peptide adopts the position 
of a 5th helix along the α2-α3 of the 4-helix bundle. That is selectively located due to the 
presence of a novel WSEK motif. In the context of the mature focal adhesion, this work 
provides the structural basis for DLC1 localisation to talin, where it can negatively regulate 
actomyosin contraction. Mutations in the binding site have disturbed molecular 
interactions and need to be tested in vivo.  If charge reversal mutations abolish interactions 
with DLC1 then this would be expected to induce phenotype changes associated with 
anchorage independent growth and tumourgenesis. 
 
 
Figure 21 – Clustal-W (Thompson et al., 2002) multiple sequence alignment of the five LD domains of paxillin 
labelled froms LDs 1-5. 
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Chapter 5 – Structure and interactions of SHANK3 N-terminal region. 
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5.1.1 - Introduction The SHANK family of proteins (SHANKs 1-3) form a diverse family 
of scaffolding proteins at the postsynaptic density (PSD). SHANK proteins interlink clusters 
of NMDA (N-methyl-D-aspartate receptor) and AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor) receptors at the PSD to the cytoskeleton (Saupe et al., 
2011). SHANK3 (Sharpin binding Ankyrin repeat protein) is a 193kDa postsynaptic density 
adaptor protein. Mutations and deletions within the SHANK3 gene manifest themselves as 
mental retardation, 22q13 deletion syndrome or autism (Durand et al., 2007; Bonaglia et 
al., 2001; De Nayer et al., 2012; Verhoeven et al., 2012). Gene targeting studies in test mice 
confirm that SHANK3 deletion induces the development of the autistic phenotype (Peca et 
al., 2011; Bozdagi et al., 2011; Wang et al., 2011). Pathogenic mutations are currently 
associated with truncations and mis-folding of SHANK3 (Durand et al., 2007). In vivo studies 
by our collaborator Dr H Kreinkamp (University of Hamburg-Eppendorf) show that familial 
mutations specifically within the N-terminal region of SHANK are associated with increased 
interactions with the integrin regulatory protein SHARPIN (SHANK associated RH domain 
containing protein).  SHARPIN competes with talin for binding to integrin tails (Rantala et 
al., 2011).  Thus the aim of the chapter is to solve the structure of the N-terminal region of 
SHANK and elucidate its intermolecular interactions. 
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5.1.1 - SHANK interactions at the postsynaptic density The SHANK family of 
genes encodes a group of scaffold proteins key to regulation of synaptogenesis at the 
postsynaptic density (PSD), and the regulation of dendritic cell morphology (Durand et al., 
2007).  SHANK proteins contain multiple domains that can bind to cell surface receptors at 
the PSD and connect them to the actin cytoskeleton via cortactin (Naisbitt et al., 1999; 
Jiang and Ehlers 2013). Thus SHANK acts in a manner analogous to talin connecting cell 
surface receptors to the actin cytoskeleton. 
 
Figure 1 
 
 
 
 
 
 
SHANKs 1 and 3 contain the newly identified SPN (SHANK/Pro-Sap/N-terminal) region 
(Mameza et al., 2013), this SPN region is predicted to be autoinhibitory to ankyrin domain 
interactions (Mameza et al., 2013). The ankyrin domain binds to α-fodrin and SHARPIN (Lim 
et al., 2001). SHARPIN is both enriched and has regulatory functions at the PSD (Lim et al., 
2001), and interactions with α-fodrin regulate connections to the actin cytoskeleton at the 
PSD (Bockers et al., 2001). The SH3 domain binds to cytosolic proteins such as densins, 
Grip-1 and Cav.1.3 (Jiang and Ehlers 2013).  One of the most functionally important regions 
of SHANK3 is the PDZ domain. The PDZ domain has multiple binding partners and is 
required for PSD formation. The PDZ domain links SHANK3 to the PSD with the C-terminus 
of GKAP (Saupe et al., 2011). The proline rich linker in-between SH3 and SAM domains 
Figure 1- SHANK3 domain interactions (diagram adapted from table 2 in Jiang and Ehlers 2013). SAM (Sterile 
Alpha Motif-2F3N), SH3 (Serine Homology Domain 3-1WA7), PDZ (Post Synaptic Density Zonuna occludin- 
3O5N) and SPN (SHANK3/ProSap/N-terminal domain). Note the SH3 domain in this diagram is used from an 
unrelated protein the structure of the SHANK3 SH3 domain is unknown. 
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contain multiple motifs that provide sites of engagement for actin regulators such as 
HOMER and cortactin. The C-terminal SAM domain regulates SHANK oligomerisation in a 
zinc dependent manner (Gundelfinger et al., 2006; Grabrucker et al., 2011). Increases in 
cytosolic zinc concentrations are associated with PSD formation (Gundelfinger 2006). GST-
fusions of the SAM domain are able to pull down the corresponding un-tagged SAM-
domain in vitro (Baron et al., 2006). Thus the SHANK family has a higher oligomeric state 
contributing to their role at the PSD (Grabrucker et al., 2011; Naisbitt et al., 1999).  Genes 
for SHANK proteins are all located on different loci (chromosome 11q13.3 for SHANK2 and 
19q13.3 for SHANK1). The domain structures of the SHANK proteins have a high degree of 
diversity that are isoform specific and contribute to tissue specific function. Different 
combinations of intragenic promoters and alterative splicing results in a plethora of 
different mRNAs and isoforms (figure 2). The exact number of protein products remains 
unknown (Jiang and Ehlers 2013). 
Figure 2 
                       
 
 
 
 
 
 
 
 
 
 
 
  
         
 
 
 
Figure 2 – Diversity of alternate splice forms of the SHANK family of proteins (based on a diagram by Jiang 
an Ehlers 2013). 
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5.1.2 - SHANK3 and Autism spectrum disorders (ASD) SHANK3 is arguably 
the most implicated and studied proteins in ASD’s (Boccuto et al., 2013). SHANK3 is heavily 
enriched at the post-synaptic density and a variety of mutations (within SHANK3) have 
been implicated in familial cases of autism. An intronic donor splice from an epileptic father 
results in a mis-sense mutation L68P (Gauthier et al., 2009). This mutation is predicted to 
potentially disrupt the ankyrin repeat and is conserved across multiple species (Gauthier et 
al., 2009). Two further mutations within the ankyrin repeat sequence have been identified 
in ASD patients (A224T and I245T) (Gauthier et al., 2009). From a structural perspective, 
these may disrupt the hydrophobic packing of the ankyrin repeat domain. 
 
  In vivo data by the Kreinkamp group shows that the first 90 conserved residues of the N-
terminal domain are inhibitory to SHARPIN binding, and in the case of the L68P mutation 
this inhibition is relieved, suggesting an intramolecular autoinhibitory complex (Mameza et 
al., 2013).  Other inherited mutations have also been identified in this SPN region that 
affect function. Over expression of GFP-tagged SHANK3 R12C in vivo causes reduced 
synaptic clustering (Durand et al., 2007; Durand et al., 2012). Thus the N-terminal residues 
(1-98) although predicted to be outside the ankyrin repeat region may contribute to the 
postsynaptic localisation of SHANK3 and require further investigation. 
 
5.1.3 - SHANK3 focal adhesion interactions   SHANK3 clusters at focal 
adhesions with typical focal adhesion markers such as vinculin, paxillin and with  actin 
filaments (Durand et al., 2012; Qualmann et al., 2004).  SHANK3 over-expression is 
observed to have a positive effect on actin polymerisation; this is seen to be dependent on 
the presence of the C-terminal cortactin-binding domain (Naisbitt et al., 1999; Durand et 
al., 2012; Du et al., 1998). The protein SHARPIN (Lim et al., 2001) is a SHANK binding 
protein that is involved in plethora of cell signalling events including the regulation of NF-κB 
(Ikeda et al., 2011). SHARPIN has been implicated in the regulation of focal adhesion 
disassembly and inhibits β1-integrin activation in human cancer cells and primary 
leukocytes.  In vivo evidence shows SHARPIN is localised to the cell membrane in NCI-H460 
cells and interacts with β-integrin in PC3 cells (Rantala et al., 2011). SHARPIN deficient mice 
showed increased levels of integrin activity, this activity is subdued by its re-expression 
(Rantala et al., 2011).  
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 SHARPIN binds to α-integrin tails and inhibits the recruitment of both talin and kindlins 
(Rantala et al., 2011). SHARPIN and SHANK3 co-immunoprecipitate in both in vivo and in 
vitro experiments and the binding to SHANK has been mapped as between the RH domain 
(predicted UBL domain) of SHARPIN, and the SHANK3 ankyrin domain (Lim et al., 2001). As 
SHANK3 and SHARPIN are co-localised, one could speculate that SHANK3 could act as a 
scaffold for SHARPIN recruitment (figure 3). 
Figure 3 
 
 
 
 
 
5.1.4 - Aims of this chapter - The N-terminal region of SHANK remains structurally 
uncharacterised.  The aim of this chapter is to solve the structure of SHANK3, and based on 
structural elucidation predict the binding of intracellular ligands. 
 
 
 
 
 
Figure 3 – SHANK3 binds SHARPIN and may act as a scaffold for talin displacement at focal adhesions. The 
mechanism of SHANK3 membrane recruitment remains elusive. 
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5.2 Results 
 5.2.1 - Expression and Purification of the SHANK N-terminal region The 
Rattus norvegicus SHANK3 N-terminal domain (1-348 and 1-99, 1-114) constructs were 
kindly provided by the Dr H Kreinkamp in pET-SUMO (encoding N-terminal His-Sumo-tag). 
This vector was chosen to maximise solubility and expression levels. SHANK3 1-348 was 
expressed in BL21*(DE3) grown at 30oC and induced using 300µM IPTG at 18oC overnight. 
Under identical conditions residues 1-99 and 1-114 are insoluble. This is of interest as it 
implies the predicted ankyrin repeat fold is required to assist in the folding of the SPN 
region.  The induction temperature and IPTG concentrations were intended to compromise 
high-level expression with enhanced protein folding at 18oC.  The fusion tag was removed 
by Sumo protease. Post Sumo cleavage the protein became prone to aggregation and 
precipitated upon concentration by centrifugation. To overcome this, 3 litres of culture 
were grown and the fusion protein concentrated through nickel affinity chromatography 
(5ml). At this high concentration Sumo protease cleavage was performed and after reverse 
purification SHANK3 (1-348) was immediately exchanged into 20 mM Tris pH 7.4, 150 mM 
NaCl, 2 mM DTT. Monodispersity was verified using analytical gel filtration.  The yield in 2YT 
was 10mg/litre of culture and was judged to be >95% pure by SDS-PAGE electrophoresis. 
Figure 4 
                    
      
 
 
 
 
 
 
 
Figure 4 – Gel filtration trace using a Superdex 75/10 300GL in 20mM Tris pH 7.4, 150mM NaCl , 2mM DTT 
with accompanying 12% SDS-PAGE gel showing pure SHANK3 (1-348) protein (Lane 3). Elution volume is 
plotted again absorbance @280nm. Lanes 1 and 2 show unrelated proteins. 
SHANK1-348 
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The elution profile on gel filtration is consistent with a monomeric globular species of the 
expected molecular weight 38kDa (in comparison with globular proteins of a similar 
molecular weight) (figure 4).  
5.2.2 - Protein crystallisation  - Crystals typically appeared within 24 hours in over 
25 conditions and the morphology of the crystals varied from bi-pyramids to multifaceted 
icosahedral crystals (figure 5).  Due to the range and quality of crystals no optimisation was 
necessary.  In figure 5 crystal forms A and C failed to diffract, crystal form D was a 50% 
merohedral twin.  Data was collected from forms B and E. 
Figure05          
 
 
 
 
 
 
 
Figure 5 - Sparse matrix crystal screens produced a variety of crystal morphologies in multiple conditions. 
Crystal screen positive hits A) 0.1 M SPG buffer pH6, 25% (w/v) PEG 1500  B) 0.1M HEPES pH 7.5, 0.4M K/Na 
tartate C) 1M Imidazole pH7 D) 20mM Tris pH 7.4, 150mM NaCl, 2mM DTT E) 0.1M MES pH 6.4 , 12% PEG 20K.  
p212121 – 2.9Å 
p41212 – 2.16Å 
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5.2.3 - Data collection Two crystal forms yielded high-resolution datasets for 
structural determination. Both crystals were prepared for cryo-crystallography by 
vitrification in mother liquor containing 30% Ethylene glycol, 10% Isopropanol.  One crystal 
form produced 2.17Å data (0.1M HEPES pH 7.5, 0.4M K/Na tartate) and the other 2.9Å data 
(0.1M MES pH 6.4 12% PEG-20K). Data sets were collected on IO4-1 (Diamond light source 
λ0.92Å) with a non-overlapping 0.5o oscillation width and a rotation of 180o using a 
PILATUS 2M detector.  The 2.17Å (in P41212) data set was of high quality with high I/σ (4.4) 
in the highest resolution shell and low Rmerge 0.59. The 2.9Å data set was of lower resolution 
and quality but of interest as it may be a different yet related space group P212121 (I/σ 1.4 
and Rmerge 0.85). 
5.2.4 - Structural determination   
  5.2.4.1 - The SHANK N-terminus (1-348) in P41212 (2.17Å) Diffraction data 
were integrated using MOSFLM (Powell et al., 2013). Early analysis of the intensities 
pattern suggests the data may be P41212 (in POINTLESS). The space group P41212 is 
enantiomorphic thus based on intensities can also be P43212.  
Molecular replacement was employed in PHASER (McCoy et al., 2007) using the small 
ankyrin repeat structure from PDB, ID 1N11, with side chains removed as a template. 
PHASER searched all enantiomorphs and possible space groups, finding the solution to be 
P41212 as suspected.   Subsequent to this, data was re-integrated and scaled in P41212 using 
MOSFLM (Powell et al., 2013) and then SCALA (Evans et al., 2006).  
Upon refinement using PHENIX.refine (Adams et al., 2012) electron density for the full 
ankyrin repeat was visible and modelled using COOT (Emsley and Cowtan, 2004). This 
allowed the SPN domain to be visible in the weighted difference map (figure 6).  Arp/Warp 
7.3 (Langer et al., 2013) provided a template backbone for PHENIX.autosol  (Adams et al., 
2012) to build in the sequence.  Through manual inspection of the model in COOT 0.7 
(Emsley and Cowtan 2004) all unassigned electron density was modelled, including the loop 
regions of the SPN domain (figure 7). This modified template was used for molecular 
replacement again and yielded favourable scores LLG=15044 TFZ=79.6 in p41212.  The fully 
refined electron density map also revealed a significant amount of ethylene glycol and 
isopropyl alcohol from the cryo-protectant bound to the structure. These bound molecules 
were assigned and accounted for in the final refinement. 
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 5.2.4.2 - The SHANK N-terminus in P212121 (2.9Å) To resolve the crystal 
structure of the SHANK3 in P212121 the crystal structure in p41212 was used as a template 
for molecular replacement yielding favourable scores LLG=6055 TFZ=38.5. This structure 
differs from the structure in P41212 as there are two components of the asymmetric unit. 
To improve agreement with experimental data at the final stages of refinement, TLS 
(translation/libration/screw) refinement strategy was used. Rigid bodies were determined 
using the online TLS motion determination online server (Painter et al., 2006). Data 
merging and final refinement statistics are shown in table 1.  
  To identify the NCS (non crystallographic symmetry) relations in the P212121 crystal form 
of SHANK3, a self-rotation function was calculated using POLRAFN in the resolution range 
15-5.5Å and a Patterson radius of integration of 12Å. The orthogonal code 3 option was 
used in POLARRFN with the crystallographic b axis along the orthogonal z-axis. This 
revealed a 4=fold NCS axis (kappa=90o; Fig 8C, left) co-aligned with the b* axis and 
contained within the ac plane at ϕ=90o and Ω=45o (Fig 8c, right) co-incident with the 
location of an equivalent crystallographic axis in the P422 point group. The NCS peak height 
is 65% of the origin peak. This demonstrates that the NCS axis is not a true crystallographic 
axis and thus that this crystal form is distinct from the P41212 described above. The lattices 
are, however, not independent and the P212121 can be considered a sub-symmetry caused 
by the disruption of the 4-fold. This could arise from deviations between structures arising 
from flexible loop regions between SPN and ankyrin domain creating partial differences in 
packing, or potentially differences in crystallisation conditions. 
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 Figure 6 
 
     
Figure 6 – Refinement and modelling of the SHANK3-SPN domain. The unmodelled SPN domain is shown in green in the F0-FC weighted differene map set to 3σ in the left panel. 
After refinment and modelling the SPN is visible in blue in the 2F0-FC map set to 1σ in the right hand panel. 
 
Modelling and refinement  
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Table 1   
Data Collection                          
 Beamline      I04-1 (λ0.92Å)     I04-1 (λ0.92Å) 
Space Group     P41212     P212121 
Cell Dimension 
  
                    a,b,c (Å) 
86.76 , 86.76 , 
158.73 
     84.99 , 85.74 , 157.84 
                    α ,β,γ (o) 90 , 90, 90      90 , 90, 90 
Resolution (Å) 48.54-2.16     44.84-2.9 
Rmerge 0.106 (0.595) 0.175(0.857) 
Mn(I) half-set correlation CC(1/2) 0.998(0.992) 0.992(0.75) 
I/σI 14.7(4.4)     5.53(1.4) 
Completeness (%) 100(100)   91.99(94.09) 
Redundancy 12.2(12.6)   7.4(7.3) 
Refinement     
No. reflections 33072(4761) 26259 (3776) 
No. atoms 
                       Protein 3025 5439 
                     Water 329 3 
B factors (Å2) 
                       Protein 41 51.2 
                     Solvent 76 51 
RMSD(bonds Å) 0.1 0.1 
RMSD(angles o) 1.2 1.2 
Rwork 16.47 20.55 
Rfree 18.74 27.64 
 
 
            
 
 
 
 
 
 
 
 
Table 2- Summary of data reduction and refinement statistics for SHANK3 (1-348) in P41212 
and P212121 . Rmerge = hkl[ i Ihkl,i - <Ihkl> ]/ hkl,i<Ihkl>, where Ihkl,i is the intensity of an 
individual measurement of the reflection with Miller indices h, k, and l and <Ihkl> is the mean 
intensity of that reflection. R =Σhkl ||Fo (h, k, l)| - |Fc (h, k, l)||/ Σhkl |Fo (h, k, l)|. Rfree is 
defined as R calculated on a random 5 % non-refined data. 
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5.3 - The Crystal structure of the SHANK N-terminus The crystal structure of 
the SHANK N-terminus reveals a new multi-domain (UBL-ankyrin domain) domain 
arrangement. In P41212 there is a solvent content of 68.7% and one chain in the 
asymmetric unit, and in P212121 (38% solvent content) (2.9Å) there are two chains related 
by a 2 fold non-crystallographic axis (figure 8). In both crystal structures only the C-terminal 
two residues are unresolved.  
The novelty of the SHANK3 N-terminus lay in the new compact multi-domain arrangement 
of UBL and ankyrin domain.  This arrangement sees a newly identified UBL (Ubiquitin-like) 
fold orientated towards the face of an ankyrin repeat domain (from this point referred to 
as the SPN domain, as consistent with Mameza et al (2013)). To date there are no ankyrin 
repeats that contain this modular arrangement. This domain is located within the SPN (1-
92) region described by (Mameza et al., 2013) and positions itself above the N-terminus of 
the ankyrin domain. 
Figure 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Ribbon representation of the SHANK3 N-terminus to 2.17Å angstrom. The N-terminal SPN domain 
connects through a flexible linker to the seven-ankyrin repeat sequences. SHANK3 is spectrum coloured from 
N to C terminus (red to magneta). 
β1 
β2 
α1 
β3 
β4 
β5 
144 | P a g e  
 
 
Figure 8 
 
 
 
 
 
Figure 8 - The SHANK3 ankyrin repeat region A) Crystal structure of SHANK3 in P212121 related by 2-fold 
symmetry axis. B) Complementary residues mediating crystal packing on both SHANK3 molecules in the 
asymmetric unit. C) SHANK3 in p212121 Graphic representation of the self-rotation function calculated using 
POLARFN and stereographic projection of sections κ=90
o 
and 180
o
. Solid line represents crystallographic 
symmetry and staggered NCS. 
180o 
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In P212121 mutual respective residues on each molecule engaging in the interface mediate 
the interaction between the adjacent chains. From one chain V345 and F305 are in a 
hydrophobic interaction mediated by Pi-Pi stacking with adjacent F305 and V345 residues 
in the second chain. The interface is further stabilised by the electrostatic interactions 
between E267 and R306 (Figure 8). 
Previous reports (Lim et al., 1999) show that SHANK3 can oligomerise. Analysis with PISA 
(Krissnel et al., 2011) revealed that although there is a substantial buried surface area 
1280Å2 at the crystallographic interface, formation of a multimeric complex in solution is 
unlikely. PISA analyses the buried surface area between proteins, searching for critical 
contacts. Analysis of protein interfaces has not revealed any specific interactions that could 
result in the formation of stable quaternary structures.  
Size exclusion chromatography is consistent with a globular monomeric structure with an 
elution volume consistent with a protein of 40kDa.  It may be the case that there is a 
degree of contact between SHANK3 ankyrin domains, but this would be a relatively weak 
interaction non-resolvable by gel filtration. SHANK3 oligomerises via its SAM domain; it 
may be that the contacts between ankyrin repeats could potentially contribute to 
dimerisation via packing of adjacent macromolecules. It may also be the case that the 
P212121 dimer is a result of crystal packing and non-existent. 
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5.3.1 - The SPN-Ankyrin domain interface The SPN domain is located at the N-
terminus of the ankyrin repeat domain. From here it positions itself above the N-terminal 
region of the ankyrin domain thus potentially masking this region. Because of this 
positioning there may be contacts that stabilise this positioning of the domain. If the 
hypothesis that the SPN domain is autoinhibitory to the ankyrin repeats region is valid, 
mutations may be a tool in disrupting this complex in vivo or in vitro. 
Mid-range electrostatic interactions between the SPN and ankyrin domain mediate this 
positioning. The Y98 and R96 side chains form electrostatic contacts with the carbonyl 
backbone of residues G139 and L140 (figure 9). Electrostatic interactions continue along 
the surface of the ankyrin repeat from H176, D178 and R180 (figure 9).  R180 and D178 are 
involved in electrostatic interactions that form ion pairs with the carbonyl backbone of L52 
and K94. The anchoring of the SPN domain to the ankyrin surface is a cumulative effect of 
multiple electrostatic contacts between the adjacent macromolecules connected through a 
flexible linker.  
When considering mutations to disrupt interdomain packing, this does not provide a clear 
hydrogen bond target. The cumulative effect of mid-range bond between the UBL domain 
and ankyrin may require charge reversals to repel the SPN domain.  
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Figure 9 
 
Figure 9 - The SPN region UBL domain is anchored to the ankyrin domain by mid-range (2Å-3Å) electrostatic 
contacts. A) Structure the SHANK3 SPN-ankyrin repeat domain B) Surface electrostatic contacts between the 
ankyrin domain and UBL domain. C) Electrostatic contacts in the inter-domain linker that tether to the ankyrin 
domain surface. SHANK3 is coloured from red (N) to the blue (C) terminus. 
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5.3.2- The SHANK3 ankyrin repeat domain Ankyrin repeat domains are defined 
as a 33 amino acid motif that results in the anti-parallel arrangement of helices (Hollenbeck 
et al., 2009; Sedgwick and Smeardon 1999). Current literature suggests that the SHANK3 
ankyrin repeat region is typical in respect that it contains 7 repeats. Most ankyrin repeat 
sequences contain 4-7 repeat sequences (Li el al 2006).   
The SHANK3 ankyrin domain was thus compared with existing ankyrin domains using the 
PDBefold online server (Krissinel et al., 2004). The PDBefold server scores structurally 
homologous PDB’s in order of structural similarity. The top search results from this search 
are shown in figure 10 as well as a structural based alignment and RMSD values. Top 
scoring structural homologues included Notch (RMSD 3.9Å), Drosophila notch (2.64Å), 
EuhMT1 (RMSD 3.09Å) and Bcl-3 (RMSD 3.09) ankyrin domains. The variety of functionally 
distinct homologues not only reflects the diverse function of the ankyrin repeat family, but 
its efficacy as a macromolecular scaffold and evolutionary conservation. 
 This comparison reveals that the core repeat is homologous to almost every other ankyrin 
repeat. The major differences include variations of length at either N or C-terminal repeats 
sequences.  
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Figure 10 – PDBefold search of the SHANK3 ankyrin repeat sequence with Notch (PDB-2QC9), Drosophila Notch (PDB-2F8X), EuhMT1 (PDB-3B95) and Bcl-3(PDB-1K1A). Structural based 
sequence alignment was performed using CCP4mg.  
Figure 10 
RMSD 3.29Å          RMSD 2.64 Å          RMSD 3.09Å               RMSD 3.09Å           
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5.3.3 - Structural features of the ankyrin repeat The ankyrin scaffold is an 
array of helices packed together.  Each repeat (besides the first repeat) has an N-terminal 
β-hairpin, followed by two anti-parallel alpha helices (figure 11A). These anti-parallel 
helices pack hydrophobically, stabilising the domain. As of date, there are no examples of a 
single ankyrin repeat being stable (Hollenbeck et al., 2009). 
The structural features of ankyrin domains vary, depending on their relative position in the 
overall domain. The SHANK3 N-terminal ankyrin repeat sequence is structurally distinct 
from the subsequent repeats. The N-terminal α1-helix (figure 11D) forms a truncated helix 
that connects to the SPN domain. In this region there is no β-hairpin, but rather a kinked 
helix in which threonine 112 adopts an inward facing rotamer (figure 11D). The inward 
facing rotamer of this T112 is unlikely to cause truncation merely occupying the space 
formed as a result of the helix break. The disruption of an α-helix by a side chain is 
thermodynamically unfavourable. 
The interface between the N-terminal helix (α2) and its adjacent helices (α3, α4 and α5) 
partners is hydrophobic. The core of this region contains hydrophobic moieties from F119 
(α2) and L139 (α4) (figure 11B). F119 on the α2 helix is altering the pitch of α2 with respect 
to α3.  This is different from the usual hydrophobic packing observed in the central repeats 
that are mediated by shorter hydrophobic residues such as leucines and valines (figure 
12A). The C-terminus of the ankyrin repeats contain solvent exposed residues that are 
conserved for solubility purposes. 
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Figure 11                              
Figure 11 - The SHANK3 (1-348) ankyrin repeat region is coloured from N to C-terminus (from red (N) to magenta (C)). A) Shows the β4 hairpin region. B) The hydrophobic residues that 
stabilise a central ankyrin repeat sequence. C) F119 and M120 alter the pitches of the N-terminal α2 helix. D) The inward face of T112 with accompanying 2F0-FC map in blue set to 1σ. 
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5.3.4 - Interactions of ankyrin repeat modules The ankyrin repeat scaffolds 
provide the basis of multiple interactions and mediate the recruitment of multiple cytosolic 
binding partners. SHANK3 binds SHARPIN via its ankyrin domain (Lim et al., 2001). Ankyrin 
domain interactions have a tremendous structural variety and can bind proteins on 
multiple faces (Hollenbeck et al., 2009). Thus examining close structural homologues of 
SHANK3 may give insight into a potential binding site. 
PDBefold search of the SHANK3 ankyrin repeat domain highlighted PDB 2F8X as the closest 
structural homologue.  2F8X is the ankyrin repeat from the Drosophila Notch receptor 
(Nam et al., 2006) and is in a complex with the protein suppressor of Hairless.  In this 
interaction, the β- barrel of suppressor of Hairless binds to the concave face of the Notch 
ankyrin repeat domain. The interface between domains in this structure is mediated by β-
sheet contacts with the ankyrin domain. As many UBL interactions are based on similar β-
sheet interactions (Kiel et al., 2005) both SHANK and 2F8X were structurally aligned and 
surface charge distribution examined (figure 12).  
Structural alignment shows that the SHANK ankyrin repeat domain aligns with 2F8X in its 
ligand-binding site. Surface charges are mainly non polar on the SHANK3 domain, whereas 
the corresponding region on Notch has mixed charges, making this site ideal for 
electrostatic interactions. Many other ankyrin repeat domain interactions are charge-
mediated (Hollenbeck et al., 2009).  Thus the surface charges on all the ankyrin domain 
faces were examined (figure 13). On side A (figure 13), there are a wide distribution of 
negative charges located to the posterior of the SPN domain and the ankyrin fold. The 
opposing face (B) of the ankyrin repeat (figure 13) also shares this distribution of charges. 
Surfaces C and D (figure 13) reveal that the concave face and the opposing face are largely 
hydrophobic.  If one was to speculate, then faces A and B of SHANK3 would be the most 
likely to engage another protein, as in 2F8X the highly charged face of the repeat maybe 
the SHARPIN binding site. 
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Figure 12 
                               
Figure 12- Surface charge representation of ankyrin domain complexes. PDBefold search identifies PDB-2F8X as the closest structural homologue of the SHANK3 N-terminal domain; and 
surface charge representation of the proteins reveals charge distribution of the 2F8X binding site, and the corresponding site on the SHANK3 N-terminus. Domains were aligned using 
CCP4mg. Surface charges show positive charges (blue) negative charges (red) and non-charged (white). 
Concave face 
Convex 
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Figure 13 
 
     
 
 
 
 
 
 
 
 
   
               
 
Figure 13 – Surface charge representation of the 4-faces of SHANK3 (1-348). Sides are labelled A, B, C and D and their orientations are shown with adjacent cartoon representation in 
panel. Surface charges show positive charges blue, negative charges red and non-charged in white. 
SPN domain 
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5.3.5 - Pathogenic mutations of the SHANK3 ankyrin domain  The primary 
focus of research surrounding SHANK3 has until now involved a comprehensive cataloguing 
of mutations that are associated with the pathogenesis of autism spectrum disorders. 
Many of these mutations are predicted to be part of the ankyrin repeat domain. The 
hypothesised result of these mutations is correlated with mis-folding events or truncations 
resulting in loss of function (Mameza et al., 2013).  
Gauthier et al (2009) identified two mutations that are relevant to pathogenesis of ASD’s. 
These are two threonine mutations in positions A223 and I245. It can be hypothesised that 
the hydroxyl group on the threonine side chains would destabilise the ankyrin fold.  
However, the relevance of these mutations is somewhat unclear, as this study was 
performed by analysing human genomes. In the rat form of SHANK3 I245T is natural and 
does not affect protein folding (figure 14). Given the nature of the repeat sequence it is 
unlikely the A223T would disrupt helical packing either (as I245 and A223 are in analogous 
positions).  
Durand et al., (2012) identified multiple de novo mutations in the ankyrin repeat sequence 
that have effects upon actin regulation and spine induction morphology. These mutations 
are R300C and Q321R. The R300C mutation could induce aberrant folding of the C-terminal 
repeat. The wild-type sequence is 298CAR300 and introduction of an additional cysteine 
residue could result in aberrant disulphide bond formation. Durand et al (2012) argue that 
Q321R results in actin accumulation in vivo, yet the residue is solvent exposed and 
switching to an arginine is unlikely to result in mis-folding in this position. Furthermore the 
actin regulatory region of SHANK3 is in the C-terminal proline-rich sequence that regulates 
actin through cortactin interactions. Therefore it is unlikely that this mutation has direct 
effects of actin polymerisation.  
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Figure 14 
 
                                           
Figure 14 – Location of pathological de novo mutations are mapped on to the structure of the SHANK3 ankyrin repeat region (coloured from green (N) to blue (C)). SHANK3 mutations have 
been referenced from Durand et al (2012) and Gauthier et al  (2009). Corresponding regions of the SHANK3 ankyrin repeat have been highlighted and zoomed upon.  
157 | P a g e  
 
5.4 - Structural features of the SPN domain   The structure of the SHANK-SPN 
domain is a typical β-grasp fold consistent with the ubiquitin super-family.  The SPN domain 
has associated mutations resulting in either deficient recruitment to the PSD  (Durand et 
al., 2007) or mis-folding events associated with ASD’s (Gauthier et al., 2009).  Analysis of 
the SPN domain shows the hydrophobic core of the fold is stabilised by multiple 
interactions between leucines and valines located on the inner face of the α1, β4 and β1 
strands (figure 15).  The hydrophobic residues stabilise the core fold of the protein, and any 
disruption of this core would destabilise the domain. Leucine 68 is conserved in SHANK3 
across all species and the structure shows L68 position as part of the hydrophobic interface 
that stabilises the fold.  Mutation of this residue to proline would result in mis-folding of 
the SPN domain. 
Figure 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 - Crystal structure of the SPN domain (spectrum colours). Zoom shows the hydrophobic core of 
the SPN domain, the 2F0-FC map in blue mesh is superimposed at 1σ and shows electron density of L68. 
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 5.4.1 - SPN comparison with ubiquitin The β-grasp fold of ubiquitin is highly 
conserved yet highly diverse. UBL folds have been implicated in cellular events ranging 
from sulphur transport, adaptor protein function and even the covalent modification of 
side chains (Burrough et al., 2012). Structure based alignment with the crystal structure of 
ubiquitin (PDB-1UBQ) reveals a number of similarities and differences with the SPN domain 
(figure 16). Although divergent in sequence, the UBL fold is remarkably structurally 
conserved (Kiel et al., 2005) shown by the backbone RMSD value of 1.6Å between the SPN 
domain and ubiquitin. The similarity is more remarkable when we consider the SPN domain 
is 18 residues larger than ubiquitin. This increase in length is reflected in the linkers 
between the β4 and β5 strands that are larger in the SPN domain (figure 16), and the linker 
between the β3 and β4 strands. The β2 strand in the SPN domain is reduced in length at 
the N-terminus and this may have some functional relevance in intermolecular interaction. 
The ubiquitin family shares a number of functional features that facilitate linkage and the 
hydrophobic packing of adjacent ubiquitin molecules for degradation signalling (Komander 
and Rape 2012). Ubiquitin substrate recognition is mediated by mainly two conserved 
epitopes the Ile36 and Ile44 patches (Komander and Rape 2012). These regions are 
highlighted on figure 17, and within the SPN domain these regions are not conserved.  
Comparison of the SPN domain with the established Rap1 effector C-Raf1 (Nassar et al., 
1995) shows that the SPN domain contains the functional epitope that confers Ras/Rap1 
binding specificity (Kiel et al., 2005). This epitope corresponds to residues R12, K22 and R25 
on the SPN domain. These share structural homology with R39, 47 and 73 on the surface of 
C-Raf1.Classically, Ras Association (RA)/Ras binding domains (RBD) share positively charged 
interfaces that are complementary to the negatively charged β-strand regions of GTPases 
(Nassar et al., 1997; Kiel et al., 2005). Complementary charges on the β1β2 strands stabilise 
an intermolecular β-sheet between the adjacent proteins.  
The Phyre2 (Kelley et al., 2007) online server identified the talin F0 sub-domain as the 
closest structural homologue of the SPN domain. Goult et al (2010) showed that the F0 
domain of talin has a Kd= 150 μM for Rap1A; figure 18 shows the RA domain epitope of 
talin F0. The surface charge distribution of F0 is more negatively charged than the SPN. 
However there are two lysines (K7, K15) that may contribute to the affinity (these occupy 
analogous positions of R12 and K22 on SPN). Given this charge distribution, and the fact 
that the SPN charge distribution has higher similarity to C-Raf1 than F0, one would expect 
the Kd of a Rap1A-SPN domain interaction to be greater than a Rap1A-F0 interaction. 
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Figure 16 
 
 
 
 
Figure 16 – Structural comparison of the SPN domain (blend of colours) with Ubiquitin (Cyan 
(1UBQ)) with structural differences highlighted and shown in boxes. The linker between the α2 and 
β5 is longer in SHANK3 than ubiquitin, as is the loop between the β3 and β4 stranges. The pitch of 
the β2 strand differs between ubiquitin and SHANK3. 
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Figure 17 
 
 
 
 
Figure 17 – Comparison of SPN domain with ubiquitin and the C-Raf1 RA domain. On Ubiquitin the 
functionally conserved patches are highlighted with surfaces. On Ras association (RA) domains these 
regions contain positively charged residues that engage the negatively charged binding site on the target 
GTPase. PDB codes accompany diagrams. 
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Figure 18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 – Comparison of high and low affinity Ras-effectors. Structural alignment using CCP4mg 
reveals the talin-F0 RA domain epitope, and residues are highlighted in blue. Surface charge 
representation of the Ras effectors generated using CCP4mg. Positive charges are shown in blue, 
negative charges are shown in red, non-charged in white. Talin-F0 PDB-2KC1, C-Raf1 PDB-1C1Y and 
the SHANK-SPN domain. 
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5.4.2 - Rap1A forms a high affinity complex with SHANK3  
      5.4.2.1 - Expression and purification of Rap1A As the SHANK3 SPN 
domain may well be an RA (Ras association) domain binding to a GTPase needs to 
established. As Rap1A has regulatory functions at the PSD (Spilker et al., 2008; Caron et al., 
2002) it may provide a functionally significant candidate for interactions with SHANK3. 
Rap1A was expressed in C6K600 cells and purified using anion affinity chromatography in 
the presence of 3mM MgCl2 (as previously described by Van den Berghe 1997). Protein was 
then subsequently purified by gel filtration using a Superdex 75 26/60 column in 20mM Tris 
pH 7.4, 150mM NaCl, 3mM DTT, 5mM MgCl2. Purification was performed in the presence of 
Mg2+ to prevent conversion to apo form; the yield was 5mg/litre in 2YT culture. 
GTPase samples are required to be homogonous and saturated in active (GTP or GMPnP) 
form or inactive (GDP). GMPnP is preferred as it is a non-hydrolysable analogue of GTP, 
inducing the same conformational change but with no hydrolysis to GDP.  To perform the 
nucleotide exchange from the mixed (GDP and GTP bound) state post purification (verified 
by 1D proton spectrum), Rap1A was exchanged into 20mM MES pH 6.5, 50mM NaCl, 2mM 
DTT. From this stock the buffer was made 5mM EDTA from a 0.5M EDTA 
(Ethylenediaminetetraacetic acid) stock. GMPnP (or GDP) was then added in a 20 molar 
excess of the protein concentration in solution determined by Bradford assay. After this, 
the buffer was exchanged back into 20mM Tris pH 7.4, 150mM NaCl, 3mM DTT containing 
no magnesium, this will remove EDTA chelated Mg2+ from the protein. After this the buffer 
was made 3mM MgCl2 to maintain the integrity of the holo-form of the protein.  
1H proton 
spectrum was used to confirm the state of the enzyme. Figure 19 shows the characteristic 
methyl resonance shifts of the GDP and GMPnP form, the success of the GTP exchange can 
be judged by comparison of the spectra shown in Figure 19. 
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Figure 19 
                  
 
 
 
Figure 19 shows a comparison of NMR spectra of Rap1 in GDP and GMPnP form. The 
spectra of the forms are distinctly different allowing to monitor the effectiveness of the 
exchange process. Small signals corresponding to the GDP form can be identified in the 
spectrum of GMPnP-Rap1 with the intensity of ~5% of the dominant signals of the GTP 
form (Fig 19). This corresponds to the GDP/ GMPnP ratio in the exchange mixture. This 
exchange level is sufficient for the binding experiments. If higher exchange level is required 
the exchange procedure can be repeated or larger access of GMPnP used. 
 
 
 
Figure 19 – Superposition of 
1
H spectra of 200µM GDP-Rap1A (blue) and GMPPnP (red). Sample buffer 
contains 20mM MES pH 6.5, 50mM NaCl and 2mM DTT (5mM GMPnP). Spectra were collected at 298k and 
at field strength of 600MHz. 
 
GMPnP 
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5.4.2.2 - Rap1A and SHANK3 form a high affinity complex To establish the 
binding between Rap1A and SHANK3, analytical gel filtration was used.  Rap1A elutes as a 
globular 19kDa protein on gel filtration, SHANK3 elutes as a globular 38kDa protein. When 
mixed in the same sample the two proteins co-elute. The elution volume of this peak is 
consistent with a 60kDa complex in comparison with calibration proteins. The Bradford 
assay used for determination of Rap1A concentration is inaccurate (as Bradford reactivity is 
protein dependent), thus ITC was used to calibrate the Rap1A concentration based on 
estimates from the Bradford assay. The inaccuracy of the Bradford assay is reflected in 
figure 20B where there is an excess of Rap1A-GMPnP in the presence of the complex even 
though both proteins were apparently loaded at 1:1. Note this could also be a small 
population of protein where GDP exchange is incomplete.  ITC calibration was used 
assuming a 1:1 stoichiometry where Kd can be estimated. The concentration of SHANK3 can 
be accurately determined due to the high extinction co-efficient of 27390 M-1 cm-1 . 
Therefore the stoichiometry is estimated at 0.95±0.05 sites is consistent with other Ras 
effector stoichiometries (Kiel et al., 2005), but this requires supporting evidence from SEC-
MALLS. 
 
Figure020 
 
 
 
 
 
 
 
 
 
 
Figure 20 – A) ITC binding curve of SHANK3 (12 μM) titrated with 150 (μM) of Rap1A-GMPnP Kd=265±15nm. 
ITC was performed in 20mM Tris pH 7.4, 150mM NaCl, 0.05 mM TCEP, 5mM MgCl2. Titration was performed 
in duplicate B) Analytical gel filtration of SHANK3 (150μM) with 150μM of Rap1A-GMPnP. Control were run 
at 50 μM. Gel filtration was performed on a Superdex 75/10 300GL in 20 mM Tris pH 7.4, 150mM NaCl, 
0.05M TCEP, 5mM MgCl2. 
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ITC measurement of the Rap1A-SHANK3 interaction shows unfavourable entropies (TΔS=-
7.49± kcal/mol) compensated for by enthalpy (-16.05±55 kcal/mol). This binding is 
exceptionally strong for a Ras effector interaction and well within the range of 
physiologically relevant interactions. Interestingly, comparison with Ral-GDS reveals 
thermodynamic similarities in their interactions. Both require large enthalpic contributions 
for high affinity engagement to compensate for unfavourable entropies (for a more 
extensive catalogue of Ras effector thermodynamics, Wohlgemuth et al., and (2005) is 
recommended). 
Table 2 
GTPase Ras effector     Kd ΔH (kCal/mol) ΔG(kCal/mol) TΔS (kCal/mol) 
Rap1A-GPPnP SHANK3 265±15 nm -16.05±55 -8.48 -7.59±50 
Rap1B-GTP Ral-GDS   77 nm -14.5 -9.8 -4.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 - Thermodynamic characterisation of Rap1A-SHANK3 binding. Errors are calculated from duplicate 
experiments ΔG=ΔH-TΔS. Therymodynamic parameters of Ral-GDS-Rap1B interaction were taken from 
(Wohlgemuth et al., 2005).  
166 | P a g e  
 
5.5 - Discussion and conclusion SHANK3 (1-348) is a UBL (SPN domain) fold 
followed by an ankyrin repeat sequence, the SPN domain wraps around the N-terminal 
region of the ankyrin repeat sequence. The RA domain is anchored to the ankyrin domain 
with mid-range electrostatic contacts decorated across the surface of the ankyrin domain. 
This work has identified a previously unidentified domain with implications for synaptic 
recruitment and focal adhesion regulation. 
Studies of ASD patients and pull down assays have shown that L68P is a de novo mutation 
that reveals a SHARPIN binding site (Mameza et al., 2013; Gauthier et al., 2009). Mameza et 
al (2013) demonstrated using co-immunocprecipitation experiments, that introduction of 
the L68P mutation increases relative levels of SHARPIN binding to SHANK 1-348. Combined 
with our new knowledge that the N-terminal contains a RA (Ras association) domain, this 
suggests that destabilisation of the SPN domain results in increased availability of the 
ankyrin repeat, substantiating the hypothesis of an autoinhibitory complex. 
The SHANK3 SPN domain binds to Rap1A with high affinity, second only to Ral-GDS in 
known binding affinities (Kiel et al., 2005). Durand et al (2012) showed that introduction of 
an R12C mutation within the SPN domain results in deficient dendritic morphology. As 
shown in figure 21, this residue is part of the RA domain epitope that is critical for GTPase 
association. Our data explains this observation and critically identifies Rap1A as potential 
GTPase in synaptic recruitment. 
Figure 21 
 
 
 
 
Figure 21- Ribbon representation of the SPN domain with the RA domain epitope highlighted with red 
surface. Ras effectors are characteristically positively charged and key residues are listed (Kiel et al., 
2005). 
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Associations with GTPases are sometimes promiscuous due to high sequence similarity and 
structural homology. Therefore a pertinent question still unanswered is whether Ras binds 
SHANK3; the answer will begin to elucidate the intracellular function of this SPN domain.  
Rap1A is mainly associated with adhesive processes (Caron et al., 2003; Shimonaka et al., 
2003; Wendholt et al., 2006), whereas Ras is associated predominantly with cell 
proliferation (Drosten et al., 2010). Irrespective of specificity, Ras/Rap GTPases contain a C-
terminal region associated with isoprenylation and this is responsible for membrane 
recruitment. Rap1A is membrane associated at the leading edge and this raises the 
possibility of SHANK3 potentially forming part of an integrin regulation pathway. 
 
Figure 22 
  
   
 
 
 
 
 
Rantala et al  (2011) shows that SHARPIN competes with talin and kindlins and negatively 
attenuates integrin activation by inside-out signalling. Therefore Rap1A binding may recruit 
a SHANK3-SHARPIN complex to the membrane in a parallel pathway to talin recruitment. 
This raises the possibility that Rap1A and SHARPIN may form a ternary complex with 
SHANK; this hypothesis requires examination in further work. 
 
 
Figure 22 - Proposed mechanism of SHANK3 based integrin regulation. Rap1A recruits SHANK3 to the cell 
membrane, recruiting SHARPIN in proximity to α-integrin tails. SHANK3 is shown in red. The talin FERM 
domain is shown in spectrum colours, as is Rap1A. 
168 | P a g e  
 
 
 
 
 
 
 
 
 
6 - Discussion 
 
 
 
 
 
 
 
 
 
 
 
169 | P a g e  
 
6 - Discussion   In cell migration a multitude of binding events leads to the formation 
and maturation of cell-matrix adhesions. The GTPase Rap1A induces adhesion formation 
(Shimonaka et al., 2003), and this thesis has highlighted the multiple functions of Rap1A in 
adhesion regulation. In this thesis I have shown how talin synergistically binds to the Rap1 
adaptor RIAM, and this thesis provides a model of force-induced RIAM displacement, in 
favour of talin-vinculin complexes. This thesis solves the structure of the SHANK3 N-
terminus, demonstrating the existence of an unrecognised Ras-association domain. If 
SHANK3-Rap1A binding is specific, Rap1A could also recruit SHARPIN to the nascent 
adhesion and provide a competitive integrin inactivation pathway, linking SHARPIN and 
integrin (Rantala et al., 2011). This could establish a new mode of adhesion regulation.  
DLC1 is recruited to mature focal adhesions through a central LD-like motif (Li et al., 2011). 
Here we show the structural basis of this interaction and suggest mutations to disrupt 
complex in vivo. This is the first structure of talin in a complex, and the topology of the 
complex is similar to talin 5-helix bundles. 
This thesis has two larger structural themes that are of pertinent interest and require 
further discussion. In chapter 3 we saw how RIAM engages the talin R3 sub-domain and we 
mapped this site to the α2-α3 face of R3. In chapter 4 we observed the formation of an 
R7R8-DLC1 complex. As the mechanisms of RIAM and DLC1-talin interactions are related 
then they may represent a general scheme of how talin binds to amphipathic ligands.  
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6.1 - 4-helix bundle interactions In both R3 and R8, ligand binding is isolated to 
the α2-α3 face of the helical bundle. As this binding site appears to be structurally 
conserved, both sites may share similarities of charge distribution. Figure 1 examines the 
surface charge distribution of α2-α3 faces on both bundles R3 and R8.  This analysis shows 
that R3 contains a hydrophobic groove that shares similar properties to the DLC1 binding 
site in R8. Consistent with chemical shift mapping in chapter 3, this suggests both RIAM and 
DLC1 bind to their cognate helical bundles via a similar mechanism of helix addition. 
Figure 1 
   
 
 
 
 
 
      
 
  
 
 
 
 
The data in this thesis suggests that the focal adhesion is an interchange of helical proteins 
that regulate the binding of intracellular ligands. In addition to R2R3, RIAM engages R8 and 
R11 representing a form of degeneracy. This could be functionally significant, and may 
suggest inactivation of the N-terminal RIAM binding sites in talin could be compensated for 
by C-terminal domains. The full extent and mechanism of RIAM interactions are yet to be 
elucidated and require further structural characterisation. 
Figure 1- Surface charge distribution across the ligand binding faces of R3 and R8. Blue represents positive 
charges and red represents negative charges and non-charged in white. The arrow shown represents the 
potential location of either RIAM or DLC1.  Talin representation based on existing solution structures; RIAM 
binding sites are shown in blue. 
RIAM binding sites 
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The data presented here have shown that RIAM and DLC1 amphipathic helices engage two 
of the 4-helix bundles of talin; this raises the possibility that the other talin 4-helix bundles 
may engage helical ligands in a similar way. To examine this hypothesis the surface charges 
of the 4-helix bundles are examined in figure 2, with the exception of R1R2. R1R2 is a 5+4-
helix bundle, thus the double-domain interface is restricted in terms of potential 
interactions. If we extrapolate potential interactions based on the presence of an 
uncharged hydrophobic patch we can predict potential 4-helix bundle interaction.  
On R3 there are two sites (figure 2), site 1 (the RIAM binding site) and potentially site 4 that 
contains this hydrophobic surface, on R8 there is the DLC1 binding site (site 2). R2 contains 
only 1 potential site, whereas R4 contains sites 1 and 4. The other faces of the bundles have 
a large distribution of positive and negative charges and this makes the engagement of an 
amphipathic helix unlikely. This, of course, does not rule out intermolecular interaction 
based on electrostatic contacts. An interesting recourse to this analysis is raised by the data 
from Goult et al (2013), who screened all the rod domains for RIAM interactions. In R4 
there were no interactions detected with RIAM. Thus it remains of pertinent interest if 
there are any specific interactions exhibited by these domains and their preferred ligands. 
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Figure 2 
Figure 2 – Surface charge distribution of talin 4-helix bundle R3, R4, R8 and the 5+4-helix bundle R1R2. Orientation of panel 1 is the same as adjacent ribbon diagram. Each panel represents a 
90
o
 rotation from the preceding diagram.  On the surface charge distribution blue represents positive charge, red negative charges and non-charged in white. 
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6.2 - 5-helix bundle interactions TBS1 also binds to R11 (Goult et al., 2013) and 
R11 is a 5-helix bundle, thus structurally this is slightly puzzling and suggests formation of a 
6-helix bundle. If we propose the hypothesis that like 4-helix bundles the binding is 
dependent on the availability of a hydrophobic patch, then closer examination is required 
of the talin 5-helix bundles, as potentially other amphipathic ligands could engage them.  
Surface charge analysis of all of the talin 5-helix bundles identifies multiple hydrophobic 
sites that could potentially engage hydrophobic ligands. In figure 3 then we can see the 5-
helix bundles with potential sites highlighted. The bundle R11 contains one site of potential 
interaction highlighted. Structural alignment and comparison with a pseudo-6-helix 
(exemplified by the FAK-FAT domain in complex with paxillin LD’s 2 and 4, PDB-2L6F (figure 
3)) bundle reveals the potential orientation of RIAM with respect to R11. Structural 
alignment using CCP4mg reveals that the hydrophobic site visible on figure 3 has an 
analogous binding site on FAK, and this may be the site of engagement of RIAM.  
The use of the structure 2L6F, however is rather limiting as an example. This NMR structure 
is a chimera and thus not a naturally occurring topology. However it does display a 
potential arrangement that R11 may adopt in a complex.  There are relatively few examples 
to date on the PDB of naturally occurring 6 helix bundles.  
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Figure 3 – Surface charge distribution of talin 5-helix bundles R5, R6, R7, R9, R10, R11, R12 and R13. 
Orientation of panel 1 is the same as adjacent ribbon diagram. Each panel represents a 90
o
 rotation from 
the preceding diagram. Positive charges shown in blue, negative charges in red and non-charged in white. 
 
Figure 3 
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Figure 4 
 
 
 
 
 
 
 
 
 
Figure 4- Comparison of the NMR structure of the FAK FAT domain in a psuedo-6 helix bundle with LDs 2 and 4 (PDB-2L6F). Structural super-imposition with the crystal structure of R11 
(PDB-3DYJ) shows that RIAM could occupy the α2-a3 or α1-α4 face of R11. 
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6.3 - SHANK and focal adhesions During this thesis we have shown that SHANK3 
contains an N-terminal Ras-association (RA) domain. Mutations within this domain are 
responsible for deficient membrane recruitment (Durand et al., 2012). Our data show a 
direct high affinity interaction with Rap1A that may be responsible for SHANK3-PSD 
recruitment. This data highlights a potential role in focal adhesion regulation, through 
potential Rap1A dependent membrane recruitment to the nascent adhesion. 
6.3.1 - The Rap1A-SHANK3 connection Rap1A has a wide variety of signalling 
roles some of contrast to its structural homologue Ras (Caron et al., 2003). Rap1A is 
activated downstream of RapGEFs (Guanine nucleotide Exchange Factor), and the GEFS are 
specific to cell surface receptors and physiological context. Figure 5 shows the diversity of 
extracellular triggers to Rap1A signalling, thus the specific role of SHANK3-Rap1 binding 
may be downstream of multiple potential pathways. 
Figure 5 
                                  
 
 
  
 
 
 
Figure 5 – Cell surface receptors and GTPases coupled to the activation of Rap1-GEF, and an increase in the 
cellular levels of Rap1A-GTP, PDGF (Platelet-Derived Growth Factor), TNFa (Tumor Necrosis Factor α), NMDA (N-
methyl- D-aspartate) receptors (Diagram based on Caron et al., 2003). 
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A pertinent direction of the future work will be the elucidation of potential biological role 
of the binding to Ras. Ras interactions are traditionally associated with cellular proliferation 
(Drosten et al., 2010). Thus if the RA domain is promiscuous there may be two potential 
intracellular roles. Either SHANK3 may be recruited as a downstream effector of EGF 
(Epidermal Growth Factor) related pathways, or recruited to the leading edge, and inhibit 
the formation of nascent adhesions regulating SHARPIN-integrin binding. 
6.3.2 - SHARPIN regulation in NF-κB SHARPIN also has a pivotal role in the 
regulation of NF-κB signalling. Mutations in SHARPIN are pathological in mice, and induce 
immune system disorders (Ikeda et al., 2011; Grabbe et al., 2009). SHARPIN forms part of 
the LUBAC (Linear Ubiquitin Chain Assembly Complex) with proteins HOIP (HOIL-1-
interacting protein) and HOIL-1 (Heme-oxidised IRP2 ligase 1). Together these proteins 
mediate ubiquitination of the NF-κB regulatory protein NEMO (NF-κB essential modulator). 
NEMO forms part of the canonical NF-κB IKK (IκB kinase) complex, ubiquitination of NEMO 
induces the phosphorylation and subsequent degradation of the IκB regulatory sub-unit of 
the NF-κB complex (consisting of p50, p65 and IκB). NEMO is in proximity to the cytosolic 
region of the TNFα (Tumour necrosis factor) receptor upon linear ubiquitination (Tokunaga 
et al., 2013). Lim et al (2001) shows that the central UBL fold of SHARPIN engages the 
ankyrin domain; thus SHANK3 could sequester SHARPIN at the cell membrane (in a GTPase 
dependent manner) providing localisation for eventual ubiquitination function. 
6.3.3 - The multiple roles of Rap1A Rap1A is activated in response to intracellular 
cAMP increases via the GEF-EPAC (Exchange Protein Activated by cAMP) (Tsygankova et al., 
2001). Rap1A is largely membrane associated, but can be localised to the mid-golgi and late 
endocytic vesicles (Beranger et al., 1991; Pizon et al., 1994). This may partially explain its 
susceptibility to the second messenger cAMP. Rap1A is predominantly associated with 
adhesive functions and T-cell receptor signalling, thus strongly linking SHANK3 with a 
potential role in adhesion regulation. Activity at the postsynaptic density is negatively 
attenuated by the neuronal RapGAP-Spa1; this raises the possibility of a direct neuronal 
signalling axis though Rap1A, and a potential role in the pathogenesis of autism-spectrum 
disorders through Ras/Rap (Spilker et al., 2008). If a high affinity SHANK3-Ras interaction is 
confirmed; this would provide a direct path to cellular proliferation and potentially the 
accelerated brain growth associated with autism-spectrum disorders. 
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The most prominent role of Rap1A in recent years has been its role in focal adhesion 
regulation. The work in this thesis confirms that its effector (RIAM) does indeed recruit talin 
as previously demonstrated in vivo. Though given RIAM recruitment is more dependent on 
lipid composition of the cell membrane (PIP2) than its RA domain (Wynne et al., 2012). It 
may be the case that the RIAM RA domain could be out-competed by higher affinity Rap1A 
partners at the nascent adhesion (namely SHANK3). This further highlights the function of 
the second messenger PIP2 in regulating the spacial distribution and activity of RIAM, as 
well as being responsible for talin regulation (Wynne et al., 2012; Martel et al., 2001). 
6.4 - Conclusion and perspectives The focal adhesion is one of the most 
important and dynamic systems posing challenges to molecular biology and biophysics. 
This thesis has biochemically-characterised interactions between talin-RIAM and vinculin. 
The integrin activation question has been central to focal adhesion research for the past 
decade and now initiation and maturation is better understood some, of the more 
challenging question remaining0are0associated0with0disassembly. This work has dealt 
with the interplay and regulation of the focal adhesion initiation complex and answered the 
questions this work sought to answer when set upon. One of the highlights of this thesis 
has been the elucidation of the crystal structure of the SHANK3 N-terminal domain and 
recognising it as a true Ras-effector, with far reaching implications for focal adhesion and 
postsynaptic density protein regulation. This work has used structural biology techniques to 
characterise intermolecular interactions on the atomic level. No other techniques provide 
the detailed information on protein-protein interactions. Recent advances in bioinformatics 
based on deposited structures provide a powerful tool for prediction. However these 
cannot replace the requirement for structural characterisation, and only through structural 
characterisation can novelty be recognised. 
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